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Introduction  
 
 
The interplay between host and microbes has fascinated many scientists and has led to the 
discovery of vaccination and antibiotics, both crucial in the history of mankind. When Robert 
Koch (1843-1910), Louis Pasteur (1822-1895) and Ferdinand J. Cohn (1828 –1898) defined 
the fundaments for microbiology, Ilya I. Metchnikov (1845-1918) laid a solid fundament for 
immunology by the discovery of phagocytosis by specialized mobile immune cells he named 
phagocytes. Phagocytes have an inherited capability to protect the host against invading 
microorganisms, and this is called the innate immune response. How the phagocytes could 
recognize pathogens has been a riddle for almost a century.   
A conceptual and visionary breakthrough was proposed by Charles A. Janeway, Jr. (1943-
2003) twenty years ago, when he proposed that cells of the innate immune system should 
possess receptors for recognition of structures unique for pathogens, in order to 
discriminate between self and non-self. He termed these receptors pattern recognition 
receptors (PRRs). It was however not until 1996 when Jules A. Hoffmann and his colleagues 
identified Drosophila Toll molecule as an essential receptor on the surface of the 
haematocyte, mediating immunity to fungal infection, which it achieved by the activation of 
the synthesis of antimicrobial peptides 1. One year later, the first homologues of Toll were 
found in humans and named Toll-like receptors (TLRs). Ligation of these receptors leads to 
secretion of cytokines and activation of the antimicrobial host defense 2,3.  
During the past decade, several classes of PRRs have been identified in addition to TLRs, 
among which C-type lectins, Nod-like receptors, and RigI-helicases. Intense research efforts 
have identified the ligands for most of them (Fig 1). Insight into the signal pathways 
activated by the engagement of these receptors and the secretion of cytokines by cells of 
the innate immune system soon identified modulatory effects of PRR activation on the 
adaptive immune responses, and led to the concept of a ‘bridge’ between innate and 
adaptive immune system (Fig 2) 2,4. One of the most important questions raised, however, 
was how apparently a ‘few’ receptors could induce specific immune responses against a 
legion of pathogens. Because pathogens express a series of ligands that can be recognized by 
different PRRs, it is the simultaneous activation of certain PRR combinations by each 
invading pathogen that is now believed to bring specificity to the immune response against 
pathogens 5. The cross-talk between these pathways leads to stimulation or inhibition of 
immunological responses, and is crucial for the outcome of an infection. 
 
Because the innate immune system is known to play an important role in infectious, 
autoimmune and autoinflammatory diseases, insight into the activation of the innate 
immune response leads to understanding the pathophysiological mechanisms of these 
diseases and eventually to development of new therapeutic strategies. Indeed, genetic 
mutations in genes coding for PRRs are linked to several diseases. Mutations in the Nod-like 
receptors (NLRs) genes are generally associated with autoinflammatory disease. 
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Figure 1. Pattern recognition receptors and their ligands. There are four different classes of 
pattern recognition receptors known:  Toll-like receptors  expressed on the cell surface (A) and 
expressed in the phagosome (B) containing a recognition domain of leucine rich repeats and a 
TLR/IL-1 receptor (TIR) domain; C-type lectin receptors expressed on the cell surface and in the 
phagosome (C) bearing a common carbohydrate recognition domain; Nod-like receptors 
expressed in the cytosol (D) containing a nucleotide oligomerization domain and mostly a leucine 
rich recognition domain; and RigI helicases (E) with a helicase domain and  a C-terminal 
repression domain. 
 
Recently, mutations in NALP3 have been shown to be the cause of Muckle-Wells syndrome 
and Familial Cold Urticaria 6, while mutations in Nod2 are associated with Crohn’s disease 
and Blau syndrome 7-9. In infectious disease, polymorphisms in PRR genes have been linked 
to a higher susceptibility for specific pathogens, e.g. polymorphisms in TLR4 have been 
linked to Gram-negative sepsis 10, malaria 11, Candida infections 12 and Aspergillus fumigatus 
infection 13, TLR2 polymorphisms to increased susceptibility to mycobacterial infections 14, 
while TLR5 have been linked to Legionella pneumonia 15. Total deficiency of the TLR 
pathways in patients with defects in MyD88 or IRAK4 leads to severe infections with 
streptococci, staphylococci or Pseudomonas, with 30% of the patients succumbing to 
infection before they reach 20 years of age 16,17. 
 
 
Outline of the thesis 
 
The aim of this thesis is to study the interaction between the signaling pathways of different 
classes of pattern recognition receptors (PRRs), in order to understand the mechanisms 
through which initial recognition of microbial ligands lead to a fully developed innate 
immune response. To achieve this aim, we will use production of cytokines as read-out for 
the activated signal pathways, as cytokines both activate innate host defense and modulate 
adaptive immunity. 
 
In the first part of the thesis, I will focus on the recognition pathways of Candida albicans, 
the most important human fungal pathogen with an important morbidity and mortality 
burden on the society. C. albicans is currently the fourth most common microorganism in 
patients with blood stream infection in the USA 18, and the mortality in patients with 
disseminated candidiasis is still 30 to 40%, despite the availability of new antifungal drugs 19. 
In addition, vulvovaginal candidiasis (VVC) causes major morbidity, with 5% of women 
suffering from recurrent VVC. We and others have previously shown that TLRs and CLRs are 
the two most important classes of receptors involved in C. albicans recognition, but little is 
known regarding the cross-talk between these receptors during fungal recognition. We will 
focus on the interaction between TLR2, TLR4 and dectin-1, as they are known to recognize C. 
albicans, their ligands have been identified, and their signal pathways have been well 
studied. These three receptors are also known to be important in the host defense against 
Candida and they may be relevant in the development of future new therapeutic strategies.  
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Figure 2. Pattern recognition receptors regulate adaptive immune responses. Dendritic cells and 
macrophages (antigen presenting cells (APC)), neutrophils and natural killer cells are the major 
innate immune cells, whereas the adaptive immune cells consist of B-cells and T-cells. Pattern 
recognition receptors are abundantly expressed on APCs. When microbial ligands bind to PRRs, 
signal pathways are activated and cytokines secreted. After phagocytosis, the microbes are 
degraded in the phagolysosome and presented on the MHCII. During this stage, also the 
intracellular PRRs signal pathways are also activated. Expression of costimulatory molecules on 
the membrane of the antigen presenting cell is induced by PRR ligation. The antigen/MHCII 
complex and costimulatory molecules on the APC will lead to activation of the T-cell receptor and 
proliferation of the naïve T-cell. The cytokines produced by the APCs are crucial and determine 
the differentiation of the Thelper cell. 
 
How do immune cells respond when two classes of PRRs are stimulated simultaneously? This 
question is studied in Chapter 2 by using specific ligands for TLR2, TLR4 and dectin-1. In 
Chapter 3, the nature of the interaction between these receptors will be further investigated 
in an in-vitro model, in order to obtain more insight in the amplification mechanism at the 
level of the intracellular signal pathways of both classes of PRRs. The dectin-1 signal pathway 
is activated by β-glucan, a major cell wall component of Candida albicans, and induces the 
production of cytokines by macrophages. In Chapter 4 we will further investigate the effects 
exerted by activation of this pathway by using a novel screening approach to identify 
membrane-bound molecules regulated by dectin-1. 
 
The role of dectin-1 and its interaction with TLRs in the pathogenesis of fungal disease is 
illustrated by the identification of a single nucleotide polymorphism (SNP) in the dectin-1 
gene, leading to defective function of the protein, with important consequences for 
recognition of beta-glucans. In Chapter 5, we explore the cellular responses of cells isolated 
from individuals homozygous for this SNP, and describe the clinical phenotype of these 
patients.  
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In Chapter 6, we will summarize the current knowledge on the interaction between TLR and 
CLRs in Candida albicans infections, and place these findings into the perspective of the 
development of new therapeutic strategies, such as vaccination, against Candida albicans. 
  
The second part of this thesis will investigate the cross-talk between TLRs and Nod2, a 
member of the Nod-like receptor (NLR) class of recognition receptors that have been 
implicated in the immune responses during both autoimmune (e.g. Crohn’s disease) and 
infectious diseases. Crohn’s disease is a chronic granulomatous inflammation of the gut, and 
mutations in the Nod2 gene have been associated with a high incidence of this disease 7,8. In 
addition, Nod2 is an intracellular receptor of bacterial peptidoglycans, and thereby might 
also play a role in the defence against intracellular pathogens. The cross-talk between TLRs 
and Nod2 will be investigated in primary mononuclear cells isolated from patients with 
Crohn’s disease bearing a mutation in the Nod2 gene, which leads to unresponsiveness to 
stimulation with the peptidoglycan component muramyl dipeptide (MDP). In Chapter 7, 
primary human mononuclear cells are stimulated with TLR and Nod2 ligands in order to 
assess the nature of interaction between these two classes of PRRs. Transcriptional and 
post-transcriptional mechanisms involved in this interaction are presented in Chapter 8. 
 
In Chapter 9 and 10, we will assess the role of Nod2 as a receptor for mycobacteria, and we 
will illustrate the consequences of mutations in the Nod2 gene for the innate immune 
response against Mycobacterium tuberculosis and Mycobacterium paratuberculosis. The 
cross-talk between TLRs and Nod2 for the host defence mechanisms to mycobacteria will be 
highlighted.  
 
In the previous chapters we have investigated the simultaneous stimulation of PRRs as 
model for invading microorganisms. Because the innate immune cells of the gut are 
continuously exposed to commensal intestinal microorganisms, suppression of the immune 
response of the host is desirable. This phenomenon is called tolerance and is thought to be 
exerted by long-lasting stimulation of pattern recognition receptors by gut commensal flora 
and downregulation of PRR-signal pathways 20. When the innate immune system is 
continuously stimulated by PRR ligands, this might lead to autoinflammatory diseases. In 
Chapter 11, we will use phased stimulation of primary mononuclear cells isolated from 
patients with mutations in the Nod2 gene, in order to study the cross-talk between TLRs and 
Nod2 as a model for continuous stimulation of PRR and induction of tolerance.  
 
The interaction between Nod2 and its ligand muramyl dipeptide (MDP) seems to play an 
important role in the pathogenesis of Crohn’s disease. In the previous chapters we 
investigated the modulatory effect of Nod2 ligation of MDP by Nod2 on TLR signal pathways, 
but what is the immunomodulatory effect of other muramyl peptides? In Chapter 12, we will 
use various muramyl peptides to stimulate primary cells in combination with TLR ligands to 
answer this question. Among these compounds are specific ligands for Nod1, a member of 
the NLR family closely related to Nod2, which will give us the opportunity to obtain more 
insight into the common and specific activated signalling pathways by both PRRs. 
A summary of our findings and conclusions of the thesis are presented in Chapter 13. 
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Abstract 
  
 
The β-glucan receptor dectin-1 and Toll-like receptors TLR2 and TLR4 are the main receptors 
for recognition of Candida albicans by the innate immune system. It has been reported that 
dectin-1 amplifies TLR2-dependent induction of cytokines in mouse models. In the present 
study we hypothesized that dectin-1 has potent synergistic effects with both TLR2 and TLR4 
in human PBMCs and macrophages. Human PBMCs and monocyte-derived macrophages 
were stimulated with curdlan, a linear β-1,3-glucan-polymer derived from Alcaligenes 
faecalis with specific ligand affinity for dectin-1, in combination with the synthetic TLR2 
ligand Pam3Cys and the ultrapure TLR4 ligand LPS. TNFα and IL-10 production was measured 
in the supernatants with ELISA. Curdlan is a specific dectin-1 ligand without TLR2- or TLR4-
stimulating properties. Human primary monocytes and macrophages express dectin-1 on the 
cell membrane. Stimulation of human PBMCs with curdlan in combination with Pam3Cys or 
LPS leads to synergistic increase in TNFα production that was inhibited by GE2, a neutralizing 
dectin-1 antibody. Dectin-1-dependent synergy between curdlan and TLR agonists was also 
apparent in human monocyte-derived macrophages. Conclusively, dectin-1 synergizes with 
both TLR2 and TLR4 pathways for the production of TNFα in human primary PBMCs and in 
monocyte-derived macrophages. 
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Introduction 
 
 
Candida albicans forms part of the commensal microbial flora of humans. However, in some 
cases C. albicans encounter can lead to inflammation and infection of mucosal surfaces 
(mucocutaneous candidiasis), or even to invasion of tissues or bloodstream (disseminated 
candidiasis), especially in the immunocompromised host. Despite the availability of effective 
novel antifungal therapies, bloodstream infections with C. albicans are still responsible for a 
high mortality up to 40% 1. 
 
Cells involved in first line defense against C. albicans, like neutrophils, monocytes and 
macrophages, are important for activation and regulation of innate immune responses. 
These cells express pattern-recognition receptors (PRRs) on their cell membrane, which 
recognize pathogen-associated molecular patterns (PAMPs) on the surface of 
microorganisms. PRR engagement leads to induction of cytokine, chemokine and 
antimicrobial peptide production, activation of oxygen radical release and eventually 
elimination of the invading pathogen 2. The best known and characterized classes of PRRs 
are the Toll-like receptors (TLRs) 3 and C-type lectin receptors (CLRs) 4,5. Both are involved in 
recognition of C. albicans 6-8 and bind to different structures of the fungal surface. The outer 
layer of the C. albicans cell wall is enriched with mannoproteins. TLR2 recognizes 
phospholipomannan 9, while TLR4 binds to O-linked mannosyl residues 10. N-linked mannosyl 
residues are detected by a CLR, the macrophage mannose receptor (MR) 11. The inner layer 
of C. albicans consists of β-glucans, which are recognized by another CLR, dectin-1 12-15. Each 
of these receptors induces specific responses after exposure to C. albicans. Their importance 
in the antifungal host defense is underlined by a higher susceptibility for C. albicans 
infections in dectin-1- and TLR4-deficient mice 16,17 and a higher resistance against C. 
albicans in TLR2-deficient mice 18. TLR2 stimulation with C. albicans induces mainly an anti-
inflammatory cytokine profile 19 and affects regulatory T-cell function 20, whereas 
stimulation of TLR4 leads to a pro-inflammatory cytokine response 21. Interestingly, it has 
been shown that CLRs and TLRs can interact with each other: in murine macrophages and 
dendritic cells the β-glucan receptor dectin-1 amplifies TLR2-mediated cytokine release 22,23. 
A picture emerges in which cross-talk of TLRs and CLRs leads to a specific innate immune 
response against C. albicans 24,25. 
 
To get more insight into the interactions of PRRs involved in recognizing C. albicans, we 
developed an in vitro model in which human PBMCs and monocyte-derived macrophages 
were stimulated with pure receptor ligands. We hypothesized that in addition to its 
synergistic effects on TLR2-mediated signaling, dectin-1 may also amplify the effects of TLR4 
triggering. The data regarding TLR/CLR interactions reported in literature until now have 
been obtained mainly with cell lines or mouse macrophages. Our results demonstrate that in 
human primary monocytes and macrophages dectin-1 synergizes with both TLR2 and TLR4. 
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Results 
 
   
Dectin-1, TLR2 and TLR4 mediate C. albicans-induced cytokine production by human PBMCs 
 
To examine the contribution of dectin-1 and TLRs in C. albicans-induced cytokine production, 
we stimulated human PBMCs with heat-killed C. albicans and inhibited different receptors 
involved in C. albicans recognition (Fig. 1). Inhibition of TLR2 with a blocking antibody 
resulted in a reduction of 55 ± 10% in TNFα secretion. When TLR4 was inhibited, TNFα 
production was decreased by 26 ± 21%. Dectin-1 inhibition with glucan phosphate inhibited 
TNFα production by 80 ± 11%. The cumulative reduction in TNFα production adding up to 
more than 100% when inhibiting dectin-1 and TLR2/4 could possibly be explained by the 
presence of synergistic effects between these receptors. In case of inhibition of one 
pathway, both the specific effects of that pathway and the synergistic action on other 
receptors will be lost. 
 
 
 
Figure 1. Cytokine induction by heat-killed C. albicans in mononuclear cells is mediated by 
different classes of receptors. Human PBMCs of five healthy volunteers were incubated with 1 × 
106 heat-killed (HK) C. albicans after 1 h pre-incubation with anti-TLR2 (10 μg ml−1), isotype-
control (10 μg ml−1), TLR4 antagonist (100 ng ml−1) or glucan phosphate (100 μg ml−1). After 24 h 
incubation at 37°C, TNFα was measured by ELISA in the supernatant. Data are presented as 
percentage of control (medium stimulated or isotype control) ± SD. 
 
Curdlan is a pure dectin-1 agonist and induces TNFα production in human PBMCs and 
macrophages 
 
Candida albicans contains dectin-1, TLR2 and TLR4 ligands. To further study the interaction 
between TLRs and dectin-1, human PBMCs and macrophages were incubated with pure 
receptor ligands. First, expression of dectin-1 by these human cell populations was 
determined. FACS analysis showed that monocytes in PBMCs are the dominant cell 
population expressing dectin-1, and that monocyte-derived macrophages in addition to the 
MR also have dectin-1 on their cell surface (Fig. 2A and B). 
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Figure 2. Human monocytes and macrophages express dectin-1 on their cell surface. Human 
PBMCs were labeled with goat anti-dectin-1 (grey shaded area) or matched isotype control (thin 
line) and fluorochrome-conjugated secondary antibodies and analyzed by FACS. Gates were set 
on lymphocyte and monocyte populations according to forward/sideward scatter characteristics. 
Among the PBMCs only monocytes express dectin-1. There is no expression detectable on the 
lymphocyte population. Data are representative of three different donors (A). Human monocytes 
and monocyte-derived macrophages were stained with anti-CD14, anti-Mannose receptor (MR) 
anti-dectin-1 (grey shaded area) or matched isotype control (thin line) antibodies and 
fluorochrome-conjugated secondary antibodies and analyzed by FACS. In contrast to monocytes, 
macrophages express MR. Both cell populations are CD14 positive and express similar levels of 
dectin-1 on their surface. Data are representative of three different donors (B). 
 
Curdlan is a linear β-1,3-glucan polymer derived from the bacterium Alcaligenes faecalis 26 
and is a known ligand for the β-glucan receptor in mice 27-29. We used HEK293 cells 
transfected with human TLR2 to determine if curdlan had any TLR activating properties. As 
shown in Fig. 3A, in contrast with zymosan, curdlan did not induce TLR2-mediated IL-8 
production in these cells. There was also no difference in TNFα production between TLR4 
wild-type and TLR4-deficient murine macrophages (data not shown), indicating that curdlan 
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is not contaminated with LPS or other TLR4 ligands. When human PBMCs were stimulated 
with curdlan, a dose-dependent induction of TNFα and to a lesser extent of IL-10 was 
observed. Human macrophages hardly produced TNFα and little IL-10 in response to dectin-
1 triggering (Fig. 3B). The differential capacity of monocytes (the dectin-1 expressing cells in 
PBMCs) and macrophages in their production of pro-inflammatory cytokines is a well-known 
phenomenon 26. 
 
 
 
Fig. 3. Curdlan is a specific dectin-1 agonist in human PBMCs and monocyte-derived macrophages. 
HEK293 cells transiently transfected with human TLR2 were incubated with zymosan (10 μg ml−1), 
Pam3Cys (1 μg ml−1) or curdlan (100 μg ml−1). After 24 h incubation at 37°C, IL-8 was measured in 
the supernatant by ELISA. Results are depicted as average of four independent experiments ± SD 
(A). Human PBMCs and monocyte-derived macrophages of four healthy volunteers were 
incubated with curdlan at concentrations of 100 or 10 μg ml−1; after 24 h incubation at 37°C, TNFα 
and IL-10 in the supernatant were measured by ELISA. Data are presented as mean ± SD (B). 
Human PBMCs and monocyte-derived macrophages of four healthy volunteers were incubated 
with curdlan (100 μg ml−1) after 1 h pre-incubation with glucanphosphate (100 μg ml−1), anti-
dectin-1 antibody GE2 (10 μg ml−1) or matching isotype control (10 μg ml−1). After 24 h incubation 
at 37°C, TNFα in the supernatant was measured by ELISA. Data are presented as percentage of 
control (medium stimulated or isotype control) ± SD (C). 
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However, this does not necessarily mean that similar effects are seen when anti-
inflammatory cytokines such as IL-10 are measured, as the regulation of the production of 
pro- versus anti-inflammatory cytokines is different. In both PBMCs and macrophages 
medium did not induce any cytokines. The curdlan-induced TNFα production in PBMCs and 
macrophages could be inhibited with specific dectin-1 inhibitors like glucan phosphate and 
the dectin-1 antibody GE2 relative to the isotype control 27 (Fig. 3C). Taken together, these 
data show that curdlan is a specific human dectin-1 agonist without TLR2- or TLR4-
stimulating properties. 
 
 
 
 
Fig. 4. Synergistic cytokine production after stimulation with curdlan and TLR agonists in human 
PBMCs is dectin-1-dependent. Human PBMCs of five healthy volunteers were stimulated with LPS 
(10 ng ml−1) or Pam3Cys (10 μg ml−1) in combination with curdlan (100 μg ml−1). Cells were pre-
incubated for 1 h with anti-dectin-1 antibody GE2 (10 μg ml−1) or isotype control (10 μg ml−1). 
After 24 h incubation at 37°C, TNFα (A and B) and IL-10 (C and D) in the supernatant were 
measured by ELISA. Data are presented as mean ± SEM and compared by Wilcoxon test (*P < 
0.05) (A and C) or as percentage of control ± SD (*P < 0.05) (B and D). 
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The synergistic cytokine production by PBMCs after stimulation with curdlan and TLR2 or 
TLR4 agonists is dectin-1-dependent 
 
To investigate the interaction of dectin-1 with TLRs, we stimulated PBMCs with a 
combination of curdlan with specific TLR agonists. When curdlan was combined with 
Pam3Cys, a synthetic TLR2 ligand, there was a 2.7 ± 0.3-fold increase in the production of 
TNFα calculated as [Pam3Cys + curdlan]/([Pam3cys] + [curdlan]) and a 4.2 ± 0.5-fold increase 
in the production of IL-10 (Fig. 4A and C). The synergistic increase in TNFα production could 
be inhibited by 53 ± 8% by blocking dectin-1 with the antibody GE2. Under the same 
experimental conditions, the synergistic IL-10 production was decreased by 38 ± 9% (Fig. 4B 
and D). When curdlan was combined with the TLR4 ligand LPS, a 3.1 ± 0.2-fold increase in 
the production of TNFα and a 3.3 ± 0.2-fold increase in the production of IL-10 were 
detected (Fig. 4A and C). This synergistic production of cytokines could be inhibited with GE2 
by 27 ± 15% for TNFα and by 18 ± 9% for IL-10 (Fig. 4B and D). 
 
In summary, these results demonstrate that synergy in cytokine production by PBMCs after 
stimulation with curdlan in combination with Pam3Cys or LPS is dectin-1-dependent. 
Interestingly, while synergistic signaling is shown for both dectin-1/TLR2 and dectin-1/TLR4, 
inhibition of dectin-1 resulted in a more pronounced inhibition of the synergy with TLR2. 
 
   
Synergy between dectin-1 and TLRs in monocyte-derived macrophages is detected for the 
pro-inflammatory cytokine TNFα 
 
Because macrophages play a crucial role in the defense against C. albicans (Ashman and 
Papadimitriou, 1995), we further investigated synergistic signaling between dectin-1 and 
TLR2 or TLR4 in human monocyte-derived macrophages. Similar to the effects in monocytes, 
the combinations of curdlan with Pam3Cys or LPS exerted robust synergistic effects on 
cytokine production in human primary macrophages (Fig. 5A and C). The synergy between 
dectin-1 and TLR2 was most evident for TNFα (13.3 ± 3.9-fold increase), and was inhibited by 
GE2 by 53 ± 13%. The synergy in IL-10 production (6.5 ± 2.2-fold increase) was not influenced 
by inhibition of dectin-1 (reduction 22 ± 37%) (Fig. 5B and D). Similarly, synergy between 
dectin-1 and TLR4 for TNFα secretion (8.8 ± 2.1-fold increase) could be reduced by 72 ± 14% 
by blocking dectin-1 with GE2 relative to the isotype control. The synergistic production of 
IL-10 after stimulation with curdlan and LPS was less pronounced (2.1 ± 0.1-fold increase) 
and not reduced by GE2 (18 ± 11%) (Fig. 5B and D). 
Synergistic signaling between dectin-1 and TLR2 or TLR4 in human monocyte-derived 
macrophages is clearly dectin-1-dependent for the production of the pro-inflammatory 
cytokine TNFα. 
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  Fig. 5. Synergistic TNFα production after stimulation with curdlan and TLR agonists in human 
monocyte-derived macrophages is dectin-1-dependent. Human monocyte-derived macrophages 
of four healthy volunteers were stimulated with LPS (10 ng ml−1) or Pam3Cys (10 μg ml−1) in 
combination with curdlan (100 μg ml−1). Cells were pre-incubated for 1 h with anti-dectin-1 
antibody GE2 (10 μg ml−1) or isotype control (10 μg ml−1). After 24 h incubation at 37°C, TNFα (A 
and B) and IL-10 (C and D) were measured in the supernatant by ELISA. Data are presented as 
mean ± SEM and compared by Wilcoxon test (*P < 0.05) (A and C) or as percentage of control ± SD 
(*P < 0.05) (B and D). 
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Discussion 
       
 
In the present study, we demonstrate that engagement of the β-glucan receptor dectin-1 
amplifies cytokine production induced by TLR2 and TLR4 stimulation. Previous studies have 
reported synergistic effects between dectin-1 and TLR2 in cell lines or mouse macrophages, 
while we demonstrate synergistic stimulation of primary human monocytes and 
macrophages by combined stimulation with TLR and CLR ligands. In addition, we report a 
synergistic interaction between human dectin-1 and TLR4. 
 
Cross-talk between different classes of PRRs is an important mechanism for signal 
integration to induce specific responses in the innate immune system 28,29. Receptors can 
interact with each other at the level of the cell surface and form complexes like 
TLR4/CD14/MD-2 30 or TLR2/TLR1 31 and TLR2/TLR6 32,33, or at the level of intracellular 
pathways like Nod2/TLRs 34. Interactions of dectin-1 with TLR2 have been shown in murine 
models by using complex particles like zymosan 35,36, which contain both β-glucans and TLR2 
ligands (Fig. 3). In addition, we have recently demonstrated synergistic effects of dectin-1 
and TLR4 in a murine system 37, and we proposed similar effects for human mononuclear 
cells. In the present study we extend these observations and demonstrate the strong 
interaction between dectin-1 and TLR2/TLR4 in both human primary monocytes and 
macrophages. 
 
The interaction of zymosan with dectin-1 expressed on murine mononuclear cells can have 
diverse effects. It can trigger TNFα and IL-12 production by cooperative signaling with TLR2. 
Binding to dectin-1 alone leads to IL-10 and IL-2 secretion 38. To fully understand these 
effects, it is pivotal to determine the underlying mechanisms regulating receptor cross-talk. 
One advantage of using particulate stimuli is that they resemble the cell surface of 
microorganisms like C. albicans. Binding of particulate ligands could approximate receptors 
to induce synergistic interactions. However, to get more insight into the cross-talk of 
intracellular pathways, pure receptor ligands are needed. To this end we have used the 
dectin-1 ligand curdlan, which consists of linear β-1,3-glucan polymers derived from 
Alcaligenes faecalis and does not contain TLR2 or TLR4 ligands (Fig. 3). Our data show that it 
efficiently triggers dectin-1 in human primary mononuclear cells inducing TNFα release (Fig. 
3). When combined with pure TLR2 or TLR4 agonists, it induced dectin-1-dependent 
synergistic TNFα and IL-10 production (Figs 4 and 5). The synergy for TNFα production was 
most pronounced in monocyte-derived macrophages. These data show that receptor 
clustering by binding to a particulate ligand like zymosan is not required for synergistic 
signaling. Synergy is thus most likely established at the level of signal pathways rather than 
by interaction of receptors in the cell membrane. Interestingly, synergistic TNFα production 
was inhibited up to 70% by the dectin-1-blocking antibody GE2 relative to the isotype control 
in human macrophages. It remains to be elucidated why synergistic IL-10 production was 
inhibited by GE2 only in PBMCs (Fig. 4) but not in macrophages (Fig. 5). It has been shown 
that dectin-1 triggering can lead to recruitment of the protein tyrosine kinase Syk to a 
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phosphorylated ITAM-motif contained in dectin-1 39. It should be noted that dectin-1-
mediated TNF production is Syk-independent, while IL-10 induction by the β-glucan/dectin−1 
interaction is Syk-dependent 40. Whether Syk dependency of cytokine production is related 
to difference in the effect of dectin-1 blocking antibody GE2, and whether Syk signaling 
interferes with TLR2- or TLR4-mediated signaling events in human mononuclear cells, as it 
has been recently shown in murine cells 41, remain to be determined. 
 
Recently, the intracellular signaling events following dectin-1 triggering have been further 
elucidated. CARD9 has been shown to control dectin-1-mediated myeloid cell activation, 
cytokine production and innate antifungal immunity. Card9 couples to Bcl10 and regulates 
Bcl10-Malt1-mediated NF-κB activation induced by zymosan 42. Dectin-1 signaling could thus 
affect TLR-induced intracellular signaling pathways. NF-κB- and ERK-dependent signaling 
lead to transcription of different cytokines, TNFα in case of NF-κB 43 and IL-10 and IL-2 in 
case of ERK 44. Similarly, other ITAM-containing receptors like Fcγ receptors and TREM-1 are 
thought to synergize with TLRs by augmenting NF-κB- and MAPK-dependent pathways 45,46. 
 
Cross-talk between dectin-1 and TLR2 and TLR4 could play an important role in the human 
immune response against C. albicans. Interestingly, it was shown that C. albicans β-glucan is 
shielded from dectin-1 by outer cell wall components and that yeast budding and cell 
separation create scars that expose sufficient amounts of β-glucan for dectin-1 triggering on 
macrophages. During filamentous growth of C. albicans, β-glucan is not exposed. Dectin-1 is 
therefore not triggered, possibly allowing the pathogen to evade an immune response 47. 
The synergy between dectin-1 and TLR2 and TLR4 for the induction of cytokines is interesting 
in perspective of Candida infections, because each layer of the C. albicans cell wall can 
trigger specific receptors. Cross-talk between these receptors will lead to an optimal 
immune response of the host. The immunomodulatory properties of β-glucans in human 
mononuclear cells could go further than host defense against Candida spp. Considering our 
findings that stimulation with a pure dectin-1 ligand in combination with pure TLR ligands 
leads to synergic cytokine production in human mononuclear cells, one could imagine using 
pure dectin-1 ligands as adjuvants to increase immune responses. Insights gained into cross-
talk between TLRs and dectin-1 will increase our understanding of how the immune 
responses against C. albicans are orchestrated and may help to improve current therapeutic 
approaches. 
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Materials and methods 
   
 
Reagents 
Synthetic Pam3Cys was purchased from EMC Microcollections. LPS (E. coli serotype 055:B5) 
was purchased from Sigma and an extra purification step was performed as described 
previously 48. Purified LPS was tested in TLR4−/− mice for the presence of contaminants and 
did not have any TLR4-independent activity 49. Zymosan (Sigma), prepared from the 
Saccharomyces cerevisiae cell wall, consists of protein–carbohydrate complexes and 
contains high amounts of β-glucans. Curdlan (WAKO) is a dectin-1 ligand consisting of linear 
β-1,3-glucan polymers derived from Alcaligenes faecalis 50-52. The inhibiting antibody against 
dectin-1, GE2, was a kind gift of Prof Gordon Brown (University of Cape Town, Cape Town, 
South Africa). A matching mIgG1 isotype control was purchased from R&D systems. 
Endotoxin-free water-soluble glucan phosphate was prepared from particulate β-glucan as 
previously described 53. The mouse anti-human monoclonal anti-TLR4 HTA125 antibody 
(aTLR4) was a kind gift of Dr Kensuke Miyake (Saga Medical School, Saga, Japan) and a 
matching mIgG2a isotype was purchased from R&D systems. The mouse anti-human 
monoclonal anti-TLR2 antibody (aTLR2, isotype IgG2a) was kindly provided by Dr Douglas 
Golenbock (University of Massachusetts, Boston, USA). 
   
Isolation of PBMCs and stimulation of cytokine production 
After obtaining informed consent, venous blood was drawn from the cubital vein of healthy 
volunteers into three 10 ml EDTA tubes (Monoject). The MNC fraction was obtained by 
density centrifugation of blood diluted 1:1 in pyrogen-free saline over Ficoll-Paque 
(Pharmacia Biotech). Cells were washed twice in saline and suspended in culture medium 
(RPMI 1640, Cambrex) supplemented with gentamicin 10 μg ml−1, l-glutamine 10 mM and 
pyruvate 10 mM. Cells were counted in a Coulter counter (Coulter Electronics) and the 
number was adjusted to 5 × 106 cells ml−1. A total of 5 × 105 MNCs in a 100 μl volume were 
added to round-bottom 96-wells plates (Greiner) and incubated with either 100 μl of culture 
medium (negative control), or the various stimuli: LPS (1 ng ml−1), Pam3Cys (1 μg ml−1) and 
curdlan (100 μg ml−1) or combinations of curdlan/Pam3Cys and curdlan/LPS. In parallel 
experiments, dectin-1 was inhibited by adding 10 μg ml−1 GE2 or matched isotype control 30 
min before adding the stimuli. After 24 h, the supernatants were collected and stored at 
−70°C until assayed. 
   
Culture of human monocyte-derived macrophages 
To culture human macrophages, 5 × 105 PBMCs were plated in flat-bottom 96-wells plates. 
After 4 h culture at 37°C, they were washed three times with RPMI1640. The adhered 
monocytes were cultured for at least 6 days in RPMI1640 with 10% heat-inactivated pooled 
human serum, until they showed macrophage-like morphology and expressed characteristic 
surface markers analyzed by flow cytometry. After washing three times macrophages were 
stimulated according to the same protocol as PBMCs.   
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Cytokine measurements 
Human TNFα concentrations were determined by a specific ELISA using four antibodies as 
described by 54. In short, the procedure started with treating microtitre plates with a duck-
anti-chicken IgY coating antibody solution (overnight at 4°C). Afterwards, the plates were 
blocked with the blocking buffer (300 μl per well, 2 h at 37°C). The next step was incubation 
with chicken anti-TNFα capture antibodies (2 h at 37°C). The incubation with the standards, 
unknowns and reference samples took place overnight at 4°C. The incubation with trapping 
antibody (rabbit anti-TNFα), as well as the subsequently incubation with detection antibody 
(HRP-labeled goat anti-rabbit antibody) were performed over 2 h at ambient temperature. 
The incubation with substrate solution was performed in darkness for 60 min at ambient 
temperature. When the color reaction was completed, 1 M H2SO4 per well was added to 
stop the reaction. The absorbance values were measured at 492 nm within 30 min. IL-10 and 
IL-8 were measured by commercial ELISA kits (Pelikine Compact, Sanquin), according to the 
instructions of the manufacturer. 
 
Transfection of HEK293 cells 
HEK293 cells were cultured in complete DMEM (Life Technologies, Gibco BRL)/10% FCS. 
Transfections were done with lipofectamine according to the manufacturer's instructions 
(Invitrogen). Human TLR2 constructs were a kind gift of Dr Douglas Golenbock (University of 
Massachusetts, Boston, USA). 
   
Flow cytometry 
Polyclonal goat anti-human dectin-1 antibodies (R&D Systems) were used for flow cytometry 
(FACS) analysis of dectin-1 expression. Donkey anti-goat Alexa647-conjugated antibody 
(Molecular Probes) was used to detect anti-human dectin-1 antibody in FACS studies. 
Murine monoclonal anti-MR and anti-CD14 antibodies (clone 19.2, BD, and RMO52, 
Beckman Coulter respectively) and PE-conjugated secondary antibodies (BD) were used to 
label monocytes and macrophages. FACS analyses were performed with a FACScalibur (BD). 
FACS data were analyzed with WinMDI (http://facs.scripps.edu/software.html) and 
CellQuest (BD). 
   
Statistical analysis 
All experiments were performed in duplicate with cells obtained from at least four healthy 
volunteers. Synergy was expressed as ratio of cytokine response of ligand in combination 
with curdlan divided by the sum of cytokine responses obtained with each ligand alone. 
Differences in cytokine production after inhibition of dectin-1 were analyzed by Wilcoxon 
tests. For all other comparisons the Student's t-test was used. The level of significance 
between groups was set at P < 0.05. Data are given as mean ± SEM. 
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Abstract  
  
 
Recognition of microbial components by germ-line encoded pattern recognition receptors 
(PRR) initiates immune responses to infectious agents. We and others have proposed that 
pairs or sets of PRR mediate host immunity. One such pair comprises the fungal β-glucan 
receptor, Dectin-1, which collaborates through an undefined mechanism with Toll-like 
receptor 2 (TLR2) to induce optimal cytokine responses in macrophages. We show here that 
Dectin-1 signaling through the spleen tyrosine kinase (Syk) pathway is required for this 
collaboration, which can also occur with TLR4, 5, 7 and 9. Deficiency of either Syk or the TLR 
adaptor MyD88 abolished collaborative responses, which include TNF, MIP-1 and MIP-2 
production, and which are comparable to the previously described synergy between TLR2 
and TLR4. Collaboration of the Syk and TLR/MyD88 pathways results in sustained 
degradation of the inhibitor of κB (IκB), enhancing NF-κB nuclear translocation. These 
findings establish the first example of Syk- and MyD88-coupled PRR collaboration, further 
supporting the concept that paired receptors collaborate to control infectious agents.  
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Introduction 
 
 
Originally identified in Drosophila, the Toll-like receptors (TLR) consist of a family of at least 
11 proteins, which recognize a diverse, but receptor-specific range of microbial structures. 
Ligand recognition leads to TLR homo- or heterodimerization and the initiation of specific 
signaling cascades mediated by the intracellular adaptors MyD88 and TRIF 1. This leads to 
the activation of transcription factors, including NF-κB, inducing TLR-specific patterns of 
gene expression. However, the specificity of these responses is incompletely understood and 
is thought to stem, at least in part, from the association with particular intracellular 
adaptors, heterodimerization, synergy between selected TLR, and the contribution of other 
non-TLR pattern recognition receptor (PRR) that are associated with the recognition of 
specific microbes1-5. Recently, it has been proposed that complex sets of PRR collaborate to 
mediate host immune responses to intact microbes 2. For fungi, one such set comprises the 
β-glucan receptor Dectin-1 and TLR2 5,6. 
 
Dectin-1 is essential for the innate response to fungal pathogens 7. In vitro studies have 
shown that recognition of fungal β-1,3-glucan by Dectin-1 can induce phagocytosis, 
phospholipase A2, COX2, the respiratory burst and the production of numerous cytokines 
and chemokines, including TNF, MIP-2, IL-12, IL-2, IL-10, IL-6 and IL-23 5. Signaling from 
Dectin-1 is mediated through novel pathways, including an unusual interaction with spleen 
tyrosine kinase (Syk) which triggers downstream signaling through CARD9 5,8. While the 
activation of Syk is sufficient for the induction of the respiratory burst in macrophages and 
IL-10 and IL-23 in dendritic cells 9-11, the role of this kinase in the induction of the other 
cytokines and chemokines, if any, is unclear. Furthermore, in macrophages, some of Dectin-
1-mediated responses, such as phagocytosis, are Syk-independent, while others, such as the 
induction of TNF, require collaborative recognition of another undefined fungal component 
by TLR2, and signaling through the MyD88 pathway 5,12-14. 
 
How Dectin-1 and TLR2 collaborate to induce proinflammatory cytokines and chemokines is 
not understood. We show here that this receptor collaboration requires the Syk kinase 
pathway, utilized by Dectin-1, and that this pathway can collaborate with many other TLR to 
induce optimal cytokine and chemokine responses. Collaboration of these pathways results 
in sustained IκB degradation and enhanced NF-κB nuclear translocation. These results 
demonstrate the importance of receptor collaboration during infection as opposed to 
receptors functioning in isolation. 
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Results and discussion 
  
 
Collaboration of dectin-1 and TLR2 using specific ligands 
 
Dectin-1 and TLR2 are known to collaborate to induce cytokine production in response to 
fungal particles 12,13. In order to determine the nature of this collaboration, we stimulated 
thioglycollate-elicited macrophages with highly purified ligands specific for each receptor 15. 
Stimulation with purified β-glucan failed to induce TNF production, even at high doses (Fig. 
1A). Given the surprising lack of response to the purified β-glucan, we measured whether 
Syk kinase was being activated by this ligand, as an indicator of Dectin-1 activation 9 (Fig. 1B 
and C). Both Syk, and its substrate SLP-76, were phosphorylated following β-glucan 
stimulation, indicating that engagement of Dectin-1 and activation of the Syk pathway is not 
sufficient to induce TNF production in macrophages.  
 
To explore collaborative signaling between Dectin-1 and TLR2, we added sub-stimulatory 
doses of the TLR2-specific ligand, Pam3CSK4, alone or in combination with β-glucan (Fig. 1A). 
While stimulation with the low dose of TLR2 ligand induced low levels TNF, a combination of 
the two ligands induced high levels of this cytokine, suggesting that the Dectin-1 and TLR2 
ligands acted in a synergistic fashion for inflammatory cytokine production. Similar results 
were also obtained with curdlan, another particulate β-glucan used as a Dectin-1 ligand 
(data not shown). Synergistic induction of TNF was most evident at lower concentrations of 
Pam3CSK4 (Fig. 1D), and was not observed in Dectin-1-/- macrophages (Fig. 1E). Chemokines 
such as MIP-1 and MIP-2 were also efficiently induced by co-ligation but not by β-glucan 
alone, indicating that synergistic stimulation of TLR2 and Dectin-1 can induce a variety of 
macrophage responses (Fig. 1F and G). As TNF and MIP-1 production after TLR2 stimulation 
never reach the levels obtained after co-stimulation, regardless of ligand concentration (Fig. 
1D and F), these data suggest that such responses are qualitatively different and not simply 
quantitative shifts in the dose-response curve. 
 
Dectin-1 and TLR2 collaboration requires MyD88 and Syk kinase-signaling pathways 
Collaboration between Dectin-1 and TLR2 in response to fungal particles could occur in two 
ways. First, Dectin-1 could capture fungal particles and present ligands to TLR2 at the cell 
surface or in the phagosome, similar to that proposed for CD36 3. Since Syk is not required 
for binding and phagocytosis of fungal particles by macrophages, such collaboration would 
be dependent on MyD88 and not Syk, as previously suggested 5,14. Alternatively, receptor 
collaboration could require signaling through both receptors and signal integration. In this 
scenario, collaboration would require both MyD88 and possibly Syk. To test these 
possibilities, we examined thioglycollate-elicited macrophages derived from wild-type, 
MyD88-/- and Syk-/- chimeric mice (Fig. 2A and B). 
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Figure 1. Collaborative induction of pro-inflammatory cytokines through Dectin-1 and TLR2 using 
specific ligands. (A) Production of TNF by C57BL/6 macrophages stimulated with 100, 10 or 1 
μg/mL particulate β-glucan, with or without 10 ng/mL Pam3CSK4. (B) Western blots showing 
phosphorylation of Syk, and its substrate SLP-76, upon stimulation of RAW macrophages with 10 
μg/mL β-glucan. Data shown are representative of two independent experiments. (C) Activation 
of Syk in 129Sv macrophages by β-glucan (arrows), as determined by fluorescence microscopy. 
Left panel, phase image; right panel phospho-Syk image. Scale bar indicates 10 m. (D) 
Collaborative production of TNF by C57BL/6 macrophages stimulated with 10 μg/mL particulate β-
glucan occurs over a range of Pam3CSK4 concentrations. (E) Collaborative TNF production by 
129/Sv macrophages stimulated with 10 μg/mL particulate β-glucan and 10 ng/mL Pam3CSK4 is 
dependent on Dectin-1 expression. Collaborative MIP-1 (F) and MIP-2 (G) production from 
C57BL/6 macrophages stimulated with 10 μg/mL particulate β-glucan occurs over a range of 
Pam3CSK4 concentrations. Data shown are mean ± SD and are representative of at least two 
independent experiments.  
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In wild-type macrophages from C57BL/6 and BALB/C mice, prominent TNF production was 
induced by a combination of the two ligands, as before. In contrast, this response was 
absent in MyD88-/- macrophages (Fig. 2A). However, responses were similarly defective in 
Syk-/- macrophages, in which the level of TNF production was comparable to that obtained 
by TLR2 ligation alone (Fig. 2B). These results indicate that efficient induction of specific 
cytokine responses in macrophages requires integration of the Dectin-1/Syk and TLR/MyD88 
signaling pathways, and can thus be defined as synergistic or collaborative responses.  
 
Receptor collaboration sustains degradation of IκB and enhances nuclear translocation of 
NF-κB 
 
Both the TLR/MyD88 and Syk pathways couple to IκB and NF-κB activation, ultimately 
leading to cytokine and chemokine induction 1,8. However, signaling through the MyD88 
pathway alone induces only transient IκB degradation, and subsequent transient NF-κB 
nuclear translocation in mouse embryonic fibroblasts 16. Similarly, activation of either the 
TLR2/MyD88 or Dectin-1/Syk kinase pathways alone induced transient IκB degradation in a 
macrophage cell line, with IκB protein levels largely recovering after 120 min (Fig. 2C and D). 
In contrast, co-stimulation induced sustained IκB degradation, which correlated with 
enhanced nuclear localization of NF-κB c-Rel (Fig. 2C and D). In order to verify these findings 
in primary cells, we measured NF-κB c-Rel nuclear translocation microscopically over time in 
thioglycollate-elicited peritoneal macrophages (Fig. 2E and F). At early time points following 
stimulation, the percentages of cells with nuclear c-Rel were significantly greater after co-
stimulation, than after stimulation of either receptor alone (Fig. 2F). However, at later time 
points there was no significant difference in nuclear c-Rel translocation between the co-
stimulated cells and the cells stimulated with TLR ligand alone. Although we have not 
defined the point of signal integration, we show that while ligation of either receptor can 
induce activation of NF-κB, collaboration of the signals induced by these receptors results in 
sustained IκB degradation and NF-κB nuclear localization at earlier time points, which is 
likely to contribute, at least in part, to the enhanced cytokine responses. 
 
The Syk kinase pathway collaborates with TLR2, 4, 5, 7 or 9 
 
Given that most TLR signal through MyD88, we examined whether the Syk kinase pathway 
can collaborate with other MyD88-coupled TLR. Stimulation of human peripheral blood 
mononuclear cells with suboptimal doses of TLR1/2, TLR4 and TLR5 ligands induced low 
levels of TNF that were greatly enhanced by activation of the Syk pathway with β-glucan (Fig. 
3A, B and C). Similarly, co-ligation of TLR7 or TLR9 with Dectin-1 induced collaborative TNF 
responses in thioglycollate-elicited macrophages (Fig. 3D). Signaling through TLR/MyD88 is 
thus a general pathway for collaboration with the Syk kinase pathway.  
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Figure 2. Collaboration of Syk kinase and TLR/MyD88 pathways sustain IκB degradation and 
enhance NF-κB nuclear translocation. TNF production from C57BL/6 wild-type and MyD88-/- (A) 
or BALB/C wild-type and Syk-/- (B) macrophages stimulated with 10 μg/mL particulate β-glucan 
and 10 ng/mL Pam3CSK4, as indicated. (C) RAW macrophages stimulated with 10 ng/mL 
Pam3CSK4 and 10 μg/mL particulate -glucan. Top: IκB degradation after 2 h was assayed by 
Western blotting. Bottom: localization of NF-κB c-Rel in nuclear lysates. Numbers above each lane 
show fold decrease (IκB) or increase (cRel) of the relative band intensities of IκB and c-Rel, with 
actin and USF-2 as loading controls, versus unstimulated control. (D) IκB degradation in RAW 
macrophages was assayed after the indicated times. Data shown are mean ± SD and are 
representative of two independent experiments. (E) Nuclear translocation of c-Rel (green) 
following co-stimulation of C57BL/6 macrophages with 10 ng/mL Pam3CSK4 and 10 μg/mL 
particulate β-glucan for 1 h. Nuclei were stained with Hoechst 33258 (red). Scale bar represents 
10 m. (F) Nuclear translocation of c-Rel was quantified microscopically over time in C57BL/6 
macrophages stimulated with 10 ng/mL Pam3CSK4 followed by 10 μg/mL particulate β-glucan. 
Data shown are mean ± SD and are representative of two independent experiments. 
 Syk-dependent collaboration of dectin-1 and TLRs 
 
43 
 
Receptor synergy has previously been described in innate immunity, notably between TLR 
that signal through MyD88 and TRIF adaptors respectively 2,17-19. Collaborative TNF 
responses after co-ligation of Dectin-1 with either TLR2 or TLR4 in thioglycollate-elicited 
macrophages were comparable to the previously described synergistic responses between 
these two TLR (Fig. 3E). As β-glucans have long been known to stimulate anti-infective 
immunity 5, our results suggest that the activity of these carbohydrates stems from their 
ability to trigger collaborative responses between Dectin-1 and the various TLR. Similar to 
specific TLR ligand combinations, the collaborative effects of Dectin-1 and TLR may provide 
an alternative approach for the development of novel adjuvants. 
 
 
 
Figure 3. Collaborative responses occur with multiple TLR and are comparable to synergistic 
responses induced through TLR2 and TLR4. Production of TNF by human peripheral blood 
mononuclear cells stimulated with or without 10 μg/mL particulate β-glucan and the indicated 
concentrations of Pam3CSK4 (A), LPS (B) or flagellin (C). Data shown are mean ± SEM of pooled 
data from five independent donors. (D) Collaborative TNF responses from C57BL/6 macrophages 
stimulated with TLR7 (0.2 μg/mL CL-097) or TLR9 (1 μg/mL ODN1826) ligands and particulate β-
glucan, as indicated. Data shown are the mean ± SD of one representative experiment of three. 
(E) Co-stimulation of C56BL/6 macrophages with 10 μg/mL particulate β-glucan and 10 ng/mL 
Pam3CSK4 or 1 ng/mL LPS induces TNF production that is comparable to the synergistic response 
following TLR2 and TLR4 co-ligation. Shown are the mean ± SEM pooled of data pooled from three 
independent experiments. 
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Concluding remarks 
 
  
In this study, we have used defined ligands to explore the nature of the collaborative 
response induced by the β-glucan receptor, Dectin-1, and TLR2. We show here that the Syk 
kinase pathway utilized by Dectin-1 is required for this collaboration, and demonstrate that 
this pathway can also collaborate with TLR4, 5, 7 and 9. The collaborative responses 
between Dectin-1 and the TLR may be particularly relevant for intact microbes bearing the 
appropriate combination of ligands. Indeed, the susceptibility to fungal infection of mice 
deficient in Dectin-1 7, or the downstream signaling pathway 8, despite normal responses to 
specific TLR ligands, indicates that the defect in these animals is due to the lack of 
collaborative signaling from the Dectin-1 pathway. Receptor collaboration may also explain 
the previously observed synergy between mannans, which may be TLR ligands, and β-glucan 
fungal cell wall components in the response to these organisms 7,20. These results thus 
highlight the importance of receptor collaboration during infection as opposed to receptors 
functioning in isolation, and further support the concept that pairs or sets of receptors 
collaborate to control infectious agents. 
 
While Syk has been implicated in the modulation of TLR responses in other systems 10,21-24, 
the interaction between Dectin-1 and Syk occurs through a novel mechanism 9, which is 
likely to be representative of other receptors involved in pathogen recognition such as the 
HIV-1 receptor CLEC-2 and CD66d, a PRR for Neisseria gonorrhoeae and Haemophilus 
influenzae 25-28. Recently, it has also been proposed that the adaptor CARD9, which is 
downstream of Syk in myeloid cells, plays a role in TLR signaling 29. We propose an 
alternative explanation in which Syk-and CARD9-coupled PRR collaborate with TLR. 
Stimulation of TLR9 with CpG, for example, induces IL-12p70 production that is dependent 
on Syk 10, suggesting that an undefined Syk- and CARD9-coupled PRR collaborates with TLR9 
in this system. There are therefore likely to be many more examples of Syk-coupled PRR that 
collaborate with TLR to control infectious agents. 
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Materials and methods 
 
 
Reagents and mice 
All TLR ligands were from InvivoGen (San Diego, CA), and the production of highly purified 
particulate β-glucan and soluble β-glucan (glucan phosphate) have been described 
elsewhere 15,30. BALB/c, C57BL/6 and C57BL/6 MyD88-/-, 129/Sv and 129/Sv Dectin-1-/- 7 
mice were obtained from the animal unit of the University of Cape Town. BALB/c Syk-/- 
chimeric mice were generated by the transfer of Syk-/- fetal liver cells into irradiated BALB/C 
recipients as described 9. All procedures were approved by the University of Cape Town 
animal ethics committee. 
 
Cell stimulation 
Murine thioglycollate-elicited macrophages were plated at 106 cells/mL in RPMI medium 
containing 10% FCS (Gibco) and incubated overnight. Medium was replaced, and cells were 
stimulated with 10 μg/mL particulate β-glucan or 10 ng/mL Pam3CSK4, unless otherwise 
indicated, for 3 h. Human peripheral monocytes were prepared as described 20,31 and 
stimulated with 10 μg/mL particulate β-glucan and relevant TLR ligands for 20 h. Cytokine 
secretion was assayed by ELISA using kits from Becton Dickinson (Mountain View, CA), R&D 
Systems (Abbingdon, UK) or KOMA Biotechnology (Korea). Data were analyzed using the 
Student's t-test. 
 
Syk and SLP-76 phosphorylation 
RAW 264.7 cells expressing Dectin-1 [12] (107cells in 100 L HBSS) were stimulated with 10 
μg/mL soluble β-glucan (glucan phosphate) for 1 min at 37°C before addition of lysis buffer 
(1% NP40, 25 mM Tris pH 8, 10 mM EDTA, 140 mM NaCl, 5 mM NaF, 1 mM Na3VO4, 5 mM 
iodoacetamide) containing protease inhibitors (Roche). Lysate supernatants were incubated 
for 2 h with 30 L streptavidin-agarose beads (Fluka) precoated with 25 M biotinylated 
Dectin-1 phosphopeptide to precipitate Syk 9 or 30 L protein G-Sepharose beads (Amersham, 
UK) precoated with 5 g SLP-76 mAb. Beads were washed with lysis buffer, boiled in 50 L SDS-
PAGE sample buffer, and samples were Western-blotted and probed with phosphotyrosine 
mAb 4G10 (Becton Dickinson) and antibodies to Syk or SLP-76 (Santa Cruz Biotechnology, 
CA). For phospho-Syk staining, 129Sv thioglycollate-elicited macrophages were stimulated 
with 10 μg/mL particulate β-glucan for 6 min, fixed with paraformaldehyde, blocked and 
permeabilized with Triton X-100. Cells were stained with anti-phosphoSyk (CellSignalling) 
followed by donkey anti-rabbit Cy3 (Jackson Immunoresearch) and analyzed by fluorescent 
microscopy. 
 
IκB degradation and NF-κB nuclear localization 
RAW 264.7 cells expressing Dectin-1 plated at 2 × 105 cells/mL were stimulated with 10 
μg/mL particulate β-glucan and 10 ng/mL Pam3CSK4 for 2 h, or the indicated times, before 
lysis and Western blotting of whole-cell lysates with antibodies to IκB or actin (CellSignaling, 
MA) as a loading control. Nuclear lysates were prepared after 20 h stimulation as described 
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32, followed by Western blotting with antibodies to NF-κB c-Rel or USF-2 (Santa Cruz 
Biotechnology) as a loading control. Band intensities were quantified using NIHImage 
software. 
 
NF-κB nuclear translocation 
C57BL/6 thioglycollate-elicited macrophages plated at 2 × 105 cells/mL were stimulated with 
10 ng/mL Pam3CSK4 for 90 min followed by 10 μg/mL particulate β-glucan for 60 min, fixed 
with paraformaldehyde, blocked and permeabilized with Triton X-100. Cells were stained 
with Hoechst and NF-κB c-Rel antibody, followed by anti-rabbit IgG-Cy6 (Jackson 
laboratories, USA) and analyzed by fluorescent microscopy. Three independent fields 
containing >100 cells were counted for each stimulation type, and data were analyzed using 
the Student's t-test. 
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Abstract 
 
 
Dectin-1 is a C-type lectin expressed on myeloid cells and is a pattern recognition receptor 
for β-glucans. The role of dectin-1 for the modulation of membrane-bound proteins involved 
in immune responses is not known. We have employed a functional approach to screen for 
the effect of dectin-1 engagement on the expression of membrane proteins by stimulating 
murine peritoneal macrophages overnight with zymosan. Changes in the expression selected 
membrane proteins were analyzed by FACS. To determine the role of dectin-1 in this process 
we compared macrophages isolated from dectin-1+/+ (WT) and dectin-1-/- macrophages. 
There was a distinct pattern of up- and down-regulation of proteins indicating a specific role 
in the immune response. The integrin-associated protein CD47 was specifically down-
regulated by zymosan in a dectin-1 dependent manner. This effect was independent on 
zymosan–induced phagocytosis, while no effect on cell death/apoptosis was apparent. 
Incubation with β-glucan alone or HK C. albicans lowered the expression of CD47, whereas 
incubation with LTA (a TLR2 agonist) had no effect on the expression of CD47. These 
experiments demonstrate that screening membrane bound proteins by FACS after overnight 
stimulation with zymosan in dectin-1 -/- and WT macrophages can reveal novel interactions 
between dectin-1 and membrane-bound molecules. Dectin-1 stimulation with β-glucan leads 
to a lower expression of CD47 on murine macrophages, and this could play a role in the 
cross-presentation fungal antigens.  
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Introduction 
 
 
The human body is colonized with microorganisms that represent our commensal 
microbiological flora 1,2. The epithelial barrier is crucial in maintaining the balance between 
colonization and invasion by these organisms 3,4. The epithelial cells and a complex network 
of immune cells located underneath the epithelial layer are capable to recognize the 
invading organism and induce an immune response to eliminate the pathogen without 
causing collateral damage the surrounding tissue 5. The residential macrophages and 
dendritic cells (DC) are both important antigen presenting cells (APC) in this network, of 
which the latter is the strongest inducer of the acquired immune response by migrating to 
the local lymph nodes and presenting the antigen to the T-cells 6,7. The macrophages are less 
mobile and  highly adapted to the local environment and regulatory function of the epithelial 
(and mucosal) immunological homeostasis 7,8.  
 
Fungi and yeast are part of the commensal microbiological flora of humans, of which 
Candida albicans can cause disease when invading the host 9-11. Macrophages play a crucial 
role in the host defense against Candida 12. Pathogen receptors of the Toll-like receptor (TLR) 
and lectin-like receptor (LR) family on the membrane of the macrophages can recognize cell 
wall components of C. albicans and activate different pathways leading to cytokine 
production, phagocytosis and antigen presentation 13. The induction of cytokines and 
chemokines will activate and attract to the site of infection other immune cells like 
neutrophils and T-cells 14. After phagocytosis, Candida can be killed intracellular by 
lysosomal enzymes and reactive oxygen species (ROS) 15. The macrophage also functions as 
an antigen presenting cell, capable to activate and regulate the acquired immune response 
16,17. In order to activate T-cells, cytokines and expression of co-stimulatory molecules and 
direct cell contact is necessary 18,19. Therefore, beside ‘communication’ through secretion of 
proteins, like cytokines , direct cell-cell interaction through membrane bound proteins play 
an important role in the regulatory function of macrophages.  
Very little is known regarding the expression pattern of membrane-bound proteins that 
determine the function of macrophages upon cell-cell interactions during stimulation with C. 
albicans. One of the main recognition receptors for Candida is the β-glucan receptor dectin-1 
20,21. We investigated in murine macrophages the dectin-1 induced modulation in the 
expression of membrane-bound proteins involved in immune responses. By screening with a 
large panel of anti-bodies in a flow cytometry assay we show that incubation with zymosan 
(cell wall components of Saccharomyces cerevisiae, containing β-glucan and TLR2 ligands) 
leads to a distinct pattern of up- and down- regulation of membrane-bound proteins. We 
further focused on the protein CD47, as this protein was specifically down regulated after 
stimulation of dectin-1 with β-glucan, and postulate that this might play a role in cross-
presentation of fungal antigens. 
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Results 
 
 
CD47 is identified as a target of dectin-1-dependent stimulation of murine macrophages 
 
To investigate the changes in the expression of membrane bound proteins on murine 
macrophages after incubation with zymosan, we used a broad panel of antibodies against 
proteins involved in immunological processes. This resulted in a distinct pattern of 
modulation of these proteins (supplemental table 1). To further investigate the specific role 
of dectin-1 in this process we compared the expression of proteins in dectin-1 defective and 
WT macrophages. There were significant differences in up-regulation of CD25, CD80, CD86 
and PD-L1 and down regulation of PDL2, CD95 and CD47 (Fig 1 and supplemental table 1).  
To validate our screening method we focused in on CD47 because the inhibition of CD47 
expression by dectin-1 is a novel function of the receptor. 
 
 
 
Figure 1. CD47 expression on murine macrophages is reduced after stimulation with zymosan. 
Biogel-elicited peritoneal macrophages were stimulated overnight with zymosan (5 particles per 
cell) or medium. For each experiment macrophages of 5 mice were pooled before stimulation and 
the expression of CD47 was measured by FACS analysis (Panel A). 5 independent experiments 
were performed and the data are expressed either as ratio CD47/rIgG2a of the geometric mean 
fluorescence (Geom. MFI) (Panel B) or ratio of CD47 expression after zymosan and medium 
stimulation (Panel C). Data presented as mean ± SD and compared with Student’s t-test (* p < 
0.05) 
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There is no difference in apoptosis between dectin-1 -/- and WT murine macrophages after 
stimulation with zymosan 
 
Because low expression of CD47 may be explained by apoptosis of macrophages induced by 
zymosan, we first determent the level of apoptosis by measuring the uptake of rhodamine 
123 as marker of early apoptosis and 7-amino-actinomycin D (7-AAD)  as marker of late 
apoptosis. There was no difference in apoptosis between dectin-1 -/- and WT murine 
macrophages after stimulation with zymosan (Fig 2A and B). This indicates that down 
regulation of CD47 in WT macrophages after stimulation with zymosan is not induced by 
induction of apoptosis by dectin-1. 
 
 
 
Figure 2. No differences in apoptosis between WT and dectin-1 -/- macrophages after incubation 
with zymosan. Biogel-elicited peritoneal macrophages were stimulated with zymosan (5 particles 
per cell) or medium overnight and degree of apoptosis was measured by rhodamine123 (Panel A 
and B) and 7-AAD (Panel C and D) by FACS analysis. For each experiment macrophages of 5 mice 
were pooled and experiments performed twice independently. Data expressed as ratio 
rhodamine 123 /background of the geometric mean fluorescence (Geom. MFI)  and presented as 
mean ± SD and compared to medium by Student’s t-test (* p < 0.05) 
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Down-regulation of CD47 after stimulation with zymosan is induced within hours and is 
dose dependent 
 
To further characterize the modulation of CD47expression by zymosan, the time curve of the 
modulation was assessed (Fig 3A). Within the first two hours the expression of CD47 was 
down-regulated and maintained at the same level for the first 12 hours; in the next 12 hours 
there is a slightly but significant reduction of CD47. In the dectin-1 -/- macrophages the CD47 
expression is not reduced after incubation with zymosan for 24 hours. The down regulation 
of CD47 is dose dependent (Fig 3B). This data points out to a sustained role for CD47 down-
regulation in the early immune response to zymosan. 
 
 
 
Figure 3. The reduction of CD47 expression after stimulation with zymosan is an early event and 
dose dependent.  Biogel-elicited peritoneal macrophages were stimulated with zymosan (5 
particles per cell) or medium and CD47 expression was measured at different time points with 
FACS analysis (Panel A). Dose response curve after overnight stimulation with zymosan (particles 
per cell) (Panel B). For each experiment macrophages of 5 mice were pooled and experiments 
performed twice independently. Data expressed as ratio CD47/rIgG2a of the geometric mean 
fluorescence (Geom. MFI)  and presented as mean ± SD and compared to medium by Student’s t-
test (* p < 0.05) 
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Down-regulation of CD47 is largely independent of zymosan phagocytosis 
 
Dectin-1 is involved in binding of zymosan which induces both a cytokine response and 
phagocytosis. Inhibiting phagocytosis of zymosan with cytochalasin D did not prevent down 
regulation of CD47 in WT macrophages, although slightly reduced it (Fig 4A). This indicates 
that engagement of zymosan by dectin-1 leads to reduction of CD47 expression largely 
independent of phagocytosis. 
 
 
 
Figure 4. The down regulation of CD47 on macrophages after stimulation with zymosan is 
phagocytosis independent, TLR2 independent and dectin-1 dependent. Biogel-elicited peritoneal 
macrophages were stimulated with 5 particles zymosan per cell (Z) or medium after 30 minutes 
pre-incubation with 10 μg/ml cytochalasin D (CytD) (panel A). Macrophages were stimulated with 
particulated β-glucan (5 particles per cell) and LTA (10 μg/ml) (panel B). Macrophages were 
stimulated with heat killed C. albicans (5 conidia per cell), heat killed N. Meningitidis (50 per cell) 
and  E. coli (50 per cell) (Panel C). CD47 expression was measured with FACS analysis after 
overnight stimulation. For each experiment macrophages of 5 mice were pooled and experiments 
performed twice independently. Data expressed as ratio CD47/rIgG2a of the geometric mean 
fluorescence (Geom. MFI)  and presented as mean ± SD. Expression was compared with Student’s 
t-test to medium (* and # p < 0.05) and to cytochalasin D (‡ p < 0.05). 
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Engagement of β-glucan by dectin-1 leads to down-regulation of CD47 
 
Zymosan consists cell-wall particles of Saccharomyces cerevisiae, rich of β-glucan, but also 
other components which induce TLR2 mediated immune responses 22,23. To further 
determine the specific role of dectin-1 in the down regulation of CD47 after stimulation with 
zymosan, we in incubated murine macrophages with purified β-glucan or with the specific 
TLR2 ligand lipoteichoid acid (LTA). β-glucan reduced CD47 expression in the WT 
macrophages but not in dectin-1-/- macrophages. Stimulation with TLR2 ligand did not 
reduce the CD47 expression in WT or dectin-1 -/- macrophages (Fig 4B). Incubation of the 
macrophages with heat killed Candida albicans resulted in a reduction of membrane bound 
CD47 in both dectin-1 -/- and WT macrophages (Fig 4B). The data imply that binding of β-
glucan to dectin-1 leads to down regulation of CD47. However, Candida albicans stimulation 
of macrophages activates redundant mechanisms that also lead to the reduction of CD47 
expression. 
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Discussion 
 
 
In this study we assessed a novel approach for identification of biological functions of 
pattern recognition receptors for changes in the expression of membrane-bound proteins 
after incubation of the target cells with specific ligands. Using the β-glucan rich particle 
zymosan in WT and dectin-1 -/- murine macrophages, we identified CD47 as a novel target of 
dectin-1 induced stimulation of macrophages. 
 
There is little insight in the modulation of protein expression on the membrane of 
macrophages during engagement of pattern recognitions receptors (PRRs) by their specific 
ligands 24,25. Screening for changes in expression of proteins by FACS analysis has the big 
advantage that it immediately leads to data pertaining PRR function, especially when 
compared to knock-out strains. By using an array of antibodies against membrane-bound 
proteins, novel functional effects of PRRs can be identified. Our screening using stimulation 
of murine peritoneal macrophages with the fungal particle zymosan, resulted in a distinct 
pattern of down-regulation of proteins (CR3, CD11b, CD210, CD229, CD45RB, CD95, ICOS-L, 
PD-1, PD-L2 and FCRII/III) and up-regulation of proteins (CD25, CD80, CD86 and CD200). 
Because we were interested in the role of dectin-1 in the regulation of membrane bound 
molecules, we compared the effect of zymosan on protein expression in macrophages 
isolated from  WT and dectin-1 -/- mice. This led to a limited number of molecules of 
interest. The difference in expression of CD80 and CD86 after stimulation with β-glucan has 
already been reported in the literature 20,26,27. The differences in expression of PD-L1 and PD-
L2 have not yet been described in fungal infection, although it has been reported that 
microparticulate β-glucan can up regulate PD-L1 27.  The inhibition of the expression of CD95 
(Fas) could be involved in the immunological response to fungal infection, because Fas-FasL 
interaction modulate cytokine responses, and MRL/lpr mice lacking the Fas molecule are 
more resistant to Candida than the WT 28.   
One of the most constant effects of dectin-1 stimulation was the down-regulation of CD47 
expression. There are no reports on the role of CD47 in fungal or mucosal infection, although 
its role in infections has been described in mice. The first reports on CD47 -/- mice show that 
these mice had a decreased resistance to bacterial infection caused by an impaired 
granulocyte function 29,30. The most studied role of CD47 is the induction of phagocytosis of 
apoptotic cells. CD47 is expressed on all cells and low expression leads to phagocytosis 31, as 
shown in the clearance of erythrocytes 32,33. The interaction of CD47 and its ligand Sirp-α 
maintain a ‘don’t eat me’ signal, and disruption of this interaction induces phagocytosis 31,34. 
The lower expression of CD47 is also involved in the controlled phagocytosis of viable cells 
during infection and inflammation. Gardai et al show that calreticulin/LRP interaction can 
induce engulfment of infected cells if CD47 expression is reduced 35. This controlled 
phagocytosis of viable cells may play a role in cross presentation of antigens 36,37. Other 
reports have shown that the expression of CD47 is also involved in the mobility of dendritic 
cells (Langerhands), and when the CD47 expression declines these cells are less mobile 38-40.  
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In the experiments we present here we show that the difference in CD47 expression could 
not be explained by difference in cell apoptosis. In addition, phagocytosis played a minor 
role (if any) in the dectin-1 mediated down-regulation of CD47. This indicates direct effects 
on CD47 expression after engagement of zymosan by dectin-1.  
To point out the specificity of our findings we repeated the experiment with highly purified 
β-glucan, resulting in the same extent of down regulation of CD47 compared to zymosan. In 
contrast, stimulation of  cells with a TLR2 ligand had no effect on CD47 expression. The 
potential importance of the CD47 expression inhibition is also suggested by the redundancy 
when dectin-1 -/- macrophages were incubated with whole Candida albicans. Although 
there is difference in binding and phagocytosis of Candida by dectin-1 -/- macrophages 20, 
activation of other receptor-pathways resulted in the down regulation of CD47 expression in 
dectin-1 -/- cells comparable to WT macrophages. This suggests that CD47 inhibition is an 
important component of the interaction of innate host defense with fungal pathogens. This 
is supported by the observation that the inhibition of CD47 is specific for a fungal pathogen 
such as C. albicans, while the Gram-negative bacteria N. meningitidis and E. coli do not 
modulate CD47 expression. 
 
The role of macrophages in fungal infection is multifaceted. On the one hand, macrophages 
function as phagocytic cells at the site of infection, with an active role in the clearance and 
killing of microorganisms like Candida albicans. On the other hand, macrophages function as 
gatekeeper and regulator in tissues like the mucosa. The activation of macrophages by 
fungal particles induces a specific immune response shown by the changes in membrane 
bound proteins involved in immunity. The down regulation of CD47 indicates a regulated 
phagocytosis-inducing signal. This consequence of dectin-1 engagement is also likely 
important for cross-presentation of the phagocytosed fungal particles, but also a marker for 
cellular mobility, signaling to the resident macrophages to stay in the tissue to which it has 
been adapted and function as a local regulatory myeloid cell. In this process, pathogen 
recognition receptors like dectin-1 seem to play an important role. 
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Materials and methods 
 
 
Isolation and stimulation of murine macrophages 
The mice used in this study (129/SvEv  Clec7+/+ and Clec7-/-) were bred in our own 
institutional colonies. Sex- and age-matched (between 8 and 12 wk of age) were used in the 
study. Animals were kept and handled in accordance with institutional guidelines. All 
experiments were approved by the ethical committee on animal experiments of Oxford 
University. 
Biogel elicited peritoneal macrophages were prepared by i.p. injection of 1 ml 
polyacrylamide gel P-100 (Bio-Rad) beads (2% w/v in endotoxin-free water). After 4 days, 
peritoneal cells were harvested by lavage with phosphate-buffered saline (PBS). The 
macrophages were plated on BP dishes in a defined serum-free medium, OPTIMEM, 
supplemented with 50 IU/mL penicillin-streptomycin and 2 mM L-glutamine. After 3-4 h, 
adherent cells were washed three times to remove non-adherent cells and bio-gel beads. For 
the screening experiments 10x106 cells were plated on BP dishes and stimulated with 
zymosan (Sigma-Aldrich) overnight. For all the other experiments 1.5x106 cells were plated 
in 6 wells plates.  
Inhibiting  phagocytosis was obtained by pre-incubation for 30 minutes with 10 μg/ml 
cytochalasin D (Sigma-Aldrich). The particulated β-glucan was a kind gift of D.L Williams 
(Department of Surgery, James H. Quillen College of Medicine, Johnson City, USA) and used 
at 5 particles per cell. LTA was purchased from Sigma Aldrich and used at 10 μg/ml. Heat 
killed Candida albicans (SC 5314) was obtained according previous described 41 and used at 5 
conidia per cell. Neisseria Meningitidis  (MC58)  and Escherichia coli (K1) were prepared as 
described by Peiser et al. 42,43 and used at 50 bacteria per cell. 
 
Flow cytometry assays  
After overnight stimulation the cells were washed 3 times with PBS and detached  by 
incubation for 15 minutes in lidocaine/EDTA on ice and thereafter by scraping. The detached 
cells were washed in 50 ml PBS and centrifuged at 1200 rpm, and the pallet was incubated in 
blocking buffer (5% heat-inactivated rabbit serum, 0.5% BSA, 5 mM EDTA, and 2 mM NaN3) 
for 30 min at 4°C. Cells were counted and divided in V-shaped 96 wells plates at 5x105 cells 
per well. Cells were incubated with primary antibodies for 1 h at 4°C in blocking buffer and 
washed three times with a washing buffer containing 0.5% BSA, 5 mM EDTA, and 2 mM 
NaN3. If necessary, secondary antibody was incubated with the cells
 for 1 h at 4°C in blocking 
buffer, and the cells were washed three times as described above and fixed in 1% 
formaldehyde. Expression patterns were analyzed on a FACSCalibur using CellQuest 
software.  
The primary antibodies used in this study were produced in the Sir William Dunn School of 
Pathology in Oxford (SWDSOP) or obtained from BD Pharmingen (BD), eBioscience (EB), 
Serotec (ST) or  Medical and Biological Laboratories Co. (MBL) as indicated in the 
supplemental table 1. Isotype controls were from BD Pharmingen and were matched to the 
isotype of the primary anti-bodies used in each experiment. 
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Apoptosis measurement 
Cells were counted and divided in V-shaped 96 wells plates at 5x105 cells per well. Early 
apoptosis was measured by mitochondrial staining with 200 nM rhodamine 123 (Sigma -
Aldrich) for 20 minutes at 37°C in the dark and washed 3 times in blocking buffer and 
analyzed by FACS. Late apoptosis was measured by DNA staining with 100 µg/ml 7-amino-
actinomycin D (Sigma-Aldrich) for 30 minutes at 4°C in the dark and washed in blocking 
buffer before FACS analysis. 
 
Statistical analysis 
Data obtained with FACS analysis was expressed as geometric mean fluorescence intensity 
(Geom.MFI). This data was compared to the background obtained by the aspecific binding of 
isotype matched control antibodies and shown as ratio Geom. MFI specific antibody/Geom. 
MFI isotype control. Differences between dectin-1 -/- and WT macrophages was calculated 
with the Student’s t-test. Level of significance was set at p < 0.05. 
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Abstract 
 
 
Mucocutaneous fungal infections are typically found in patients who have no known 
immune defects. We describe a family in which four women who were affected by either 
recurrent vulvovaginal candidiasis or onychomycosis had the early-stop-codon mutation 
Tyr238X in the β-glucan receptor dectin-1. The mutated form of dectin-1 was poorly 
expressed, did not mediate β-glucan binding, and led to defective production of cytokines 
(interleukin-17, tumor necrosis factor, and interleukin-6) after stimulation with β-glucan or 
Candida albicans. In contrast, fungal phagocytosis and fungal killing were normal in the 
patients, explaining why dectin-1 deficiency was not associated with invasive fungal 
infections and highlighting the specific role of dectin-1 in human mucosal antifungal defense.  
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Introduction 
 
 
Recurrent vulvovaginal candidiasis is a relatively common pathological condition, afflicting 
women of all ages, with more than 90% of cases caused by C. albicans 1. Although the role of 
diabetes as a predisposing condition has been recognized, most cases occur in healthy 
women. Recurrent oral, esophageal, or mucocutaneous candidiasis is also diagnosed in some 
patients without clear predisposing factors. Onychomycosis is a common infection of the nail 
beds, most often caused by dermatophytes but sometimes caused by C. albicans, that also 
affects immunocompetent persons 2. In contrast, disseminated forms of candida infections 
are mostly found in patients in whom a defect in neutrophil function is easily recognized or 
candida species have been introduced in the bloodstream through invasive procedures 3. 
Very little is known about the genetic factors predisposing patients to mucosal or 
disseminated candida infections.  
Recognition of C. albicans by the innate host defense system is mediated by pattern-
recognition receptors from the toll-like–receptor (TLR) and lectinlike-receptor families 4. 
Mannans from the candida cell wall are recognized by the mannose receptor and TLR4 5, and 
TLR2 recognizes phospholipomannan 6 and collaborates with the β-glucan receptor dectin-1 
in the stimulation of cytokine production 7,8. Recognition of 1,3-linked β-glucans by dectin-1 
has been shown to be one of the main fungal-recognition pathways, and mice deficient in 
dectin-1 have an increased susceptibility to C. albicans 9 and Pneumocystis carinii 10. Dectin-1 
amplifies TLR2- and TLR4-induced cytokine production in both murine and human cells, 
resulting in the production of cytokines such as tumor necrosis factor 11, but also induces 
signals, independently of the TLRs, for the production of interleukin-17, interleukin-6, and 
interleukin-10 through a pathway dependent on spleen tyrosine kinase 12.  
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Results 
 
 
Patients and pedigree 
 
During the first phase of the screening, we identified a patient (the index patient) who had 
recurrent vulvovaginal candidiasis and had cells that were hyporesponsive to C. albicans 
stimulation, defined as cytokine production that was 15% or less of that stimulated by C. 
albicans in cells from healthy volunteers. The lack of cytokine production was pinpointed to 
an impaired response to β-glucan, indicating a potential defect in dectin-1 recognition.  
 
To test this hypothesis, we sequenced the dectin-1 gene in the patient. All six exons of 
dectin-1 gene, and the nearby intronic regions, were sequenced (see Table 1 in the 
Supplementary Appendix). We identified a homozygous SNP in exon 6 that caused a change 
of amino acid 238 from tyrosine to a stop codon (Tyr238X), leading to the loss of the last 
nine amino acids of the carbohydrate-recognition domain (Figure 1A). Additional clinical 
questioning revealed that one of the patient's two sisters also had recurrent vulvovaginal 
candidiasis and both sisters had onychomycosis. The mother of the patient also had chronic 
onychomycosis, whereas the father had had only transient onychomycosis, with a relatively 
late age at onset and a complete recovery. The nucleotide sequence of wild-type dectin-1 in 
one healthy volunteer and the nucleotide change (AC) in exon 6 in two persons who were 
heterozygous or homozygous for the stop mutation are shown in Figure S3A in the 
Supplementary Appendix.  
 
Figure 1. Dectin-1 mutation in a family with mucocutaneous fungal infections. Panel A shows the 
structure of the dectin-1 gene and the location of an early-stop-codon mutation consisting of a 
homozygous single-nucleotide polymorphism (rs16910526, exon 6, chromosome 12; location, 
10162354 bp). The mutation (AC) causes a change of amino acid 238 from tyrosine to a stop 
codon (Tyr238X), leading to the loss of the last nine amino acids of the carbohydrate-recognition 
domain (CRD). Cyto denotes the cytoplasmic tail and TM the transmembrane region. Panel B 
shows the genetic pedigree of the index family with dectin-1 deficiency. Circles indicate female 
patients; the square indicates the father. Solid symbols denote homozygosity for the mutation 
(X/X, seen in all three daughters), and half-solid symbols denote heterozygosity (X/Tyr, seen in the 
parents). 
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The clinical characteristics of the patients are presented in Table 1. Microbiologic 
assessment of the nails of the three patients who were homozygous for the dectin-1 
mutation revealed growth of Trichophyton rubrum. The patients had no known predisposing 
factors, such as diabetes mellitus or infection with the human immunodeficiency virus. 
Genetic analysis revealed that both sisters of the patient were homozygous for the Tyr238X 
mutation, whereas the parents were heterozygous (Figure 1B). The family members were 
white persons of Dutch ancestry, according to self-report, and the parents were not known 
to be related. Investigation of the human dectin-1 protein structure containing the early stop 
codon (Figure S3B in the Supplementary Appendix) revealed that a cysteine disulfide bridge 
between the helix and the deleted strand was absent, a finding likely to have important 
functional consequences.  
 
 
Table 1. Clinical characteristics of a family of patients with the Tyr238X dectin-1 mutation 
and with mucocutaneous fungal infection, onychomycosis, or both. 
 
Immunologic defects 
 
In the patients who had the early-stop-codon mutation, both monocytes (Figure 2A) and 
macrophages (not shown) had significant defects in the production of interleukin-6 after 
stimulation with β-glucan for 4 hours (P=0.04 for monocytes). Similar defects were apparent 
after stimulation of cells with either heat-killed or live C. albicans yeast (Figure S1A in the 
Supplementary Appendix). The cytokine response was also defective after 24 hours of 
stimulation with heat-killed C. albicans hyphae (with a 25% reduction of tumor-necrosis-
factor production and a 34% reduction of interleukin-6 release). In addition, cells from 
dectin-1–deficient patients had a marked reduction in interleukin-17 production as 
compared with cells from persons with the dectin-1 wild-type allele (Figure S4A in the 
Supplementary Appendix). Heterozygotes had intermediate production of proinflammatory 
cytokines on stimulation with C. albicans or β-glucan. In contrast, the response of the 
patients' cells to TLR stimuli, such as lipopolysaccharide or lipopeptides, was normal (Figure 
S1B in the Supplementary Appendix). In addition, the amplification effect of the interaction 
between β-glucan and dectin-1 on TLR2 stimulation of cytokines 7 was absent in persons 
who were homozygous for the mutation (Figure S1C in the Supplementary Appendix).  
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Figure 2. Functional defects resulting from dectin-1 mutation. Panel A shows interleukin-6 
production in monocytes isolated after stimulation for 4 hours with β-glucan; for five healthy 
subjects with wild-type dectin-1 (with data pooled), the two patients who were heterozygous for 
the dectin-1 mutation, and the three patients who were homozygous for the mutation. Panel B 
shows the mean binding of nonopsonized fluorescent heat-killed Candida albicans to monocytes 
isolated from healthy subjects with wild-type dectin-1 and from the patients who were 
homozygous for the mutation. In both panels, T bars indicate standard deviations. 
 
To demonstrate that the defect in β-glucan recognition in the patients was indeed due to the 
truncated dectin-1 variant, we constructed vectors for both wild-type and mutated isoforms 
A and B of dectin-1 and transfected them into NIH3T3 cells. These experiments revealed that 
neither mutated isoform A nor mutated isoform B could mediate β-glucan binding, in 
contrast to the wild-type receptors (Figure S4B in the Supplementary Appendix). Moreover, 
although the wild-type dectin-1 isoforms A and B were normally expressed, the mutated 
isoforms were associated with significantly lower expression on the cell surface of the 
transfected cells (Figure S4C in the Supplementary Appendix).  
 
The in vitro data were corroborated in freshly isolated cells from the patients bearing the 
stop-codon mutation. Messenger RNA production by cells with the dectin-1 isoforms was 
similar in persons who were homozygous for the wild-type allele and the patients who were 
homozygous for the stop mutation (Figure S4D in the Supplementary Appendix). In contrast, 
monocytes and neutrophils from the patients who were homozygous for the stop-codon 
polymorphism lacked cell-membrane expression of dectin-1 (Figure S4E in the 
Supplementary Appendix). Heterozygotes had intermediate expression of dectin-1.  
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The binding of heat-killed fluorescence-labeled C. albicans, which has high levels of β-glucan 
13, to monocytes was significantly lower in the patients who were homozygous for the 
mutation than in healthy controls (Figure 2B). However, phagocytosis of live C. albicans was 
normal in both monocytes and neutrophils from the patients who were homozygous for the 
stop codon (Figure S2 in the Supplementary Appendix), showing the importance of 
alternative receptors for phagocytosis of live yeasts (other lectinlike receptors and TLRs) 4. 
Monocytes and neutrophils from the patients who were homozygous for the mutation were 
as effective at killing C. albicans as were cells from normal persons (Figure S2 in the 
Supplementary Appendix).  
 
Frequency of the mutation in populations 
 
To determine whether the dectin-1 stop mutation was occurring in a phylogenetically 
conserved site, we compared the amino acid sequence of dectin-1 among several mammals 
(Figure S5A in the Supplementary Appendix). This investigation revealed that the mutation 
lies in an evolutionarily conserved region within the mammalian lineage. We then 
investigated the prevalence of the mutation in various human populations, and we 
genotyped persons from four cohorts of healthy persons of various ethnic groups, each 
representing populations from the major continents: 138 whites of Dutch ancestry (Europe), 
99 people from Tanzania (Africa), 100 Han Chinese (Asia), and 105 Trio Indians (Native 
Americans) from Surinam (South America). Dectin-1 was sequenced completely in the Dutch 
population, with Tyr238X being the only nonsynonymous mutation identified. The Dutch 
population had an allele frequency of 0.069, and the Tanzanian population, 0.035; all 
persons with the mutation were heterozygotes. The mutation was absent in the populations 
from China and Surinam. This variant has been recorded in the dbSNP database, as 
rs16910526.  
 
A Human Genome Diversity Project selection browser was used to obtain further 
information about the frequency and world distribution of the SNP; this analysis confirmed 
our findings (Figure 3). We analyzed haplotype diversity within a white population and a 
black population by studying genomewide SNP data sets for samples obtained from 1422 
whites from the U.K. 1958 birth cohort 14 and 171 African Maasai from Kinyawa, Kenya (from 
HapMap Phase III) 15. Allele frequencies of the polymorphism within both populations did 
not differ significantly from those reported previously (whites, 0.078, and blacks, 0.023, as 
measured in our populations) 14. Minimal mutation-network analysis revealed that, among 
the 23 haplotypes found in both populations, only 2 contain the stop mutation (Figure SB in 
the Supplementary Appendix). Both haplotypes are present in both the European and 
African populations, and therefore are not population specific. In addition, the haplotypes 
are located near the ancient haplotype in the network, indicating that they are closely 
related to the ancient haplotype (Figure S5C in the Supplementary Appendix).  
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Figure 3. Polymorphisms and haplotypes of the dectin-1 stop mutation worldwide. The frequency 
of the dectin-1 polymorphism rs16910526 is shown for various populations of the world. The 
ancestral allele A leads to a functional dectin-1 receptor, whereas the derived allele C leads to an 
early-stop-codon mutation and nonfunctional dectin-1 receptor. The derived allele is observed 
only in populations from Africa and western Eurasia. The highest prevalence of the mutation 
(nearly 40%) is found in the San population in South Africa. 
  
Chapter 5 
76 
 
Discussion 
 
 
Defective surface expression of dectin-1 due to the Tyr238X polymorphism results in lack of 
β-glucan recognition and an impaired cytokine response by monocytes and macrophages but 
normal killing of C. albicans by neutrophils. These data show the important role of β-glucan–
dectin-1 pathways for normal activation of the cytokine response 16, but also show the 
redundant nature of dectin-1 in the phagocytosis and killing of Candida albicans. The normal 
function of neutrophils in persons in whom dectin-1 function is absent provides protection 
against invasive fungal infection. In contrast, the defective function of monocytes and 
macrophages with regard to cytokine release in the patients who were homozygous for the 
Tyr238X dectin-1 mutation is the most likely cause of the clinical phenotype characterized by 
mucocutaneous fungal infections.  
 
Dysregulation of cytokine profiles is typically seen in patients with mucocutaneous fungal 
infections such as recurrent vulvovaginal candidiasis 17. Dectin-1 is expressed on epithelial 
cells, and proinflammatory cytokines have been reported to be secreted by vaginal epithelial 
cells 18 and to increase the natural antifungal activity of these cells 19. It is therefore 
conceivable that dectin-1 function on epithelial cells would also be defective in our patients. 
Our data showing that a complete deficiency of dectin-1 is accompanied by mucosal fungal 
infections are in line with a recent study showing the susceptibility of dectin-1–knockout 
mice to mucosal candidiasis 20.  
 
Dectin-1 is also important for the development of the responses of type 17 helper T cells 21, 
and interleukin-17 production in our patients with defective dectin-1, as compared with 
healthy subjects, was reduced by 50% to 80% (Figure S4A in the Supplementary Appendix). A 
clinical syndrome that closely resembles the syndrome in our family, with regard to fungal 
complications, is the hyper-IgE syndrome. Patients with the hyper-IgE syndrome have a 
defect in interleukin-17 production in response to infections with Staphylococcus aureus 
(cutaneous and pulmonary infection) and C. albicans (onychomycosis and mucosal infection) 
22,23. Our family had an isolated interleukin-17 defect in response to C. albicans stimulation, 
and it is tempting to speculate that this is the cause of the clinical picture of fungal infections 
in the patients. Our findings are strengthened by the description in this issue of the Journal 
of a family with a mutation of CARD9, the adaptor molecule for dectin-1, who presented 
with a phenotype practically identical to that of our family 24.  
 
Finally, the finding of this dectin-1 mutation in persons from both Europe and Africa leads to 
additional hypotheses. First, the identification of this polymorphism in all African 
populations assessed (including the San population) suggests that this is an ancient mutation 
that most likely emerged more than 60,000 years ago, before the split of the modern human 
populations in the late Paleolithic 25. This hypothesis is supported by the finding that the 
location of the haplotypes containing the Tyr238X mutation was close to the ancient 
haplotype. Second, the relatively high prevalence of the polymorphism in these populations 
may represent an important genetic susceptibility factor for mucosal fungal infection.  
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Materials and methods 
 
 
Index family and other subjects 
To identify functional defects in the immune response to C. albicans, we designed a 
functional screening assay of mononuclear cells isolated from patients with recurrent 
vulvovaginal candidiasis or oral or esophageal candidiasis. Cells were stimulated with heat-
killed C. albicans, and cytokine production after 24 hours was assessed during screening. An 
immunologic and genetic analysis was performed on mononuclear cells obtained from a 
patient who had defective cytokine production, on stimulation with C. albicans or β-glucan, 
and from four family members. The study protocol was approved by the ethics committee of 
Nijmegen–Arnhem, the Netherlands. Written informed consent was obtained from all family 
members studied.  
 
In addition, we studied DNA samples, previously collected to assess the prevalence of the 
Tyr238X mutations, from several populations in various geographic locations. These samples 
were obtained from the country of origin, with the exception of the Chinese Han cohort, for 
which samples were from the Corriell Institute (catalog number, HD1000CHI). For all 
populations, subjects had provided written informed consent, and study approval was 
obtained from local ethics committees.  
 
For haplotype analyses, we used genomewide data on single-nucleotide polymorphisms 
(SNPs) from 1422 whites from the 1958 United Kingdom birth cohort 14 and from 171 Maasai 
from Kinyawa, Kenya 15. Genotype data for the Maasai population were downloaded from 
the International HapMap Project Web site (www.hapmap.org) and for the white population 
were obtained with the use of HumanHap300 BeadChips (Illumina). A region of 20 kb around 
the SNP rs16910526 was extracted from all samples in both genomewide SNP data sets. We 
used the Beagle software program to determine the haplotypes from genotypes of all 
subjects 26.  
 
Genetic analysis 
A detailed description of the methods used to sequence the dectin-1 gene is presented in 
the Supplementary Appendix (available with the full text of this article at NEJM.org). 
Network analysis was performed with the Network program, version 4.5.0.0 (www.fluxus-
engineering.com), which uses the median-joining method 27. The ancient haplotype was 
determined with the use of the dbSNP database (www.ncbi.nlm.nih.gov/projects/SNP/). 
Various analyses were conducted, with weighting applied separately for synonymous 
changes, nonsynonymous changes, transitions, and transversions.  
 
Modeling of dectin-1 structure 
The crystal structure of mouse dectin (Protein Data Bank code 2cl8 [PDB] ) was used as a 
template to build a homology model of the extracellular domain of human dectin-1. 
Modeling of the extracellular domain was performed on the "WHAT IF" server 
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(http.//swift.cmbi.ru.nl). Energy minimization and analysis were performed, to obtain the 
most reliable model of protein folding, with the YASARA program (www.yasara.org/) 28. 
 
 Fluorescence-Activated Cell Sorting 
Human peripheral-blood mononuclear cells (PBMCs) were obtained from the three family 
members who were homozygous for a dectin-1 mutation, the two family members who 
were heterozygous for a dectin-1 mutation, and five persons who were homozygous for the 
wild-type dectin-1 allele. The cells were incubated with murine anti–dectin-1 monoclonal 
antibody GE2 (5 µg per milliliter) 29 or isotype-control antibody, followed by allophycocyanin-
conjugated goat antimouse antibody (Pharmingen). Dectin-1 expression was determined by 
means of flow cytometry with the use of a fluorescence-activated cell sorter (FACSCalibur, 
BD Biosciences). Dectin-1 expression was assessed in cells from a mouse embryonic 
fibroblast cell line (NIH3T3) after transfection, with the use of an antihemagglutinin antibody 
(Covance), an IgG1 isotype-control antibody, and an antimouse antibody covalently labeled 
with R-phycoerythrin (Jackson ImmunoResearch).  
 
Candida binding, phagocytosis, and fungal-killing assays 
Binding of PBMCs to C. albicans yeast cells was measured by means of flow cytometry 30. The 
phagocytosis and fungal-killing assays for C. albicans were performed as previously 
described 31.  
 
Cytokine measurements 
PBMCs 12 (5x105) were incubated with 100 µl of β-glucan (10 µg per milliliter) and C. albicans 
that was live or had been heat-killed (through heating for 30 minutes at 56°C) at a 
concentration of 1x106 yeast cells per milliliter. For interleukin-17 stimulation assays, PBMCs 
were stimulated for 5 days in RPMI medium supplemented with 10% pooled human serum. 
After 4 hours, 24 hours, or 5 days of incubation at 37°C, supernatants were collected and 
stored at –70°C until enzyme-linked immunosorbent assay with the PeliKine-Tool set of 
reagents (Sanquin).  
 
Cloning and transfection studies 
The human dectin-1 isoforms were amplified, by means of a polymerase-chain-reaction 
(PCR) assay, from complementary DNA isolated from samples of peripheral-blood leukocytes 
obtained from the patients. The two primers used were 5'-
AAAGGATCCAGGGGCTCTCAAGAACAATG-3' and 5'-AAACTCGAGTCTTCCACCCTTCCCCTTAC-3'. 
The PCR products were purified with the use of the QIAquick PCR purification kit (Qiagen), 
cloned into the pCR4-TOPO3.1 vector (Invitrogen), and sequenced. The wild-type and 
mutant dectin-1 were cloned with the use of reverse primers — 5'-
CCCTTCCTCGAGCATTGAAAACTTC-3' and 5'-AAATCTCGAGTGAGGGCAGACTAC-3', respectively 
— allowing for the in-frame cloning of a hemagglutinin tag, which does not affect β-glucan 
binding 7. The products were subcloned into the retroviral vector pFB-Neo (Stratagene) and 
transfected into ecotropic packaging cells (Phoenix) with the use of FuGENE transfection 
reagent (Roche Molecular Biochemicals). After 48 hours, retroviral supernatants were 
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harvested and used to transduce NIH3T3 cells in the presence of Polybrene (Sigma), at a 
concentration of 5 µg per milliliter. A binding assay for zymosan was also performed, as 
previously described 32.  
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Supplemental methods and figures 
 
 
Isolation of cDNA, DNA and development of primers 
RNA was isolated from whole blood using the PAXgene blood RNA kit (Qiagen) according to 
the protocol. Isolated RNA was thereafter treated with DNase (Ambion) and reverse 
transcribed to cDNA using oligo(dT) primers and MMLV reverse transcriptase (Invitrogen). 
PCR on the cDNA to investigate transcription of the different Dectin-1 isoforms was 
performed with primer pairs adapted from Meyer- Wentrup et al (2007). DNA isolation was 
performed on whole blood using the isolation kit Puregenetm (Gentra system). DNA 
template of the Dectin-1 (also named CLEC-7A) sequence was taken from Genebank, 
chromosome position 12q13, NC_000012.10 (10160643..10174135, complement). Primer3 
software was used to develop all primers shown in Table 1. After amplification PCR products 
were cleaned using the kit High Pure PCR product purification kit (Roche) according to the 
manufacture protocol. Sequencing was performed at the Sequence Faculty at the 
department of human genetics Nijmegen. Sequence for four out of six exons was obtained 
using both forward and reverse primers (Table S1). However,  equences for exon 3 and 4 
were based on more than one forward sequences due to the lack of reverse primer 
specificity. No variations were detected in any exons other than exon 6. 
 
 
Supplementary table S1 
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Supplementary figure S1. Dectin-1 mutation leads to functional defects. Panel  A: IL-6 production 
capacity of monocytes isolated from healthy volunteers (dectin-1 wt), patients heterozygous 
(dectin-1 het), or patients homozygous for the mutation (dectin-1 hom), and stimulated for 4h 
with heat-killed or live C. albicans. Each patient represents a white or a black bar. Variation in the 
control group is presented as SD (n=5). Panel B:  IL-6 production capacity of monocytes isolated 
from healthy volunteers (dectin-1 wt), patients heterozygous (dectin-1 het), or patients 
homozygous for the mutation (dectin-1 hom), and stimulated for 4h with the TLR4 antagonist LPS, 
or the TLR2 antagonist Pam3Cys. Panel C: Synergism between dectin-1 and TLR2 stimulation of 
proinflammatory cytokines in cells isolated from control volunteers (dectin-1 wt) or patients 
homozygous (dectin-1 hom) for the stop codon mutation, after 24h stimulation at 37°C. (means ± 
SD of three experiments, n=5 healthy volunteers, n=3 homozygous patients; p<0.05). 
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Supplementary figure S2. Dectin-1 deficiency does not impair Candida phagocytosis and killing. 
Phagocytosis (A) and killing (B) of opsonized C. albicans by monocytes and neutrophils from 
healthy volunteers (five healthy volunteers without clinical signs of fungal infections, dectin-1 
con) or patients homozygous for the mutation (dectin-1 hom). Using this methodology in medium 
enriched with 10% human serum, phagocytosis receptors such as Fc-receptors or complement-
mediated binding are apparently sufficient to compensate for the absence of dectin-1. Results are 
presented as means ± SD of four experiments. 
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Supplementary figure S3. Dectin-1 mutation in a family with mucocutaneous fungal infections.  
Panel A: The nucleotide change (A > C) in exon 6 is shown in a person with the functional dectin-1 
receptor (wild type) and two individuals having the stop mutation in heterozygote or homozygote 
state. Panel B: Modeling of the mutated dectin-1 receptor. The missing nine aminoacids are 
depicted in red, the diagram showing the loss of a disulfide bridge and a Ca2+-binding site. 
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Supplementary figure S4. Dectin-1 mutation leads to functional defects. Panel  A: IL-17 
production capacity of PBMC from healthy volunteers (dectin-1 wt), patients heterozygous 
(dectin-1 het), or patients homozygous for the mutation (dectin-1 hom) stimulated for 5 days with 
heat-killed C. albicans. Panel B: Only wild-type, but not mutated, isoforms A or B of dectin-1 were 
able to mediate binding of zymosan to the transfected NIH3T3 cells. The specificity of the binding 
was demonstrated by its inhibition with the dectin-1 antagonist laminarin. Representative results 
of five independent experiments are presented. Panel C: The variant dectin-1 isoforms A (dectin-
1Amut) and isoform B (dectin1-Bmut) were poorly expressed on the surface of transfected 
NIHT3T cells, when compared to wild-type dectin-1 isoforms. Panel D: The pattern of 
transcription of the dectin-1 isoforms is similar between healthy individuals with wild-type dectin-
1 gene and patients homozygous for the early stop codon mutation. Panel E: Extracellular FACS 
staining of monocytes (Mo) and neutrophils (PMN) isolated from healthy volunteers (dectin-1 
con) or patients homozygous for the mutation (dectin-1 hom). 
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Supplementary Figure S5. Dectin-1 stop mutation/polymorphism and haplotypes in different 
populations. Panel A: Phylogenetic representation of the dectin-1 receptor aminoacid area 
surrounding the Tyr238Stop, shown in green, in the mammalian lineage showing that the location 
of the mutation is conserved. Panel B: Dectin-1 allele haplotype network of 1422 Caucasian (2844 
haplotypes) and 171 African (342 haplotypes) individuals. Each circle represents a unique 
haplotype node and colors represent the different populations. Green is used for Caucasian 
haplotypes, Blue for African, and black for the ancient haplotype according to the dpSNP 
information. Circles with red outline contain the two haplotypes containing the stop 
polymorphism. The red circle following the ancient haplotype represents a vector node and does 
not represent an observed haplotype. Area of all circles indicates the amount of alleles with that 
haplotype. At the lower part, which includes the two haplotypes containing the stop 
polymorphism, SNP rs numbers that change between the nods are presented. Panel C:The two 
haplotypes containing the 238Stop mutations. Only the first three SNPs differ between these 
haplotypes, which are located after exon 6. 
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Review 
 
 
The incidence of invasive fungal infections has increased over the past decades, due to the 
augmented use of immunosuppressive therapy, higher incidence of HIV, performance of 
major surgical procedures and aging of the population 1-3. Candida species are the fourth 
most common cause of nosocomial bloodstream infections and have a mortality rate up to 
40% despite the availability of new effective antifungal agents 4,5. The current consensus is 
that antifungal treatments strategies supplemented with immunotherapy, or vaccination in 
specific patient groups at risk, can improve the outcome and reduce mortality 6,7. 
 
The role of innate and acquired immunity for vaccination 
 
Long-lasting protection against microorganisms is gained through the activation of  the 
adaptive immune system represented by cellular immune and humoral immune responses 8. 
Depending on type of pathogen and site of infection, an adjusted balance between cellular 
and humoral responses is desirable 9,10. Historically, development of many vaccines 
emphasized induction of the humoral response. However, vaccines against pathogens that 
cause chronic or mucosal infections should preferable elicit a cellular response 11. 
Attenuated or killed microorganisms and pathogen specific proteins or polysaccharide-
protein conjugates have been used as vaccination strategies 8. Three signals are critical for 
effective stimulation of an adaptive immune response: (a) the presentation of antigens by 
antigen-presenting cells (APC) on MHC-II to T-cell receptor (TCR) on naïve CD4+ T-cell, (b) the 
up-regulation of co-stimulatory molecules, and (c) production of cytokines that direct 
differentiation of a certain type of helper T-cell (Th) response (Figure 1). This process is 
induced and regulated by recognition of pathogen associated molecular patterns (PAMPs) by  
pattern recognition receptors (PRRs) on the surface of APCs 12-14. Depending on the cytokine 
cocktails induced by PRR activation, the induction of the adaptive immune response is 
directed towards a Th1, Th2 or Th17 phenotype 15-17. Optimal inflammatory conditions are 
induced by immunization with living organisms, while vaccines containing only purified 
antigens need addition of adjuvants that have to induce stimulation of co-stimulatory 
molecules and cytokines 11,18. Most commonly used adjuvants are aluminum and calcium 
salts which are licensed for human use and enhance the humoral response 19 and they 
induce their effects through activation of PRRs. For example alum has been shown to exert 
its effect through recognition by NALP3, a pattern recognition receptor from the NLR family 
20,21. It is also expected that the novel squalene-based emulsion MF59 acts through 
activation of intracellular innate immune receptors, although the precise mechanism has to 
be further investigated 22,23. The deeper insight in the innate immune system obtained in the 
last years has lead to the design of new adjuvants based on PAMP-PRR interaction, in order 
to enhance specific cellular immunity elicited by vaccines. One such adjuvant now in clinical 
trials is the TLR9 agonist CpG-DNA 24.  
Chapter 6 
92 
 
 
Figure 1. Modulation of T-cell responses by innate immune system. Engagement of pathogen 
associated molecular patterns (PAMPs) from Candida albicans by pattern recognition receptors 
(PRRs) lead to the induction of specific cytokine profiles regulating the differentiation of naive 
CD4+ T-cells in to Th1 (T-helper 1), Th2 (T-helper 2), Th17 (IL-17 secreting T-helper) or Treg (T-
regulatory) cells. For activating naïve CD4+ T-cells, presentation of antigens on MHC class II to T-
cell receptor (TCR) is necessary in combination with engagement of co-stimulatory molecules. 
 
Vaccination strategy against Candida albicans 
 
C. albicans is a commensal microorganism, capable of colonizing mucosal sites of humans. 
Normally this does not lead to disease, because the epithelial barrier protects us against 
invasion of fungi. This protection is based on the anatomical barrier and the local immune 
response, both limiting the fungal burden and leading to a state of tolerance. When the local 
immune response is insufficient, a high fungal burden at the mucosal site will cause 
mucocutaneous candidiasis. When the epithelial barrier is breached, for example by surgical 
procedures or catheters, the local immune response will be crucial to prevent translocation 
of fungi to the blood stream (candidemia), which can lead to systemic candidiasis when the 
fungi cannot be cleared. Individuals with an impaired mucosal immune response have and a 
high local fungal burden and are at higher risk to develop a systemic candidiasis when their 
epithelial barrier is breached, or their systemic immune response is insufficient (e.g. 
neutropenia).  
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The innate host defense and cellular immune responses against C. albicans play an 
important role in the pathogenesis of mucocutaneous candidiasis, as illustrated by the high 
incidence of C. albicans infections in patients with HIV infection and low number of  CD4+ T- 
cells 25,26, or after treatment with immunosuppressive agents like corticosteroids 27. These 
clinical facts are strengthened by results obtained in experimental models of candidiasis in 
which it has been shown that the T-cells lead to protection against mucosal 28,29 and 
disseminated 30 C. albicans  infections. The humoral immune response may also play a role in 
invasive candidiasis, as shown by the antibody response against specific fungal cell-wall 
components in C. albicans infections 31,32. Opsonization by antibodies leads to enhanced 
phagocytosis and killing of C. albicans by human and murine mononuclear cells in vitro 33-35, 
while B-cell knock-out mice are more susceptible to experimental systemic, but not mucosal, 
candidiasis 36. Interestingly however, there is no higher incidence of fungal infections in 
human with immunoglobulin disorders 37,38. Passive immunization and the humoral response 
after active vaccination induces protection against disseminated infections with C. albicans 
39,40, but does not seems to play a crucial role in mucosal infections 41.  At this moment there 
is no active Candida vaccine available for humans, and passive immunization with 
neutralizing or opsonizing antibodies are in clinical trials. An excellent overview of the 
progress in development of fungal vaccines has recently published 7, but less work has been 
done regarding the optimal adjuvants to be used for C. albicans vaccines. 
Different strategies have been used to develop an active vaccine against C. albicans. The use 
of specific cell-wall components of Candida like Als1P, Als3P, Hsp90, mannans or enzymes 
like SAP2 42-45, led to protection against systemic C. albicans infection in mice as measured by 
decreased fungal outgrowth and improved survival. This response was mainly mediated by 
cellular immunity 30. These vaccines were mostly administered subcutaneously (s.c.) and 
adjuvants were needed to optimize protection. In other vaccination models, primary 
administration of a low dose of live C. albicans 46 or a low virulent Candida strain like PCA2 
47,48 intravenously (i.v.) led to protection after reinfection with a high dose of C. albicans. 
Orally administered or locally administered C. albicans in a low inoculum protected mice 
against reinfection with a higher infectious inoculum, this process was mediated by cellular 
immune mechanisms 41. These models provided insight in the type of cellular response 
needed for protection against Candida and provided a proof-of-principle that vaccination 
against Candida is feasible. 
 
Type of cellular responses needed for protection against Candida infections 
 
Activation of the innate immune system by C. albicans induces the production of a variety of 
proinflammatory cytokines and the expression of co-stimulatory molecules, which in turn 
mediate specific adaptive immune responses leading to protection against disseminated 
candidiasis and tolerance at the mucosal barrier. It is generally accepted that induction of a 
Th1 type cellular response is crucial for the defense against C. albicans 49-51. In contrast, a 
Th2 cellular response is considered non-protective, as it induces class-switch to non-
opsonizing antibody subclasses and IgE 52. Investigation of the role of Th17 in mediating the 
immune response has shown that Th17 memory cells are induced by Candida hyphae 53,54, 
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and in a murine model IL-17AR knock-out mice had an increased susceptibility to systemic 
candidiasis 55. However, deleterious effects of IL-17 inflammatory activities have also been 
described 56-58. Patients with an impaired IL-17 production suffer from mucosal C. albicans 
infections in hyper IgE syndrome (HIES)  and chronic mucocutaneous candidiasis (CMC) 59-61.  
In contrast to T-helper cells, regulatory T-cells (Treg) suppress inflammatory responses  in 
disseminated C. albicans, resulting in higher susceptibility in mice 62,63. However, the 
tolerization-inducing effects of Tregs seem to be beneficial at mucosal sites 58,64. 
Summarizing these data, one could conclude that for optimal protection against (chronic) 
mucosal Candida infections Th1, Th17 and Treg are important. An effective Th1 and antibody 
(humoral) response are important for defense against disseminated Candida infections. This 
information should be considered when making a choice of an adjuvant for anti-Candida 
vaccination. 
 
Role of TLRs in immune response against C. albicans 
 
The PRRs involved in the recognition of C. albicans have been recently reviewed 65. A short 
overview is given to determine the potential role of TLR ligation in modulating adaptive 
cellular immune responses in Candida vaccination.  
Toll-like receptors (TLRs) are type I integral membrane glycoproteins with a cytoplasmic 
domain containing a signal motif homologue to interleukin-1 receptors (Toll-IL-1 receptor 
domain or TIR). The TIR domain can associate with adaptor molecules for downstream 
signaling. All TLRs use the adaptor molecule MyD88 (myeloid differentiation factor 88 
adaptor molecule) for induction of intracellular signals with the exception of TLR3. TLR4 also 
uses adaptor molecule TRIF (Toll-interleukin-1 receptor  domain- containing adaptor 
inducing IFN) for induction of type I interferons, whereas TLR3 only uses TRIF. After ligation 
of TLRs, activation of a protease cascade leads to nuclear translocation of transcription 
factors NF-κB and IRF3, followed by transcription of cytokine and chemokine genes (Figure 
2). Ligation of TLRs on DCs also induces expression of co-stimulatory molecules (maturation), 
and this in combination with specific cytokine profiles drives the differentiation of naïve 
CD4+ T-cells (Figure 1). In this way TLRs function as mediators between innate and adaptive 
immune responses. TLRs might also play a direct role in humoral responses, shown by an 
impaired B-cell dependent antigen-specific antibody response in MyD88 -/- mice 66,67, 
although other groups could not confirm these results 68,69. 
Several TLRs are involved in inflammatory responses induced by C. albicans, of which TLR2 
and TLR4 are the most studied 65. Activation of TLR2 signal pathways in APCs by ligation of C. 
albicans cell-wall components like phospholipomannan leads to production of cytokines 
such as TNF, IL-1β and IL-10 70-73, while IL-12 and IFNγ is not induced, resulting in a balance 
favoring a Th2 and Treg cellular response 74. Indeed, TLR2-/-  mice are more resistant to 
lethal disseminated candidiasis, indicating a TLR2-mediated inhibitory effect on 
inflammation in this model 62,63. However, other groups have reported a higher susceptibility 
for disseminated candidiasis in TLR2 -/- mice 73. These discrepancies likely depend on the 
difference in background of mouse used and different Candida strains. It would be useful to 
have additional information on the differences in the adaptive cellular immune responses in 
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these models, as this could give important information over the delicate balance between 
Th1/Th2/Th17 response and the consequences for fungal burden and survival.   
Vaccination with an i.v. low virulent Candida strain PCA2 in TLR2-/- mice lead to lower 
induction of cytokines and antibodies, but these mice were normally protected against 
rechallenge with a virulent C. albicans strain 48. After sublethal i.v. infection with a virulent C. 
albicans strain, TLR2-/- mice were not protected against lethal i.v. hyphae reinfection 75. 
These differences could be explained by differences in the induction of adaptive immune 
responses by the PCA2 or the virulent Candida strain. Both blastoconidia and hyphae can 
induce TLR2-dependent cytokine production, whereas blastoconidia are also potent INFγ 
inducers (TLR4-dependent).  Hyphae fail to induce INFγ and consequently induce a Th2 
response 76.  
 
 
 
 
Figure 2. TLR signal pathways activated by C. albicans and induction of cellular immune responses. 
Engagement of cell-wall components and DNA of C. albicans conidia or hyphae by TLRs activates 
the Toll-IL-1 receptor domain (TIR) which lead to association with MyD88 (myeloid differentiation 
factor 88 adaptor molecule) or TRIF (Toll-interleukin-1 receptor  domain- containing adaptor 
inducing IFN) activating a protease cascade, inducing nuclear translocation of transcription factors 
NF-κB and IRF3/7. Transcription of cytokine genes lead to production of specific cytokine profiles 
and regulation of T-cell differentiation.  
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TLR2 forms heterodimers with TLR1 and TLR6 77. While TLR1 is not involved in the 
recognition of C. albicans, TLR6 -/- showed an impaired production of IL-10 and an increased 
production of INFγ, similarly to TLR2-/- mice. However, the susceptibility to disseminated 
candidiasis was not increased in TLR6 -/-mice 78. The effect of TLR6 has not been investigated 
in vaccination models. 
Blastoconidia of C. albicans induce TLR4- mediated immune responses by ligation of O-linked 
mannan 79.  The role of TLR4 in disseminated candidiasis is illustrated in murine models, in 
which TLR4 -/- mice  are more susceptible for disseminated C. albicans infection due to a 
decreased induction of KC and MIP2. This results in a deficient recruitment of neutrophils 
and higher fungal burden in the kidneys of TLR4 -/- mice compared to that of WT mice 71,75. 
The human TLR4 polymorphisms Asp299Gly and Thr399Ile led to a higher susceptibility for 
Candida bloodstream infections 80. Stimulation of DCs by C. albicans induces TLR4-
dependent cytokines production like IFNγ and IL-12 resulting in a Th1-mediated cellular 
response 76. Although the recognition of C. albicans by TLR4 has been shown in vitro and 
vivo, differences between various Candida strains may account for reports showing that 
TLR4 plays a minor role in candidiasis 81,82. TLR4 also seems to be important for adaptive 
immune responses induced by C. albicans. Mice are protected against i.v. hyphal Candida 
infection after a sublethal i.v. infection with C. albicans, and this is mediated in a TLR4-
dependent manner 75. This inflammatory response is apparently mediated by TLR4, as O-
linked mannans are known to be recognized by TLR4 79. 
Finally, TLR9 has a redundant role in disseminated candidiasis in mice, although C. albicans 
can induce TLR9-dependent cytokine production 83. Also in a reinfection model, TLR9 -/- 
mice were normally protected against i.v. C. albicans hyphae infection after preinfection 
with i.v. conidia 75. There is no data on CpG-DNA as adjuvants in C. albicans vaccination 
models, although it has been shown that they enhanced the Th1 induced protection against 
invasive aspergillosis in mice vaccinated with recombinant Aspergillus proteins 84. 
 
Signal pathways activated by C-type lectin receptors 
 
C-type lectins receptors (CLRs) are pattern recognition receptors (PRRs) characterized by  C-
type lectin-like domains (CTLDs) and some of them are involved in antifungal immunity 85. 
These receptors are expressed as transmembrane proteins with or without intracellular 
signal motifs, or occur as extracellular proteins functioning as opsonins. Several of these 
CLRs can directly induce production of cytokines, while they also modulate innate and 
adaptive immune responses or function as binding and uptake receptors. The CLRs involved 
in recognition of C. albicans have recently been reviewed 65,86; here we will discuss their 
possible role in adaptive immune responses. 
 
Dectin-1 
 
Dectin-1 is  a type II transmembrane receptor and belongs to the NK-cell-receptor-like C-type 
lectin receptor family (CLRs) 87. Dectin-1 has an extracellular carbohydrate-recognition 
domain (CRD), a stalk region and an intracellular immunoreceptor tyrosine-based activation 
motif (ITAM)-like motif 88. Phosphorylation of the single tyrosine in this signal motif leads to 
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recruitment of SH2-domain-containing protein spleen tyrosine kinase (SYK) in a Scr kinase 
dependent manner 89,90. Activation of SYK pathways by dectin-1 is not induced in all myeloid 
cells and seems to be restricted to dendritic cells and a subset of macrophages which are 
reversibly programmed by growth factors like GM-CSF 90,91. Dectin-1 signaling in myeloid 
cells (BMDC) recruit SYK dependent CARD9 and Bcl-10-Malt1 leading to activation of 
transcription factors MAPK and NF-κB 92-94, resulting in cytokine production and maturation 
of DCs. Dectin-1 also synergizes with TLR2 and TLR4-induced signals that are dependent on 
the adaptor molecule MyD88, inducing TNF, IL-10, TGF-β and maturation of DCs 95-97. 
Nuclear transcriptional factor NFAT is activated by dectin-1 signaling after engagement of 
zymosan leading to the production of cytokines independent of TLR2 98. The signal pathway 
involved in the induction of phagocytosis of β-glucan by dectin-1 in macrophages is 
depending on the proximal tyrosine of the ITAM-like motif and Src kinase activation, but is 
SYK independent 90,99.  Engagement of dectin-1 induces phagocytosis mediated by the 
GTPases Cdc42 and RAC-1 involving reorganization of the actin cytoskeleton 99,100.   
 
Role of dectin-1 in the immune response against C. albicans 
 
The cell wall of C. albicans consists of large amounts of β-glucan that is covered by a layer of 
mannans that prevent direct exposure to dectin-1. β-glucan is exposed and can bind dectin-1 
only at the level of the budding scars of blastoconidia, where the integrity of the cell wall is 
disrupted. Hyphae do also have a thin layer of β-glucan in their cell wall which can be 
detected by antibodies against β-glucan 101, however, this β-glucan does not seem to bind 
dectin-1 65,102.  Dectin-1-/- mice are more susceptible to disseminated candidiasis 103, and 
this is observation is strengthened by higher susceptibility to disseminated candidiasis in 
CARD9 -/- mice 92. However, another study could not confirm the nonredundant role of 
dectin-1 in C. albicans infection 104. The role of dectin-1 in mucosal candidiasis has not been 
established yet, but several facts suggest that dectin-1 plays a crucial role in the mucosal 
immunity against Candida. First of all, dectin-1 is expressed in the intestinal tract, and the 
outgrowth of Candida in the digestive tract from dectin1 -/- mice was disproportionally high, 
leading to occlusion and contributing to the increased mortality 103,105,106. Secondly, dectin-1 
is paramount for IL-17 induction by Candida  94,107, and patients with an impaired IL-17 
production caused by STAT3 mutations (hyper-IgE syndrome) and chronic mucocutaneous 
candidiasis have recurrent Candida infections 59-61. 
No data are currently available on the role of dectin-1 in vaccination against C. albicans, 
although one would expect that engagement of dectin-1 will lead to a cytokine response 
inducing Th1 and Th17, which are both protective against Candida. Moreover, β-glucans are 
not only a cell wall component of all fungi but also occur abundantly in some algae, plants 
and mushrooms, and have been used for their immunomodulatory property for a long time 
108,109. It has been therefore hypothesized that β-glucans can exert patent adjuvant effects, 
presumably through interaction with dectin-1. However, the usage of β-glucans as adjuvants 
has to consider the chemical and biological properties of the various β-glucan preparations. 
The most commonly used β-glucan preparation is zymosan, a particle of the cell-wall of 
Saccharomyces cerevisiae, containing besides β-glucan also components that activate MR 
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and TLR2 signal pathways. The consequence of using this stimulus is parallel activation of 
different signal pathways. By using a soluble β-glucan that does not induce activation of the 
cell by itself, engagement of zymosan to the β-glucan receptor could be inhibited. This 
method indicates differences between soluble β-glucans that are biological inert and can 
even prevent binding to dectin-1 and phagocytosis, and particulated β-glucans that induce 
phagocytosis and activate signal pathways. Not only there are differences between soluble 
and particulated β-glucans, but the size of  the particles also influences the immunological 
response 109. Curdlan is a β-1,3-glucan derived from Alcaligenes feacalis that is used as a 
pure dectin-1 ligand. The larger particles obtained from curdlan induced higher production 
of pro-inflammatory cytokines in mBMDC compared to the smaller pure β-1,3-glucan 
particles obtained from S. cerevisiae. This difference in cytokine response largely depended 
on particle size, because the difference in cytokine production disappeared when curdlan 
was sonicated to the same particle size as the particles obtained from S. cerevisiae 91. These 
differences in response caused by the nature of  β-glucan should be taken in account when 
targeting dectin-1 for potential adjuvant activity in vaccination.  
 
Dectin-2 
 
Dectin-2 is a type II transmembrane receptor with a single CRD and a stalk region, but 
without an intracellular signaling motif 110. Dectin-2 is expressed on macrophages and 
dendritic cells and is up-regulated when these cells are stimulated with particles containing 
high-mannose structures like C. albicans hyphae 111,112. The specific ligand for dectin-2 is not 
known. Dectin-2 signaling occurs in collaboration with FcRγ chain and activates NF-κB and 
can induce IL-1Ra and TNF production 113. No data on dectin-2 involvement in Candida 
reinfection or vaccination models are currently available. 
 
Macrophage mannose  receptor 
 
The macrophage mannose receptor (MR) is a type I transmembrane receptor with an 
extracellular domain existing of a fibronectin type II domain, a cysteine-rich domain, eight 
CRDs and a short cytoplasmic tail. The CRD 4-8 function as binding site for PAMPs and can be 
activated by terminal mannose, fucose and N-acetyl glucosamine leading to Ca++  
dependent signaling 114-116. MR is also expressed intracellularly and can be shed from the cell 
membrane. Both macrophages and dendritic cells (DC) express MR 117-119. Ligation of MR can 
induce phagocytosis of fungi, although this has been recently challenged in case of C. 
albicans 120.  Because MR has no known cytoplasmic signaling motif, there is not much 
known about the signal pathways activated by engagement of MR. Cross-linkage of MR with 
an activating anti-MR-antibody induced cytokine  (IL-10 and IL-1Ra) production in DC, and 
up-regulation of co-stimulatory molecules leading to Th2 polarization in vitro 121. MR 
engagement by mannans of M. tuberculosis also induced a Th2 immune response, by 
inhibiting production of Th1 cytokines 121,122. From these data one could conclude that MR 
binding leads to Th2 polarization. However, mannans on pathogens are complex molecules 
and their biological effects can differ depending on the structure 123,124. On the outer layer of 
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the cell-wall, C.  albicans expresses N-linked phosphomannans and their binding to MR on 
human DC lead to internalization and cytokine production 124,125. Human mononuclear cells 
produced Th1 cytokines after stimulation with Candida in a MR-dependent manner 79. Also 
in murine models engagement of MR by C. albicans induced the proinflammatory cytokines 
IL-1β, IL-6, and GM-CSF 126, and MR deficiency led to a reduction of TNFα and MCP-1 release 
in response to C. albicans uptake 127. Intra-peritoneal infection of  MR deficient mice lead to 
a higher fungal burden compared to their WT littermates, although it did not influence 
mortality 128. The general conclusion that can be drawn from these studies is that 
engagement of MR by C. albicans mannans induces proinflammatory cytokine responses 
that result in a predominant cellular Th1 response. There are no data published on the role 
of MR in reinfection models. If an adjuvant MR-ligand would be used, the structure of the 
candidate mannans to be employed may be crucial, as shown by the differences in cytokine 
profiles induced by the mannans of different microorganisms. In addition, the chemical 
treatment of mannans influences biological responses 129.  
 
DC-SIGN and Mincle 
 
DC-SIGN (Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin) is 
a type II transmembrane receptor with a single CRD, a stalk region and a cytoplasmic tail 
with signal motifs. DC-SIGN can form multimers and activate internalization signal pathways. 
DC-SIGN is expressed on dendritic cells and endothelium. Ligation with high-mannose 
structures leads to Ca++ dependent activation and tetramerisation of the receptor 130. The 
role of DC-SIGN in phagocytosis is disputable, whereas induction of endocytosis and uptake 
of pathogens is well established 131. DC-SIGN activates intracellular signal pathways involving 
Raf-kinase, ERK1 and ERK2, leading to cytokine production and modulation of TLR signal 
pathways. Activation of these signal pathways leads to an enhanced IL-10 production, 
thereby favoring a Th2 cellular immune response 132,133. The uptake of C. albicans by human 
dendritic cells depends on the binding of N-linked mannan to DC-SIGN and induces IL-6 
production 124,134. Stimulation of DC-SIGN signal pathways for immunomodulation in 
vaccination is therefore likely to elicit mainly Th2 responses, limiting the usefulness of DC-
SIGN as target for adjuvant effects.  
Mincle (macrophage-inducible C-type lectin) is a type II transmembrane protein with a single 
CRD, a short stalk region and an intracellular region that signals by association with FcRγ 
adaptor  and activates the Syk-CARD9 pathway 135,136. Both human and mouse Mincle have 
been recently shown to bind C. albicans and contribute to cytokine stimulation 137 and 
Mincle deficient mice were more susceptible to systemic candidiasis 138. Nothing is known 
about the role of Mincle in reinfection or vaccination models. 
 
Cross-talk between dectin-1 signals and TLR-induced inflammatory pathways 
 
Activation of inflammation leads to phagocytosis and killing of microorganisms, production 
of cytokines, migration, maturation of APCs and activation of specific of T-cells subsets. As 
microorganisms can activate more pathways simultaneously by ligation of different PRRs, 
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interaction between these pathways will occur and could induce a certain degree of 
specificity in the innate immune response to pathogens. Besides the MyD88-dependent 
interaction between dectin-1 and TLR2 for the induction of proinflammatory cytokines in 
macrophages, it has also been shown that dectin-1 signal pathways synergize with other 
TLRs. Particulated pure β-glucan derived from S. cerevisiae induced synergistic effects on the 
production of TNF, MIP-1α and MIP-2  when murine macrophages were stimulated in 
combination with Pam3Cys (TLR2-ligand), LPS (TLR4), flagellin (TLR5), CL-097 (TLR7) and 
ODN1826 (TLR9). These effects were exerted in a SYK and MyD88-dependent way by 
enhanced translocation of NF-κB 139. Stimulation of primary human cells with soluble curdlan 
in combination with Pam3Cys (TLR2) or LPS (TLR4) induced synergistic IL-10 and TNFα 
production in a dectin-1-dependent manner 140. In human monocyte-derived DCs (mono-
DC), simultaneous stimulation with β-glucan and Pam2Cys (TLR2) or R848 (TLR8) induced 
synergistic IL-23 production, resulting in enhanced induction of IL-17 by co-cultured CD4+T- 
cells 141. In human mono-DC, β-glucan did not induce IL-12p75 in absence of R848 (TLR8) and 
the induction could be inhibited by TLR2 stimulation 141. Similarly, stimulation of murine DC 
with β-glucan did not induce IL-12p75 in the absence of INFγ, indicating interaction between 
dectin-1 and INFγ signal pathways 97. These insights into the collaboration between TLR- and 
CLR-induced inflammatory pathways are therefore crucial for development of effective 
adjuvants and vaccine design (Figure 3). Therefore, an efficient adjuvant for Candida 
vaccination should probably be able to stimulate several of these receptors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. C-type lectin receptor signal pathways activated by C. albicans and induction of cellular 
responses. Cell-wall components of C. albicans blastoconidia and hyphae can activate C-type 
lectin receptor signal pathways that induce cytokine production and regulation of T-cell 
proliferation. Engagement by dectin-1 and DC-SIGN can modulate TLR pathways and enhance or 
inhibit cytokine responses. Ligation of dectin-1 leads to phosphorylation of the immunoreceptor 
tyrosine-based activation motif (ITAM)-like motif and activation of a protease cascade containing 
CARD9 leading to translocation of NF-κB or NFAT. The dectin-2 and Mincle signaling cascade is 
activated by association of the Fcγ receptor-adaptor molecule (FcγR-adapt). 
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Concluding remarks and future directions 
 
Recent progress has provided important novel insights in the processes driving the adaptive 
immune responses. Central to these developments is the discovery of pattern recognition 
receptors like TLRs and CLRs that not only induce innate immune responses, but also 
modulate cellular and humoral adaptive immunity. As vaccination is one of the great 
achievements in medicine and probably the most powerful tool to protect human and 
animals against infectious disease, further vaccine development and optimization of current 
strategies can improve health status of large groups of people. Development of a vaccine 
against Candida spp. should induce both cellular and humoral immune responses. While the 
TLRs are strong inducers of inflammatory responses, it seems that the CLRs have the 
potential to modulate these responses by enhancement or inhibition of cytokine production. 
Understanding the natural host defense mechanisms against pathogens like C. albicans 
therefore helps to identify the proper targets for inducing a strong adjuvant effect, in order 
to stimulate an effective adaptive immune response and protection.  
An exciting new development is the discovery that specific human gene mutations and 
polymorphisms are linked to signal pathways resulting in susceptibility for specific 
pathogens. STAT3 mutations identified in patients with hyper IgE syndrome have recently 
been linked to a defective IL-17 production and a diminished Th17 response, resulting in 
recurrent mucosal Candida infections. Similarly, we have recently described a family with 
defective dectin-1 expression due to an early stop-codon mutation leading to an increased 
susceptibility to mucosal Candida infection 142, and a similar phenotype has been described 
in a family with CARD9 deficiency 143. Linkage of genetics to functional immunological data 
proves therefore to be a very powerful research tool. 
A very important task of future studies will be to identify the adjuvant activity of specific PRR 
ligands in context of Candida vaccination. Combinations of various candidate vaccines with 
the known TLR/CLR adjuvants should be tested. In addition, new adjuvants containing 
combinations of TLR and CLR specificities should be designed and tested. Through these 
strategies, we should be able to develop new and potent vaccine candidates against Candida 
infections in the coming years. 
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Abstract 
 
  
The recognition of peptidoglycan by cells of the innate immune system has been 
controversial; both TLR2 and nucleotide-binding oligomerization domain-2 (Nod2) have been 
implicated in this process. In the present study we demonstrate that although Nod2 is 
required for recognition of peptidoglycan, this leads to strong synergistic effects on TLR2-
mediated production of both pro- and anti-inflammatory cytokines. Defective IL-10 
production in patients with Crohn’s disease bearing loss of function mutations of Nod2 may 
lead to overwhelming inflammation due to a subsequent Th1 bias. In addition to the 
potentiation of TLR2 effects, Nod2 is a modulator of signals transmitted through TLR4 and 
TLR3, but not through TLR5, TLR9, or TLR7. Thus, interaction between Nod2 and specific TLR 
pathways may represent an important modulatory mechanism of innate immune responses.  
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Introduction   
 
  
Several years ago, a susceptibility locus for Crohn’s disease on chromosome 16 was 
identified and named the IBD1 locus 1; later, the candidate nucleotide-binding 
oligomerization domain-2 (Nod2) gene was identified within the IBD1 locus 2-4. Because 
Nod2 is a member of the NOD-leucine-rich repeat protein family (also named the 
CATERPILLER family), which is known to be involved in recognition of microbial structures, 
and is expressed intracellularly in APCs 5, it has been hypothesized that Nod2 may be 
involved in pattern recognition of pathogens.  
 
Initially, Nod2 was suggested to be an intracellular pattern recognition receptor for LPS 6, 
similar to the Nod1 7, but later studies have demonstrated that Nod2 is the intracellular 
receptor for the muramyl dipeptide (MDP) component of peptidoglycan (PGN) 8,9. However, 
other studies have shown that PGN stimulates cytokine production through TLR2, and it has 
been unclear whether Nod2 and TLR2 pathways are independent or interact with each 
other. The latter possibility has been suggested in patients with Crohn’s disease homozygous 
for the 3020insC mutation of the Nod2 gene, who were found to have a defective release of 
cytokines not only after stimulation with MDP and PGN, but also after other TLR2 stimuli 
such as tripalmitoyl-S-glycerylcysteine (Pam3Cys) 10. Moreover, the interaction between the 
Nod2 and TLR2 pathways is sustained by recent data from mice deficient in Nod2, which 
show down-regulation of TLR2-mediated Th1 responses by MDP 11.  
 
In the present study we investigated the possible interaction between Nod2 and TLR 
pathways in human cells by studying the modulation of TLR-induced cytokine production by 
Nod2 signals activated by MDP. We assessed 1) the differential role of Nod2 and TLR2 for 
the induction of cytokines by Staphylococcus aureus PGN; 2) the synergistic effects of MDP 
on the cytokine production stimulated by the TLR2 ligands Pam3Cys and macrophage-
activating lipopeptide 2 from Mycoplasma fermentation (MALP2); and 3) the functional 
consequences for the Nod2/TLR2 synergism of the Nod2 3020insC frameshift mutation in 
patients with Crohn’s disease. In addition, we have investigated the possible interaction of 
Nod2 with other TLRs, namely the synergism of MDP/Nod2 with LPS (TLR4 signals), flagellin 
(TLR5), polyinosinic-polycytidylic (poly(I:C); TLR3), unmethylated CpG sequences of bacterial 
DNA (TLR9), and loxoribin (TLR7).  
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Results   
 
 
Requirement for TLR2 and Nod2 for stimulation of cytokines by PGN 
 
To investigate the involvement of TLR2 and Nod2 in the recognition of PGN, we stimulated 
cells isolated from mice deficient in TLR2 or from patients homozygous for the 3020insC 
mutation. TLR2–/– macrophages released significantly less TNF and IL-10 after stimulation 
with commercial PGN than control TLR2+/+ mice, whereas the production of TNF and IL-10 
by TLR4-defective ScCr mice was intact (Fig. 1A). In contrast, stimulation with purified PGN, 
although less than that of commercial PGN, was independent of both TLR2 and TLR4 (Fig. 
1B). In contrast, MNC isolated from patients homozygous for the 3020insC Nod2 mutation 
showed deficient production of TNF and IL-10 after stimulation with purified PGN (Fig. 2).  
 
 
 
Figure 1. PGN stimulation of cytokines: requirement for TLR2. Peritoneal macrophages isolated 
from either wild-type mice or mice deficient in TLR2 or TLR4 were stimulated with 1 µg/ml 
commercial PGN (A) or purified PGN (B) for 24 h at 37°C. TNF and IL-10 were measured by 
specific RIA and ELISA, respectively. Data are presented as the mean ± SD (n = 10/group) and 
were compared by the Mann-Whitney U test (*, p < 0.05). 
  
The data showing the requirement for TLR2 only for the recognition of commercial PGN are 
further strengthened by the observations of CHO cells transfected with human TLR2. 
Stimulation with commercial PGN led to signal transduction and CD25 expression in TLR2-
transfected cells, as did Pam3Cys, but not in cells transfected with human TLR4. In contrast, 
the purified PGN did not induce CD25 expression in either TLR2- or TLR4-transfected cells 
(not shown).  
Chapter 7 
118 
 
 
 
 
Figure 2. PGN stimulation of cytokines: requirement for Nod2. MNC isolated from four 
patients with Crohn’s disease homozygous for the 3020insC Nod2 mutation (Nod2fs) and five 
patients with the wild-type Nod2 allele were stimulated with 1 µg/ml purified PGN for 24 h at 
37°C. TNF and IL-10 were measured by specific RIA and ELISA, respectively. Data are presented 
as the mean ± SD and were compared by the Mann-Whitney U test (*, p < 0.05). 
 
Nod2 synergizes with TLR2 for production of cytokines 
 
The data showing the requirement for both Nod2 and TLR2 for the production of cytokines 
by commercial PGN suggest an interaction between these two pathways. In line with this 
hypothesis, the specific Nod2 ligand MDP was found to have a synergistic effect on the 
induction of TNF, IL-1β, and IL-10 upon co-stimulation with the specific TLR2 agonists 
Pam3Cys (Fig. 3A) and MALP2 (Fig. 3B). In contrast, no IL-12p70 production was measured 
with any of the stimuli tested in both ELISAs used. 
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Figure 3. MDP synergizes with TLR2 agonists for the production of cytokines. MNC isolated from 
five healthy volunteers were stimulated with 10 µg/ml MDP, 1 µg/ml Pam3Cys or a combination 
of both (A). A similar combination of stimuli, but using MALP2 instead of Pam3Cys, is presented in 
B. After stimulation for 24 h at 37°C, TNF, IL-1, and IL-10 were measured by specific RIAs or ELISA, 
respectively. Data are presented as the mean ± SD, and were compared by the Mann-Whitney U 
test (*, p < 0.05). 
 
To investigate whether MDP/Pam3Cys synergism is dependent on Nod2 and TLR2, we 
repeated the same experiment in patients bearing Nod2 mutations or mice deficient for 
TLR2. The MDP/Pam3Cys synergism was abrogated in patients homozygous for the 3020 
insC mutation (Fig. 4). In addition, no synergism between MDP and Pam3Cys was observed 
in TLR2–/– mice (Fig. 5). These data demonstrate that both Nod2 receptors and TLR2 are 
required for the synergistic effect of MDP and Pam3Cys.  
 
 
 
Figure 4. MDP/Pam3Cys synergistic stimulation of cytokine production depends on Nod2. MNC 
isolated from four patients with Crohn’s disease homozygous for the 3020insC Nod2 mutation 
(Nod2fs), five patients heterozygous for Nod2 mutations (Nod2het), five patients with the wild-
type Nod2 allele (Nod2wt),and five healthy volunteers with wild-type Nod2 (controls) were 
stimulated with 10 µg/ml MDP, 1 µg/ml Pam3Cys or a combination of both (A and B). TNF and IL-
10 were measured after 24-h stimulation at 37°C by specific RIA and ELISA, respectively. Data are 
presented as the mean ± SD, and were compared by the Wilcoxon paired test (*, p < 0.05). 
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Figure 5. MDP/Pam3Cys synergistic stimulation of cytokine production depends on TLR2. 
Peritoneal macrophages isolated from either wild-type mice (TLR2+/+) or mice deficient in TLR2 
(TLR2–/–) were stimulated with 10 µg/ml MDP, 1 µg/ml Pam3Cys or a combination of both. TNF 
and IL-10 were measured after 24-h stimulation at 37°C by specific RIA and ELISA, respectively. 
Data are presented as the mean ± SD and were compared by the Wilcoxon paired test (*, p < 
0.05). 
 
Nod2 modulates signaling via TLR4 and TLR3 pathways, but not TLR5-, TLR9-, and TLR7-
mediated signals 
 
Microorganisms display complex combinations of pathogen-associated molecular patterns 
(PAMPs) involved in simultaneous stimulations of more TLR pathways. We have investigated 
whether Nod2 modulates signals induced by various TLR agonists. Co-stimulation with the 
specific Nod2 ligand MDP potentiated the induction of TNF induced by LPS (TLR4 
stimulation; Fig. 6A) and poly(I:C) (TLR3; Fig. 6C), whereas no effect was observed after 
stimulation with CpG (TLR9; Fig. 6B), flagellin (TLR5; Fig. 6D), or loxoribin (TLR7; not shown). 
The loss of synergistic activity in patients homozygous for the 3020insC Nod2 allele 
demonstrates that Nod2 is crucial for the potentiation of TLR4 and TLR3 signals by MDP (Fig. 
6). 
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Figure 6. Nod2 signals potentiate TNF production induced by TLR4 and TLR3 ligands. MNC isolated 
from four patients with Crohn’s disease homozygous for the 3020insC Nod2 mutation (Nod2fs), 
five patients heterozygous for Nod2 mutations (Nod2het), five patients with the wild-type Nod2 
allele (Nod2wt), and five healthy volunteers with wild-type Nod2 (controls) were stimulated with 
10 µg/ml MDP, 1 ng/ml LPS (A), 5 µg/ml CpG motifs (B), 50 µg/ml poly(I:C) (C), or 10 ng/ml 
flagellin (D), either alone or in combination with MDP . TNF was measured after 24-h stimulation 
at 37°C by specific RIA. Data are presented as the mean ± SD and were compared by the Wilcoxon 
paired test (*, p < 0.05). 
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Discussion   
  
In the present study we demonstrate that both TLR2 and Nod2 are required for the 
stimulation of cells by commercial PGN, whereas only Nod2 recognizes purified PGN. Nod2- 
and TLR2-mediated signals synergize at the level of proinflammatory and anti-inflammatory 
cytokine production, and this synergism is absent in patients with Crohn’s disease who are 
homozygous for the Nod2 3020insC mutation. Patients with Crohn’s disease bearing the 
3020 insC mutation mainly display a defective release of the anti-inflammatory cytokine IL-
10 12. In addition to its synergistic activity with TLR2, we have demonstrated that Nod2 
modulates the intracellular signals induced by TLR4 and TLR3, but not by TLR5, TLR9, and 
TLR7 agonists.  
There has been both confusion and controversy about whether recognition of PGN by the 
cells of the innate immune system occurs by surface TLR2 or by intracellular Nod2. Based on 
the studies performed in TLR2–/– mice, which are unresponsive to PGN and display 
enhanced susceptibility to Gram-positive microorganisms 13, it has initially been proposed 
that TLR2 is the cellular receptor for PGN. This assumption has later been challenged by the 
discovery of Nod2 as an intracellular receptor for the MDP component of PGN 14. Nod2 
mediates recognition of MDP and induces NF-κB activation after MDP challenge 15,16, and 
mice deficient in Nod2 fail to respond to a challenge with MDP 17. In addition, mutations in 
Nod2 have been implicated in the pathogenesis of Crohn’s disease 18,19, and patients 
homozygous for the 3020insC mutated allele have defective cellular responses to MDP and 
PGN 20. The apparent discrepancy between the studies implicating either TLR2 or Nod2 for 
the recognition of PGN could be explained in two ways: firstly, by the contamination of 
commercial PGN by TLR2 ligands such as lipoteichoic acid, and secondly, by the cooperation 
between Nod2 and TLR2 pathways for the induction of cytokines. In the present study we 
demonstrate that although Nod2 recognizes purified PGN, both TLR2 and Nod2 are required 
for the efficient induction of proinflammatory cytokines by commercial PGN preparations, 
demonstrating that there is interaction between the TLR2 and Nod2 pathways.  
 
A possible interaction between TLR2 and Nod2 pathways was also suggested by our 
observation that patients homozygous for the loss of function 3020insC Nod2 mutation are 
defective for the release of cytokines not only after PGN stimulation, but also after challenge 
with other TLR2 stimuli, such as Pam3Cys 21. In the present study we demonstrate a 
synergism between Nod2- and TLR2-mediated signals, as shown by the synergistic effect of 
MDP on both Pam3Cys- and MALP2-induced TNF, IL-1β, and IL-10 production. The need for 
both receptors for this effect is demonstrated by the absence of synergism in patients 
bearing the 3020insC Nod2 mutation as well as in TLR2–/– mice. Our data regarding the 
interaction of the TLR2 and Nod2 pathways in human MNC are supported by earlier studies 
showing synergistic effects of MDP with PGN and lipoteichoic acid 22,23 and are reinforced by 
the findings of Watanabe et al. 24, who reported an interaction between Nod2 and TLR2 
signals in murine macrophages. Interestingly, stimulation of the anti-inflammatory cytokine 
IL-10 by Pam3Cys, a specific TLR2 ligand, also seems to be decreased in patients with the 
Nod2 3020insC mutation. We observed this effect in a previous study 25, and this suggests 
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that Nod2 might exert some of its actions through directly mediating TLR2 signals. No such 
defects were observed when cells of the patients bearing the Nod2 mutation were 
stimulated with other TLR2 ligands.  
 
Watanabe et al. 26 reported inhibitory effects of murine Nod2 signals on TLR2-induced Th1-
type responses, as measured by IL-12 production. In our experiments using human Nod2-
defective and control cells, IL-12 production was under the detection limit despite the use of 
stimulus concentrations as high as 10 µg/ml. We cannot confirm the inhibitory effect of 
Nod2 signals on Th1 responses found by Watanabe et al. 27 in murine cells, but a note of 
caution about their data should be mentioned, because the effects seen in their study were 
observed mainly at an MDP concentration of 100 µg/ml, which is hardly relevant for the in 
vivo situations. Another source of differences between our study and that of Watanabe et al. 
28 is that they did not find differences in IL-10 release after PGN stimulation of murine  
Nod2–/– and Nod2+/+ cells 29. This is an important observation, because it may underline 
important differences between the function of Nod2 in murine vs human cells and may 
explain the striking observation of the lack of intestinal inflammation in Nod2–/– mice 30 
despite the crucial role of Nod2 in the development of Crohn’s disease in humans. 
Alternatively, the observed differences between studies performed in human and murine 
cells may be caused by the presence of a defective Nod2 in patients, whereas a complete 
deletion of Nod2 was present in the knockout mice. Despite these differences, the 
synergistic interaction between Nod2 and TLR2 signals for the production of IL-10 in human 
MNC as well as the negative regulation of IL-12 production by Nod2, as shown by Watanabe 
et al. 31 with a shift toward protective Th2-type responses are probably important 
pathogenetic mechanisms in Crohn’s disease.  
 
The impact of Nod2 loss of function seems, therefore, to be related to the Th1/Th2 balance, 
rather than to the absolute defect in one of these cytokines. Thus, although production of 
the proinflammatory cytokines TNF and IL-1β is lower in Crohn’s disease patients with the 
Nod2 3020 insC mutation, this effect seems to be over-run by the lack of protective Th2-type 
responses. This does not contradict the important role of TNF, because patients with Crohn’s 
disease have been shown to have higher TNF production capacity and to be effectively 
treated by anti-TNF Abs 32. An alternative explanation for the decreased proinflammatory 
cytokine production in patients with the mutation could be represented by defective 
antibacterial defense, leading to bacterial overgrowth and inflammation, as also suggested 
by others 33.  
 
In addition to the interaction of Nod2-induced signals with TLR2, we demonstrate synergism 
of Nod2 with TLR4- and TLR3-mediated signals. Intestinal microorganisms are complex 
pathogens, with PAMPs requiring recognition by diverse TLRs, such as TLR2, TLR4, TLR5, and 
TLR9. From this perspective, interaction of the Nod2 pathway with other TLRs can be of 
considerable importance. In line with this idea, spontaneous enterocolitis associated with IL-
12 overproduction in STAT3 knockout mice does not occur in the absence of TLR4 34,35, and 
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TLR9 stimulation by CpG motifs increases the severity of dextran sodium sulfate-induced 
colitis 36.  
 
Synergism between either PGN or MDP and bacterial LPS has been previously reported 37-39. 
By showing the loss of MDP/LPS synergism in patients with the 3020insC Nod2 mutation, we 
demonstrate that this effect is mediated by the interaction between Nod2 and TLR4 
pathways. In addition, we report synergism between Nod2 and TLR3; this interaction needs 
to be explored in models of intestinal inflammation.  
 
The effects of Nod2 on TLR pathways seem to be selective, because we found no interaction 
with TLR5, TLR9, or TLR7. Despite the fact that TLR9 has been implicated in the pathogenesis 
of Crohn’s disease based on experimental data 40,41 as well as the association of Crohn’s 
disease with a TLR9 polymorphism 42, we could not find an interaction of Nod2 with the TLR9 
pathway. Although the TLR5 agonist flagellin is an important PAMP of intestinal 
microorganisms, intestinal microvascular cells express TLR5, and bacterial flagellin has been 
suggested to be a dominant Ag in Crohn’s disease 43,44, no interaction between Nod2 and 
TLR5 was detected. Likewise, there was no interaction between Nod2 and TLR7.  
 
In conclusion, we report in this study that Nod2 enhances the signaling by TLR2, TLR4, and 
TLR3, whereas it does not influence the signals mediated by TLR5, TLR9, and TLR7. The 
interaction between Nod2 and TLRs is likely to be involved in the pathogenesis of Crohn’s 
disease, because the lack of synergism in patients with loss of function mutations of Nod2 
results in defective IL-10 production and a Th1 bias, effects that seem to over-ride the lower 
production of TNF and IL-1β. Studies are ongoing in our laboratory to decipher the precise 
intracellular mechanisms responsible for the Nod2/TLR synergism. Other studies have 
suggested the involvement of receptor-interacting protein 2 in the transduction of signals to 
both Nod2 and TLRs 45. In addition, Wolfert et al. 46 proposed that the synergistic effect of 
MDP and LPS is exerted at the translational level; MDP is effective in transcribing DNA 
information in mRNA, but little translation of proteins takes place. Co-stimulation with 
specific (but not all) TLR ligands provides the signals able to translate the mRNA pool, leading 
to synergistic effects at the protein level. It remains to be demonstrated which of these 
mechanisms is responsible for the synergistic effects of these two pathways.  
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Materials and methods   
 
 
Genotyping of Nod2 variants 
Blood was collected from 74 patients with Crohn’s disease and 10 healthy volunteers. PCR 
amplification of Nod2 gene fragments containing the polymorphic site 3020insC was 
performed in 50-µl reaction volumes containing 100–200 ng of genomic DNA, as previously 
described 47. The 3020insC polymorphism was analyzed by Genescan analysis on an ABI 
PRISM 3100 Genetic Analyzer according to the protocol of the manufacturer (Applied 
Biosystems).  
 
Four patients with Crohn’s disease were found to be homozygous for the 3020insC mutation, 
and they were further investigated in the cytokine studies. As control groups, five patients 
with Crohn’s disease heterozygous for the 3020 insC Nod2 mutation, five patients with 
Crohn’s disease bearing the wild-type allele, and five healthy volunteers homozygous for the 
wild-type Nod2 allele were included.  
 
Isolation of mononuclear cells and stimulation of cytokine production 
After informed consent, venous blood was drawn from the cubital vein of patients and 
healthy volunteers into three 10-ml EDTA tubes (Monoject; s-Hertogenbosch). Isolation of 
mononuclear cells (MNC) was performed as described previously 48 with minor 
modifications. The MNC fraction was obtained by density centrifugation of blood diluted 1/1 
in pyrogen-free saline over Ficoll-Paque (Pharmacia Biotech). Cells were washed twice in 
saline and suspended in culture medium (RPMI 1640 DM) supplemented with 10 µg/ml 
gentamicin, 10 mM L-glutamine, and 10 mM pyruvate. The cells were counted in a Coulter 
counter (Coulter Electronics), and the number was adjusted to 5 x 106 cells/ml.  
 
MNC (5 x 105) in a 100-µl volume were added to round-bottom, 96-well plates (Greiner) and 
incubated with either 100 µl of culture medium (negative control) or the various stimuli 
(MDP (10 µg/ml; Sigma-Aldrich), commercial staphylococcal peptidoglycan (1 µg/ml; Sigma-
Aldrich), purified peptidoglycan (gift from Dr. S. Girardin, Institute Pasteur, Paris, France), or 
synthetic Pam3Cys or MALP2 lipopeptides (1 µg/ml; EMC Microcollections)).  
 
In separate experiments, stimulation of MNC with other TLR agonists was performed: TLR3 
with poly(I:C) (50 µg/ml), TLR4 with purified Escherichia coli LPS (1 ng/ml), TLR5 with 
bacterial DNA (5 µg/ml), TLR5 with flagellin (10 ng/ml), TLR7 with loxoribin (5 µg/ml), and 
TLR9 with CpG (5 µg/ml). The synergism between Nod2 and TLR pathways was assessed 
using combinations of MDP with the various TLR stimuli. Submaximal concentrations of the 
TLR agonists were used in the experiments to allow better distinction of the synergistic 
effects with MDP among the various groups. The submaximal concentrations described 
above were determined in pilot experiments (not shown). All TLR agonists were checked for 
contamination with LPS in the Limulus amebocyte lysate assay and were found to be 
negative.  
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Cytokine production by murine peritoneal macrophages 
Resident peritoneal macrophages from either ScCr (TLR4-defective) or C57BL/10J (TLR4 
control) mice and from either TLR2–/– or control TLR2+/+ mice (provided by Dr. S. Akira, 
Research Institute for Microbiol Diseases, Osaka University, Osaka, Japan) 49 were harvested 
by injection of 4 ml of sterile PBS containing 0.38% sodium citrate50. After centrifugation and 
washing, the cells were resuspended in RPMI 1640 containing 1 mM pyruvate, 2 mM L-
glutamine, 100 µg/ml gentamicin, and 2% fresh mouse plasma. Cells were cultured in 96-
well microtiter plates (Greiner) at 1 x 105 cells/well in a volume of 100 µl. The cells were 
stimulated with either purified staphylococcal peptidoglycan (1 µg/ml; commercial or 
purified) or a combination of MDP with Pam3Cys (both 1 µg/ml). After 24-h incubation at 
37°C, the supernatants were collected and stored at –70°C until cytokine assays were 
performed.  
 
Cytokine measurements 
Human and murine TNFα and IL-1β concentrations were determined by specific RIAs as 
previously described 51,52. IL-10 was measured by a commercial ELISA kit (Pelikine Compact; 
CLB) according to the instructions of the manufacturer. IL-12 concentrations were measured 
using two ELISA kits from R&D Systems and Pierce.  
 
PGN signaling through human TLR2 in transfected cell lines 
Chinese hamster ovary (CHO) fibroblasts stably transfected with human CD14 and TLR2 
(3E10-TLR2) or TLR4 (3E10-TLR4), were a gift from Dr. R. Ingalls (Boston University, Boston, 
MA 53). Cell lines express inducible membrane CD25 under control of a region from the 
human E-selectin (ELAM-1) promoter containing NF-B binding sites. Cells were maintained at 
37°C and 5% CO2 in Ham’s F-12 medium (Invitrogen Life Technologies) supplemented with 
10% FCS, 0.01% L-glutamine, 50 µg/ml gentamicin, 400 U/ml hygromycin, and 0.5 mg/ml 
G418 (for 3E10-TLR2) or 0.05 mg/ml puromycin (for 3E10-TLR4) as additional selection 
antibiotics. TLR2 and TLR4 expression was confirmed by flow cytometry (EPICS XL-MCL, 
Beckman Coulter) using PE-labeled anti-TLR2 (clone TL2.1) or anti-TLR4 (clone HTA125; 
Immunosource).  
 
For stimulation experiments, 500 µl of cells in culture medium at a density of 1 x 105/ml 
were plated in 24-well culture plates. After an overnight incubation, cells were incubated 
with control medium, PGN (10 µg/ml), Pam3Cys (10 µg/ml), or LPS (1 µg/ml) for 20 h; 
thereafter, cells were harvested using trypsin/EDTA (Cambrex) and prepared for flow 
cytometry (Coulter FACScan). CD25 expression of the CHO cells was measured using FITC-
labeled anti-CD25 (DakoCytomation).  
 
Statistical analysis 
The human experiments were performed in triplicate with blood obtained from patients and 
volunteers. The mouse experiments were performed twice in 10 mice/group, and the data 
are presented as the cumulative results of all experiments performed. The differences 
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between groups were analyzed by Mann-Whitney U test and, where appropriate, by Kruskal-
Wallis ANOVA. The level of significance between groups was set at p < 0.05. The data are 
given as the mean ± SD.  
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Abstract  
  
 
Synthesis and release of pro-inflammatory cytokines, such as IL-1β, play a crucial role in the 
intestinal inflammation that characterizes Crohn's disease. Mutations in the nucleotide 
oligomerization domain 2 (Nod2) gene are associated with an increased risk of Crohn's 
disease. Although it is known that Nod2 mediates cytokine responses to muramyl dipeptide 
(MDP), it is yet unclear whether Nod2 stimulation mediates only transcription of pro- IL-1β 
mRNA, or whether Nod2 is also involved in the activation of caspase-1 and release of active 
IL-1β. By investigating the response of MNC from Crohn's disease patients homozygous for 
the 3020insC Nod2 mutation, we were able to show that Nod2 signaling after stimulation 
with MDP has a dual effect by activating pro IL-1β mRNA transcription and inducing release 
of bioactive IL-1β. Because Nod2 engagement amplifies TLR stimulation, we investigated 
whether activation of caspase-1 by MDP is involved in the Nod2/TLR synergism. The synergy 
in IL-1β production between Nod2 and TLR is mediated at post-translational level in a 
caspase-1-dependent manner, which indirectly suggests that Nod2 also induces caspase-1 
activation. In contrast, the synergy in TNFα production after stimulation with MDP and LPS is 
induced at transcriptional level. This demonstrates that both caspase-1-dependent and -
independent mechanisms are involved in the synergy between Nod2 and TLR.  
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Introduction 
  
 
NOD-like receptors (NLR) are intracellular receptors for bacterial peptidoglycans, which 
complement the recognition of pathogen-associated molecular patterns (PAMP) by 
membrane-bound TLR 1,2. Nucleotide oligomerization domain 2 (Nod2) is a member of the 
NACHT-LRR (NLR) receptor family, which recognizes muramyl dipeptide (MDP), the minimal 
motif of peptidoglycan of both Gram-positive and Gram-negative bacteria 3. Mutations in the 
Nod2 gene are associated with Crohn's disease 4,5, but how Nod2 exactly acts in the 
pathogenesis of this auto-inflammatory disease is unclear 6-8. Therefore, a better 
understanding of the intracellular events induced by the interaction between Nod2 and 
peptidoglycan is crucial for both the insight into recognition of Gram-positive pathogens by 
the innate immune system, and for the pathogenesis of the inflammatory reactions in 
Crohn's disease. 
 
Activation of human mononuclear cells (MNC) by MDP leads to production of pro-
inflammatory cytokines, especially IL-1β 7,9. IL-1β is produced as pro- IL-1β a 31-34-kDa 
inactive form of the cytokine, which is later cleaved by caspase-1 to the bioactive 17-kDa IL-
1β 10. This is followed by IL-1β excretion in microvesicles into the extracellular environment 
11. Apparently, MDP is capable of inducing all three steps, but it is unclear whether Nod2 
alone or other receptors are involved in one or more of these steps of IL-1β production. It 
has been proposed that several of the NLR family members are able to recognize MDP, most 
notably Nod2, NALP3, and NALP1, and that they execute different functions necessary for 
cytokine production. In this concept, recognition of MDP by Nod2 would mainly activate NF-
κB and thereby gene transcription of pro- IL-1β, whereas NALP3/NALP1-mediated 
recognition of MDP leads to caspase-1 activation and the subsequent release of the active IL-
1β form 12-14. However, there are controversies regarding this mechanism of IL-1β 
production by MDP. The caspase-recruitment domain (CARD) of Nod2 interacts with the 
serine/tyrosine kinase RIP2, leading to NF-κB translocation and transcription of mRNA for 
pro-inflammatory cytokines 15-17. However, it is also known that RIP2 interacts with the CARD 
domain of caspase-1 18,19. Thus, one could envisage that Nod2 engagement by MDP could 
activate caspase-1 and lead to the release of mature IL-1β, without the need for a secondary 
interaction with NALP3/NALP1. 
 
In the present study, we aimed to assess whether recognition of MDP by Nod2 is important 
for both the induction of pro-inflammatory cytokines gene transcription, as well as for the 
activation of caspase-1 and IL-1β release, by comparing the response of MNC from patients 
with Crohn's disease homozygous for the 3020insC Nod2 mutation (Nod2fs) with the 
response of MNC isolated from individuals with wild-type Nod2 allele (Nod2wt). In addition, 
because MDP is able to amplify the TLR stimulation through a Nod2-dependent pathway 9,20, 
we also investigated whether activation of caspase-1 by MDP is involved in the Nod2/TLR 
synergism. 
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Results 
    
 
MDP induces Nod2-dependent transcription of cytokine genes 
 
In MNC of Crohn's disease patients with a homozygous 3020insC mutation (Nod2fs), the 
cytokine production after stimulation with MDP is completely abolished, whereas the 
cytokine production after stimulation with the TLR4 ligand LPS is normal compared to 
healthy volunteers (HC) and Crohn's disease patients bearing the wild-type allele (Nod2wt) 
(Fig. 1A). This impaired cytokine response to MDP is caused by a transcriptional defect, since 
MDP was found to increase mRNA in MNC of healthy volunteers and Crohn's disease 
patients without Nod2 mutations of IL-1β and TNFα, but not in patients homozygous for the 
3020insC mutation (Fig. 1B).  
 
 
 
Figure 1. MDP induces Nod2 dependent cytokine production and transcription of pro-IL-1β and 
TNFα in MNC. MNC of five healthy controls (HC), five Crohn's patients without Nod2 mutations 
(Nod2wt) and four patients homozygous for the 3020insC mutation (Nod2fs) were stimulated 
with LPS (10 ng/mL) or MDP (100 nM). Cytokines were measured by ELISA in the supernatant 
after 24-h incubation at 37ºC (A). Quantitative measurement of mRNA levels of IL-1β and TNFα 
was performed by real-time PCR and expressed as fold increase compared to unstimulated cells. 
Cells were lysed in RNAzolB after 4-h incubation at 37ºC. (B). Data are presented as means ± SEM 
and compared by Mann-Whitney U test (*p <0.05). 
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Induction of IL-1β by MDP is caspase-1 dependent 
 
Various bacterial stimuli can induce mature IL-1β production, which requires both 
transcription of pro- IL-1β mRNA and post-translational processing by caspase-1. The IL-1β 
production in MNC after stimulation with MDP was blocked with the caspase-1 inhibitor 
(ICE-i) Ac-Tyr-Val-Ala-Asp-2,6-dimethylbezoyloxymethylketone (YVAD) (Fig. 2A). This 
indicates that the post-translational processing of pro- IL-1β by caspase-1 is important for 
the IL-1β production by MDP. Inhibition of the IL-1R with IL-1Ra did not block the IL-1β 
production (Fig. 2A). Thus, an autocrine feedback of IL-1β inducing IL-1β, as shown 
previously using LPS as a stimulus 21, does not seem to play a major role in MDP-induced IL-
1β.  
 
 
 
Figure 2. MDP activates caspase-1 but does not enhance transcription of caspase-1 mRNA. 
Stimulation of MNC of five healthy volunteers with MDP (100 nM) during inhibition of caspase-1 
with ICE-i (20 µM) or the IL-1-receptor with IL-1Ra (10 µg/mL). Cytokines were measured by ELISA 
in the supernatant after 24-h incubation at 37ºC (A). MNC of four healthy controls (HC), four 
Crohn's patients without Nod2 mutations (Nod2wt) and four patients homozygous for the 
3020insC mutation (Nod2fs) were stimulated with MDP (100 nM). After 4-h incubation at 37ºC, 
cells were lysed in RNAzolB. Quantitative measurement of mRNA levels of caspase-1 was 
performed by real-time PCR and expressed as fold increase compared to unstimulated cells (B). 
 
During the exposure to MDP, caspase-1 mRNA levels did not increase compared to 
unstimulated cells, as shown in Fig. 2B. Since the caspase-1 activity is not regulated at 
transcriptional level, the regulation of caspase-1 activation is likely post-translational by 
enzymatic cleavage of pro-caspase-1 22. 
 
The synergism between Nod2 and TLR for IL-1β is caspase-1 dependent 
 
Stimulation of cells with MDP and the TLR4 ligand LPS induces cytokines in a synergistic 
fashion [9], [20]. Because MDP can activate caspase-1 and induce mature IL-1β,  
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Figure 3. The synergism between TLR and Nod2 for the release of IL-1β is exerted at post-
transcriptional level. MNC from four healthy volunteers were stimulated with MDP (100 nM), LPS 
(10 ng/mL) or a combination of MDP and LPS. After 4-h incubation at 37ºC, cells were lysed in 
RNAzolB. Quantitative measurement of mRNA levels of IL-1β and TNFα was performed by real-
time PCR and expressed as fold increase compared to LPS-treated cells (A). The proIL-1β 
production after 4-h stimulation was assessed by a specific ELISA (B) or Western blots (C). 
Similarly, IL-1β concentrations were assessed by an ELISA (E). The percentages of mature IL-1β 
secreted from the cells when they were stimulated with MDP, LPS or the combination MDP/LPS 
are presented in (D). Stimulation of MNC of nine healthy volunteers with LPS (10 ng/mL) in 
combination with MDP (100 nM) during inhibition of caspase-1 with ICE-i (20 µM) or the IL-1R 
with IL-1Ra (10 µg/mL). Cytokines were measured by ELISA in the supernatant after 24-h 
incubation at 37ºC (F). Data presented as means ± SEM and compared by Mann-Whitney U test 
(*p <0.05). 
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investigated whether caspase-1 is important for this synergy. The induction of IL-1β mRNA in 
MNC of HC, Nod2wt and Nod2fs does not increase after stimulation with MDP and LPS  
compared to LPS alone (Fig. 3A). In addition, there is no synergy in the production of pro-IL-
1β production, as assessed both by a specific pro-IL-1β ELISA (Fig. 3B) or Western blots (Fig. 
3C). However, mature IL-1β is secreted in a synergistic way (Fig. 3E). The increased ratio 
between intracellular pro IL-1β and secreted IL-1β indicates that the synergistic production 
of IL-1β after stimulation with MDP and LPS is established either by extra cleaving of pro-IL-
1β or/and by increased release of bioactive IL-1β (Fig. 3D).  
In support of the notion that processing of pro- IL-1β is the level at which the synergism 
between Nod2 and TLR takes place, when caspase-1 was inhibited with YVAD (ICE-i) the 
synergy declined, showing that caspase-1 is responsible for the synergy of IL-1β production 
after stimulation with MDP and LPS (Fig. 3F). In contrast to IL-1β, the induction of TNFα 
mRNA in MNC of HC and Nod2wt increases after stimulation with MDP and LPS compared to 
LPS alone in the same ratio as TNFα in the supernatant. In MNC of Nod2fs no increase of 
TNFα mRNA and TNFα is found (Fig. 3A). Inhibition of caspase-1 does not influence the TNFα 
production or synergy (Fig. 3F). Blocking the IL-1R with IL-1Ra has no effect on the synergistic 
production of IL-1β and TNFα, indicating that autocrine stimulation of IL-1R cannot explain 
the synergy (Fig. 3F). These data show that the synergy in TNFα production after stimulation 
with MDP and LPS is induced at transcriptional level, whereas the synergy in IL-1β 
production is regulated at post-translational level by activation of caspase-1. 
 
Activation of caspase-1 and release of bioactive IL-1β by MDP is Nod2 dependent 
 
To test whether MDP uses another receptor than Nod2 for the activation of caspase-1 (e.g. 
NALP3), and in the absence of a reliable caspase-1 p10 Western-blot methodology in human 
primary cells, we designed an indirect functional assay to evaluate this hypothesis. If MDP 
would activate capsase-1 through NALP3 or NALP1, one would expect that although MDP is 
unable by itself to induce IL-1β in cells from Nod2fs patients, due to its inability to activate 
transcription, it would still be able to amplify IL-1β production induced by a TLR ligand (Fig. 
4). This would happen because of the intracellular pro IL-1β induction by the TLR agonist, 
while processing of IL-1β at the level of caspase-1 activation would be amplified by the MDP-
NALP3/NALP1 interaction (Fig. 4A). However, the data presented in Fig. 4B strongly argue 
against this hypothesis. These data show clearly that MDP was unable to amplify IL-1β 
production when cells of Crohn's disease patients with Nod2fs were stimulated with LPS, 
suggesting that Nod2 is necessary for the caspase-1 activation by MDP.  
 
In order to investigate the role of Nod2 for the release of active IL-1β from the cells, we have 
tested the effects of the Nod2-deficiency in an ATP/LPS stimulation assay. When ATP was 
added to LPS-primed cells, a significant increase in the IL-1β secreted from the cells bearing 
only the wild-type Nod2 allele was observed. In contrast, the ATP-dependent IL-1β release 
was severely impaired in the cells isolated from individuals homozygous for the Nod2fs 
mutation (Fig. 4C). IL-1β production after LPS stimulation alone was not different in Nod2wt 
and Nod2fs individuals (Fig. 4C).  
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Figure 4. Activation of caspase-1 by MDP is Nod2 dependent. Putative scheme of activation of the 
inflammasome by MDP, in which the MDP/Nod2 interaction activates transcription, processing 
and release of IL-1β. A potential interaction of Nod2 with NALP3/NALP1 for the activation of the 
inflammasome is still unclear (A). Stimulation of MNC of four healthy controls (HC) and 4 patients 
homozygous for the 3020insC mutation (Nod2fs) with MDP (100 nM), LPS (10 ng/mL) or a 
combination of MDP and LPS. Cells were incubated for 24 h at 37ºC and IL-1β was measured in 
the supernatant by ELISA (B). The role of Nod2 for the release of IL-1β by MNC primed for 4 h with 
LPS (1 μg/mL), and after an additional incubation with ATP (1 mM) for 15 min (C). Data are 
presented as means ± SEM and compared by Mann-Whitney U test (*p <0.05). 
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Discussion 
 
 
In this study, we show that Nod2 has dual effects on both pro IL-1β mRNA transcription and 
the release of bioactive IL-1β from the cells. In addition, indirect functional tests on the role 
of caspase-1 for the synergistic effects between Nod2 and TLR also suggest a role for Nod2 
for the activation of caspase-1 by MDP, the active component of bacterial peptidoglycan. 
 
The regulation and activation of caspase-1 and thereby the regulation of the production of 
mature IL-1β, followed by its secretion from the cells, is a rapid evolving field of research. 
The importance of understanding these crucial steps in IL-1β processing and release is 
stressed by the role of IL-1β in virtual all forms of inflammation and especially in auto-
inflammatory diseases, such as familial Mediterranean fever (FMF), 
hyperimmunoglobulinemia D syndrome (HIDS) and Muckle-Wells syndrome 22. Targeting IL-
1β in these disorders has shown spectacular results 23-27, and targeting caspase-1 could lead 
to new treatment strategies. Some reports indicate that caspase-1 activity is partially 
regulated at transcriptional level 28. However, our results show that stimulation with MDP 
did not result in an increase expression of caspase-1 mRNA. This is in line with the current 
opinion that caspase-1 activity is mainly regulated at post-translational level 29,30. In this 
view, caspase-1 is activated by close proximity mechanism in a multimeric protein platform, 
called the inflammasome. It is unclear which pathway directly activates the inflammasome 
and how many different of these platforms exists. The most studied inflammasomes consist 
of NALP3/ASC/cardinal/caspase-1 and NALP1/ASC/caspase-1/caspase-5. NALP belong to the 
same protein family as NOD and CIITA, which is named the NLR (NACHT-LRR receptors or 
NOD-like receptors) family. All NLR have a NACHT domain that is involved in forming 
multimers. In addition, some members have a CARD used for interaction with other CARD-
containing proteins, such as caspases. Finally, the LRR domain can interact with PAMP (e.g. 
MDP interaction with LRR of Nod2). An interesting hypothesis is that the interaction of a 
PAMP with the LRR of an NLR in the inflammasome can activate caspase-1. Indeed, Martinon 
et al. 12 proposed that MDP interacts with the LRR of NALP3 in cell lines and can activate the 
inflammasome in human macrophages. Similarly, a recent study has suggested that NALP-1 
is also an MDP receptor activating caspase-1 14. 
 
In human MNC, we confirm the activation of the inflammasome by MDP, indicated by the 
release of mature IL-1β after stimulation with MDP. Importantly, indirect proof based on a 
Nod2/TLR stimulation assay suggests that activation of the caspase-1 seems to occur in a 
Nod2-dependent manner. If MDP would activate caspase-1 independently of Nod2, 
stimulation of cells lacking a functional Nod2, such as Nod2fs MNC, with LPS and MDP 
should result in an amplification of LPS-induced IL-1β production through MDP-
NALP3/NALP1-dependent mechanisms. In Nod2-deficient cells, LPS induces pro-IL-1β and 
activation of caspase-1, and MDP should amplify caspase-1 activation and IL-1β release in a 
Nod2-independent, NALP3- or NALP1-dependent manner. However, the data presented 
here clearly show that this is not the case: no increase in IL-1β production was documented 
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when Nod2fs cells are stimulated with LPS and MDP at the same time. This suggests that 
Nod2 has a non-redundant function for caspase-1 activation by MDP (Fig. 4A). However, it 
cannot be excluded that Nod2 also requires the presence of NALP3 and/or NALP1 and 
collaborate with one or both of these molecules for the activation of caspase-1. A recent 
study by Pan and colleagues 31 showing that both Nod2 and NALP3 are necessary for IL-1β 
secretion by MDP in murine macrophages gives weight to this hypothesis. Unfortunately, the 
lack of a reliable Western blot assay for the activated caspase-1 p10 in human primary 
monocytes has precluded us to obtain direct evidence of the role of Nod2 for the caspase-1 
activation. However, by using a well-established model of IL-1β release after LPS priming of 
cells, followed by stimulation with the K+-channel activator ATP, we were able to 
demonstrate an important role for Nod2 in the release of active IL-1β. This is in line with a 
recent study showing that NALP3, another member of the NLR family, binds ATP 32. 
 
Some of the differences between our findings and the study of Martinon et al. 12 in terms of 
IL-1β induction by purified LPS could be explained by the use of different cell types: freshly 
MNC produce mature IL-1β after stimulation with LPS, whereas monocytes-derived 
macrophages do not. Furthermore, it has to be realized that data from cell lines and 
overexpression models are not always compatible with data obtained from freshly isolated 
human cells. In addition, differences exist between NALP3-/- mice and human cells 12,33,34, 
and between Nod2-/- mice and cells obtained from Crohn's disease patients homozygous for 
the Nod2fs allele 7,35. 
 
The unique role of Nod2 as key receptor of MDP for the induction of NF-B-dependent 
transcription of mRNA of cytokines is underlined by showing that mRNA of IL-1β and TNFα in 
Nod2fs cells is not increased after stimulation with MDP. Subsequently, the production of 
the cytokines is abolished. Our quantitative data by real-time PCR, obtained in primary cells, 
are supported by the results obtained by other groups 36-38. 
 
When MNC are stimulated with low dose MDP and the TLR4 ligand LPS, a remarkable 
synergy in cytokine production is apparent in MNC from individuals with an intact Nod2 9,20. 
A potential role for caspase-1 in the synergy between TLR4 and Nod2 could be envisaged, 
since MDP can activate caspase-1 and induce IL-1β, which is known to induce IL-1β 
production in an autocrine fashion through stimulation of the IL-1R 21. In addition, IL-1β can 
induce the production of other cytokines, like IL-10 and IL-6 39. Indeed, the synergistic 
production of IL-1β by MDP and LPS is caspase-1dependent, and not regulated at 
transcriptional level. However, in line with other studies, we show that the mechanism of 
synergy for TNFα is exerted at a transcriptional level 40. 
 
In conclusion, we demonstrate that Nod2 is non-redundant for both the production of IL-1β 
mRNA and the IL-1β release from the activated cells. In addition, indirect data supports a 
role for Nod2 in the activation of caspase-1 in human MNC after stimulation with MDP. 
Furthermore, caspase-1-dependent mechanisms are responsible for the synergistic effect on 
IL-1β production between Nod2 and TLR. Currently, it is unclear whether Nod2 is part of an 
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inflammasome protein complex or it directly activates caspase-1. Further investigation is 
needed to unravel the complete extension of the role of Nod2, but the picture emerges that 
Nod2 is the key receptor for MDP and executes its function at different levels in the 
pathways of cytokine production. 
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Materials and methods 
        
 
Reagents 
Synthetic Pam3Cys was purchased from EMC Microcollections (Tubingen, Germany). LPS 
(Escherichia coli serotype 055:B5) was purchased from Sigma (St. Louis, MO) and an extra 
purification step was performed as previously described 41. The purified LPS was tested in 
TLR4-/- mice for the presence of contaminants and it did not have any TLR4-independent 
activity. Synthetic MDP was obtained from Sigma. The reversible caspase-1 inhibitor (ICE-i) 
Ac-Tyr-Val-Ala-Asp-2,6-dimethylbezoyloxymethylketone (YVAD) was purchased from Alexis 
Biochemicals (San Diego, CA) and solubilized in DMSO at 10 mg/ml. The ICE-i was diluted to 
the desired concentration in RPMI. 
 
Genotyping of Nod2 variants 
Blood was collected from 154 patients with Crohn's disease and 10 healthy volunteers. PCR 
amplification of Nod2 gene fragments containing the polymorphic site 3020insC was 
performed in 50-L reaction volumes containing 100-200 ng genomic DNA as previously 
described 42. The 3020insC polymorphism was analyzed by Genescan analysis on an ABI-
Prism 3100 Genetic Analyzer according to the protocol of the manufacturer (Applied 
Biosystems). 
 
Seven patients with Crohn's disease were found homozygous for the 3020insC mutation, and 
four of them were further investigated in the cytokine studies. As control groups, four 
patients with Crohn's disease and four healthy volunteers homozygous for the wild-type 
Nod2 allele were included. 
 
Isolation of MNC and stimulation of cytokine production 
After obtaining informed consent, venous blood was drawn from the cubital vein of patients 
and healthy volunteers into three 10 mL EDTA tubes (Monoject). Isolation of MNC was 
performed as described elsewhere 43, with minor modifications. The MNC fraction was 
obtained by density centrifugation of blood diluted 1:1 in pyrogen-free saline over Ficoll-
Paque (Pharmacia Biotech). Cells were washed twice in saline and suspended in culture 
medium (RPMI 1640) supplemented with gentamicin 10 μg/ml, L-glutamine 10 mM and 
pyruvate 10 mM. The cells were counted in a Coulter counter (Coulter Electronics) and the 
number was adjusted to 5 × 106 cells/ml. MNC (5 × 105) in a 100-L volume were added to 
round-bottom 96-wells plates (Greiner) and incubated with either 100 L of culture medium 
(negative control), or the various stimuli: LPS (1 ng/ml), MDP (10 nM), or combinations of 
MDP and LPS at various concentrations. In separate experiments, inhibitors (ICE-i, 20 µM or 
IL-1Ra, 10 µg/ml) were added 10 min before stimulation. The stimuli were checked for the 
contamination with LPS in the LAL assay and found to be negative. After 24 h, the 
supernatants were collected and stored at -70°C until assayed. 
 
To investigate the role of Nod2 for the release of IL-1β, PBMC were initially stimulated for 4 
h with LPS (1 μg/mL). After 4 h, supernatants were collected and medium containing 1 mM 
ATP was added to the cells for another 15 min. The LPS-dependent IL-1β production during 
the first 4 h and the ATP-dependent IL-1β secretion after the additional 15 min was assessed 
in the supernatant. 
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Cytokine measurements 
Human TNFα concentrations were determined by specific ELISA 44. IL-1β, proIL-1 and IL-10 
were measured by commercial ELISA kits (R&D Systems, and Pelikine Compact, Sanquin), 
according to the instructions of the manufacturer. 
 
Quantitative PCR 
MNC were stimulated as described above, after 4 h the supernatant was removed and the 
cells resuspended in 200 µL RNAzolB RNA isolation solvent (Campro Scientific) and frozen at 
-80°C for storage. mRNA was isolated following the manufacturer's protocol. The amount 
and quality of mRNA were determent by spectrophotometry and analyzed by agarose gel 
electrophoresis for DNA contamination. cDNA was synthesized from 1000 ng of total RNA 
using SuperScripttm Reverse Transcriptase (Invitrogen; 18064-014). 
 
Relative mRNA levels were determined using the Bio-Rad iCycler and SYBR Green method 
(Invitrogen; S7563) 45. The following primers were used: IL-1β forward (5-
TGGCCCAGGCGTCAGA-3), IL-1β reverse (5-GGTTTGCTACAACATGGGCTACA-3); TNFα forward 
(5-GCCCTAAACAGATGAAGTGCTC-3), TNFα reverse (5-GAACCAGCATCTTCCTCAG-3); B2M 
forward (5-ATGAGTATGCCTGCCGTGTG-3), B2M reverse (5-CCAAATGCGGCATCTTCAAAC-3) 
(Biolegio, Malden, The Netherlands). Mean relative mRNA expression from at least two 
replicate measurements was calculated using Bio-Rad iCycler IQ software. Values are 
expressed as fold increase to mRNA levels of unstimulated cells. 
 
Western blots for pro- IL-1β and IL-1β 
Human MNC were stimulated as described above. After 4-h stimulation, supernatant was 
removed and cells were lysed in 25 L of ice-cold lysis buffer containing 150 mM NaCl, 0.5% 
Triton X-100, 5 mM EDTA, 0.1% SDS and protease inhibitors (SigmaFast, Sigma). Lysates of 4 
× 106 cells were pooled. Samples were taken up in 25 µL sample buffer (125 mM Tris-HCl, pH 
6.8, 2% SDS, 10% -mercaptoethanol, 10% glycerol and 0.5 mg/mL of bromophenol blue), 
were separated by SDS-PAGE and were blotted onto polyvinyldifluoride membranes 
(Millipore). Membranes were blocked in 0.1% Tween-20 in Tris-buffered saline containing 
5% nonfat dry milk and were incubated overnight with antibody against cleaved IL-1β (Cell 
Signaling) in 1% BSA and 0.1% Tween-20 in Tris-buffered saline. Horseradish peroxidase-
conjungated secondary antibodies were visualized with Lumilite plus (Boehringer-
Mannheim). 
 
Statistical analysis 
All experiments were performed at least in duplicate with blood obtained from four Crohn's 
disease patients bearing the Nod2fs mutation, four Crohn's disease patients with the wild-
type Nod2 genotype, as well as four healthy volunteers. Synergy was expressed as ratio of 
cytokine response of ligand in combination with MDP divided by the sum of cytokine 
responses obtained with each ligand alone. The differences in cytokine production between 
groups were analyzed by Mann-Whitney U test or Wilcoxon, and where appropriate by 
Kruskal-Wallis ANOVA test. For all other comparisons the Student's t-test was used. The level 
of significance between groups was set at p <0.05. The data are given as means ± SEM. 
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Abstract  
 
 
Infection with Mycobacterium tuberculosis is one of the leading causes of death worldwide. 
Recognition of M. tuberculosis by pattern recognition receptors is crucial for activation of 
both innate and adaptive immune responses. In the present study, we demonstrate that 
nucleotide-binding oligomerization domain 2 (Nod2) and Toll-like receptors (TLRs) are two 
nonredundant recognition mechanisms of M. tuberculosis. CHO cell lines transfected with 
human TLR2 or TLR4 were responsive to M. tuberculosis. TLR2 knock-out mice displayed 
more than 50% defective cytokine production after stimulation with mycobacteria, whereas 
TLR4-defective mice also released 30% less cytokines compared to controls. Similarly, 
HEK293T cells transfected with Nod2 responded to stimulation with M. tuberculosis. The 
important role of Nod2 for the recognition of M. tuberculosis was demonstrated in 
mononuclear cells of individuals homozygous for the 3020insC Nod2 mutation, who showed 
an 80% defective cytokine response after stimulation with M. tuberculosis. Finally, the 
mycobacterial TLR2 ligand 19-kDa lipoprotein and the Nod2 ligand muramyl dipeptide 
synergized for the induction of cytokines, and this synergism was lost in cells defective in 
either TLR2 or Nod2. Together, these results demonstrate that Nod2 and TLR pathways are 
nonredundant recognition mechanisms of M. tuberculosis that synergize for the induction of 
proinflammatory cytokines. 
 
 
Synopsis  
 
Tuberculosis is one of the most prevalent infections worldwide, with 2 billion people 
believed to be infected, and 2 million deaths each year. In addition to representing a major 
health care problem in developing countries, concern is also growing about the increased 
incidence of tuberculosis in developed countries, especially in immunocompromised 
patients such as those with AIDS, transplantation, and immunosuppressive therapy. The 
present study describes the pathways that enable leukocytes to recognize M. tuberculosis, 
and demonstrates for the first time that Nod2, member of a new class of intracellular 
receptors, is an independent recognition mechanism for mycobacteria. Nod2 acts together 
with the earlier-described Toll-like receptors for the activation of host defenses during the 
encounter of leukocytes with M. tuberculosis. Understanding the mechanisms through which 
the cells of the immune system recognize M. tuberculosis can be an important step in 
designing new therapeutic approaches, as well as improving the limited success of current 
vaccination strategies. 
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Introduction  
 
 
Worldwide, 2 billion people are currently believed to be infected with Mycobacterium 
tuberculosis, with an estimated death toll of 2 million patients each year 1. M. tuberculosis is 
an intracellular pathogen capable of infecting and surviving within the host's mononuclear 
cells (MNCs), and a coordinated response of the innate and adaptive immune systems is 
required for an effective host defense. This involves sequestration of the microorganism in 
macrophages within organized granulomas, and elimination of the pathogen through a 
combination of killing mechanisms and apoptosis of host macrophages 2. These responses 
are coordinated by T helper 1-type proinflammatory cytokines, which are synthesized by 
phagocytes upon recognition of pathogen-associated molecular patterns of mycobacteria by 
pattern recognition receptors (PRRs). 
Toll-like receptors (TLRs) are believed to be an important pattern recognition system of M. 
tuberculosis. A soluble, heat-stable mycobacterial fraction was initially reported to signal 
through TLR2, whereas heat-labile components associated with the cell wall were reported 
to signal through TLR4 3. Later, several components of mycobacteria were identified as being 
responsible for TLR2-dependent activation: the 19-kDa lipoprotein 4, lipomannan 5, 
phosphatidyl-myo-inositol mannoside 6, but not mannosyl-caped lipoarabinomannan from 
virulent M. tuberculosis, which mainly has anti-inflammatory effects through its interaction 
with the mannose receptor and dendritic cell-specific intercellular adhesion molecule 3-
grabbing nonintegrin, also termed DC-SIGN 7,8. Despite an abundance of in vitro data 
regarding the recognition of mycobacterial structures by TLR2 and TLR4, knock-out mice 
deficient for these receptors display remarkably little enhanced susceptibility to infection 
with M. tuberculosis. TLR4−/− mice showed variable responses to the challenge with M. 
tuberculosis, with either normal resistance to infection 9,10 or chronic pneumonia and 
increased mortality 11,12. In one study, TLR2−/− mice had a decreased clearance of the 
bacteria and developed chronic pneumonia when infected with a low dose of 
microorganisms 13, whereas in other studies only minor effects have been found 14,15. The 
role of TLRs in the recognition of mycobacteria was further highlighted in mice deficient for 
MyD88 (an adaptor molecule shared by almost all the receptors of the TLR family), which are 
highly susceptible to M. tuberculosis infection 16. 
 
Nucleotide-binding oligomerization domain 2 (Nod2), initially described as a susceptibility 
gene for Crohn's disease 17,18, is an intracellular protein containing leucine-rich repeats 
(LRRs) similar to those found in TLRs. Nod2 is the PRR responsible for recognition of bacterial 
peptidoglycans from both Gram-positive and Gram-negative bacteria, through its interaction 
with muramyl dipeptide (MDP) 19. In contrast, Nod1 recognizes peptidoglycans of Gram-
negative bacteria only 20. The intracellular localization of both Nod2 and M. tuberculosis, the 
cell wall of which contains peptidoglycans, makes Nod2 a highly suitable candidate for the 
recognition of mycobacteria. Our results support the hypothesis that TLRs and Nod2 
represent two nonredundant recognition systems of M. tuberculosis, and that an efficient 
activation of innate immunity requires both classes of receptors. 
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Results  
 
 
The role of TLR2 and TLR4 in the recognition of M. tuberculosis 
 
TLR2 and TLR4 have been suggested to recognize bacterial structures of M. tuberculosis 21. 
Indeed, sonicated M. tuberculosis strongly activated a Chinese hamster ovary fibroblast 
(CHO) cell line co-transfected with human TLR2 and CD14, whereas cells transfected with 
CD14 alone or a combination of CD14 and TLR4 displayed no signaling upon activation with 
the sonicated mycobacterial preparation (Figure 1A). However, when cells were stimulated 
with a preparation of whole mycobacteria, both TLR2 and TLR4-transfected cells were 
activated, although TLR2 activation was stronger (Figure 1A). 
 
 
Figure 1. TLR2 and TLR4 are partially responsible for induction of cytokine production by M. 
tuberculosis. (A) CHO cells co-transfected with CD14 and TLR2 (CD14/TLR2, hatched bars) induced 
potent expression of CD25 on the cell membrane as measured by FACS analysis, after stimulation 
with both a sonicated M. tuberculosis (MTB-son, 1 μg/ml) or whole mycobacteria (MTB-whole, 1 × 
107/ml). In contrast, cells transfected with CD14 and TLR4 (CD14/TLR4, black bars) were only 
moderately activated by whole M. tuberculosis, but not by the sonicated material. LPS (1 μg/ml) 
and Pam3Cys (5 μg/ml) served as control stimuli for TLR4 and TLR2, respectively. As controls, cells 
transfected only with CD14 were used (white bars). (B and C) Stimulation of TNF production by M. 
tuberculosis in peritoneal macrophages of mice deficient for TLR2 (TLR2-KO) (B) or TLR4 (TLR4-
def) (C). Groups of five mice were stimulated with the indicated reagents, and the experiment was 
repeated twice. Medium-stimulated cells resulted in cytokine concentrations below detection 
limit. Data are presented as mean ± SD (n = 5; *p < 0.05). 
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In line with these data, macrophages isolated from TLR2−/− mice displayed a 50%–75% 
reduction in tumor necrosis factor (TNF) production after stimulation with both M. 
tuberculosis preparations (Figure 1B), whereas TLR4-deficient macrophages showed a 30%–
40% reduction of TNF release only when stimulated with the whole mycobacteria (Figure 
1C). To confirm the role of TLR4 in the stimulation of cytokines by M. tuberculosis, we 
stimulated human MNCs with the whole mycobacterial preparation in the absence or 
presence of 10 μg/ml of a blocking anti-TLR4 antibody. TLR4 blockade completely inhibited 
lipopolysaccharide (LPS)-induced TNF secretion, and reduced M. tuberculosis-induced TNF 
secretion from 0.9 ± 0.2 to 0.5 ± 0.2 ng/ml (p < 0.05). These data confirm the role played by 
TLR2 and TLR4 in the recognition of M. tuberculosis; however, the significant remaining 
production of cytokines induced by M. tuberculosis in TLR2−/− or TLR4-defective mice points 
to the presence of additional signaling pathway(s) for cytokine induction. 
 
The role of intracellular recognition systems in the recognition of M. tuberculosis 
 
The role of internalization in cytokine induction by M. tuberculosis was assessed by blocking 
it with cytochalasin B, an inhibitor of actin polymerization. Blocking internalization of M. 
tuberculosis partially inhibited M. tuberculosis-induced cytokine release in freshly isolated 
human MNCs (Figure 2). In contrast, cytochalasin B increased the zymosan-induced cytokine 
production in these MNCs, which likely results from prolonged stimulation of receptors at 
the cell surface by zymosan. The difference in the effect of cytochalasin B on M. tuberculosis- 
or zymosan-induced cytokines strongly suggests that internalization of M. tuberculosis is 
important for the induction of cytokine production through intracellular receptors. 
 
 
Figure 2. Blockade of internalization of M. tuberculosis impairs recognition and cytokine 
production. Blockade of M. tuberculosis internalization by cytochalasin B (20 μg/ml) impairs TNF 
(A) and IL-10 (B) stimulation in human MNCs stimulated with sonicated M. tuberculosis (1 × 106 
microorganisms/ml), but not zymosan (1 μg/ml). Data are presented as mean ± SD (n = 5; *p < 
0.05). 
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The role of Nod1 and Nod2 in the recognition of M. tuberculosis 
 
Next, human embryonic kidney 293T cells (HEK293Ts) were transfected with either Nod1 or 
Nod2 expression vectors, and the ability of M. tuberculosis sonicates to activate these 
pathogen recognition receptors was followed by monitoring the level of Nod-dependent 
activation of a nuclear factor κB (NF-κB)-driven luciferase reporter gene. Strikingly, M. 
tuberculosis sonicates efficiently stimulated Nod2, while Nod1-transfected cells responded 
only modestly to the bacteria (Figure 3). 
 
 
 
Figure 3. Stimulation of HEK cells transfected with Nod1 or Nod2. HEKs transfected with Nod2 
were strongly activated by whole M. tuberculosis, in contrast to cells transfected with Nod1, 
which were only weakly activated by M. tuberculosis. MDP (100 nM) and TriDAP (100 nM) served 
as control stimuli for Nod2 and Nod1, respectively. Data are presented as fold increase over 
unstimulated cells (mean ± SD). 
 
To investigate further the role of Nod1 and Nod2 in the recognition of M. tuberculosis, we 
stimulated peritoneal macrophages from Nod1−/− or Nod2−/− mice. We observed that 
peritoneal macrophages from Nod2−/− mice produced significantly less TNF than did control 
cells, supporting a role of Nod2 in the recognition of M. tuberculosis (Figure 4). In contrast, 
macrophages from Nod1−/− mice responded normally to M. tuberculosis (Figure 4), although 
as a control, their response to the Nod1 ligand FK156 was abrogated (unpublished data). 
Together, these results strongly support the notion that Nod2 represents an intracellular 
recognition system for M. tuberculosis. 
 
Stimulation of cells from patients with defective Nod2 recognition 
 
In line with the hypothesis that Nod2 is involved in the recognition of mycobacteria, MNCs 
isolated from patients homozygous for the 3020insC mutation synthesized 65%–80% less 
cytokines after stimulation with M. tuberculosis than did Crohn's disease patients 
heterozygous for the mutation or patients and volunteers homozygous for the wild-type 
variant (Figure 5A). This demonstrates that Nod2 is critical for the recognition of M. 
tuberculosis cell wall. In control experiments, cells from patients homozygous for the 
3020insC mutation were defective in their response to MDP, but not LPS (Figure 5B), as 
previously described 22. 
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Figure 4. Stimulation of cells from mice deficient in Nod1 or Nod2. Stimulation of cytokine 
production by sonicated M. tuberculosis in peritoneal macrophages of mice deficient for either 
Nod1 (A) or Nod2 (B). Groups of four mice were stimulated; medium-stimulated cells resulted in 
cytokine concentrations below detection limit. Data are presented as mean ± SD (*p < 0.05). 
 
 
TLR2 and Nod2 synergize for the induction of cytokine release 
 
In order to study the cross talk between TLR2 and Nod2 in the recognition of M. tuberculosis, 
we investigated whether mycobacterial TLR2 and Nod2 ligands synergize for the induction of 
cytokine release. Indeed, the Nod2 ligand MDP, the minimal component of peptidoglycan 
responsible for Nod2 activation, had strong synergistic effect on TNF production induced by 
the 19-kDa lipoprotein of M. tuberculosis, a specific mycobacterial TLR2 ligand (Figure 6A). 
Similar synergistic effects between the 19-kDa lipoprotein and MDP were observed when IL-
6 (4.5-fold synergism), and IL-1β (7.2-fold synergism) were measured. This synergism was 
lost in individuals homozygous for the Nod2 3020insC mutation (Figure 6B) or macrophages 
harvested from TLR2−/− mice (5.7-fold synergism between lipoprotein 19-kDa and FK-156 in 
control macrophages, and 1.9-fold synergism in TLR2−/− cells). No such synergy was 
observed between MDP and mannosyl-caped lipoarabinomannan, a component of M. 
tuberculosis that does not interact with TLR2 (unpublished data). 
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Figure 5. Human Nod2 is a receptor for M. tuberculosis. (A) MNCs isolated from four patients with 
Crohn's disease homozygous for the 3020insC Nod2 mutation (Nod2fs), five patients 
heterozygous for Nod2 mutations (Nod2het), five patients with the wild-type Nod2 allele 
(Nod2wt), and five healthy volunteers with wild-type Nod2 (control) were stimulated with 10 
μg/ml sonicated M. tuberculosis. TNF (white bars) and IL-10 (black bars) were measured after 24 h 
of stimulation at 37 °C by specific RIA and ELISA, respectively. (B) MNCs isolated from four 
patients with Crohn's disease homozygous for the 3020insC Nod2 mutation (Nod2fs, black bars), 
five patients with the wild-type Nod2 allele (Nod2wt, gray bars), and five healthy volunteers with 
wild-type Nod2 (control), were stimulated with 1 μg/ml MDP or 10 ng/ml LPS. TNF were 
measured after 24 h of stimulation at 37 °C by specific RIA. Medium-stimulated cells resulted in 
cytokine concentrations below detection limit. Data are presented as mean ± SD (*p < 0.05). 
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Figure 6. Nod2 and TLR2 have synergistic effects on cytokine production. (A) MNCs isolated from 
five healthy volunteers with wild-type Nod2 were co-stimulated with 1 μg/ml MDP and increasing 
concentrations of 19-kDa lipoprotein (indicated on the x-axis). TNF was measured after 24 h of 
stimulation at 37 °C by specific RIA. (B) The synergistic effects observed in the five control 
volunteers, as well as in five Crohn's disease patients heterozygous for Nod2 mutations (Nod2-
het), and in five patients with the wild-type Nod2 allele (Nod2-WT), was lost in patients 
homozygous for the Nod2 3020insC mutation. Medium-stimulated cells resulted in cytokine 
concentrations below detection limit. Data are presented as mean ± SD (*p < 0.05). 
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Discussion  
 
 
In the present study, we investigated the role of TLRs and NODs, the two most important 
classes of PRRs in the recognition by macrophages of M. tuberculosis. Although we 
confirmed the role of TLR2 and TLR4 for in mycobacterial recognition, strong residual activity 
was detectable in cells lacking TLR2, which suggests the existence of TLR-independent 
recognition mechanisms; this idea is supported by a study demonstrating MyD88-
independent pathways of macrophage stimulation by M. tuberculosis 23. Using cell lines 
transfected with Nod1 and Nod2, as well as primary MNCs defective in these receptors, we 
demonstrated that, in addition to TLRs, Nod2 represents a nonredundant recognition system 
of M. tuberculosis. We also demonstrated that mycobacterial TLR2 and Nod2 ligands 
synergize for the production of proinflammatory cytokines, and that this synergism is lost in 
cells lacking either of these receptors. 
 
Several studies have demonstrated the role of TLR2 and TLR4 in the recognition of M. 
tuberculosis. The 19-kDa lipoprotein 24, lipomannan 25, and phosphatidyl-myo-inositol 
mannoside 26, all components of mycobacteria, have been identified as being responsible for 
TLR2-dependent activation, whereas heat-labile components associated with the cell wall 
were found to signal via TLR4 27. A role for TLRs in antimycobacterial defense was also 
suggested by the enhanced susceptibility to M. tuberculosis infection in mice deficient for 
MyD88, an adapter molecule shared by almost all TLR family members 28. Similarly, TLR2−/− 
mice had a decreased clearance of the bacteria and developed chronic pneumonia when 
infected with low doses of microorganisms 15,29,30, whereas TLR4−/− mice showed variable 
responses to challenge with M. tuberculosis 31,32. 
 
Our data confirm the important role played by TLRs, and especially TLR2, in the recognition 
of M. tuberculosis, but at the same time demonstrate strong TLR-independent induction of 
cytokines by this microorganism. The contribution of TLR4 was found to be less crucial in our 
study, and could be observed only when cells were stimulated with intact microorganisms. 
 
Because M. tuberculosis is an intracellular pathogen, we hypothesized that intracellular 
recognition systems could contribute to the sensing of mycobacteria and stimulation of 
innate immunity. To test this hypothesis, we studied the effect of blocking the 
internalization of M. tuberculosis with cytochalasin B. Blocking internalization of M. 
tuberculosis partially inhibited M. tuberculosis-induced cytokine release in MNCs, whereas 
cytochalasin B potentiated the cytokine induction by zymosan, likely due to prolonged 
stimulation of receptors at the cell surface by zymosan. The differential effects of 
cytochalasin B on M. tuberculosis- or zymosan-induced cytokine secretion demonstrate that, 
in addition to the interaction with cell-membrane bound TLRs, M. tuberculosis is recognized 
by and induces cytokine production through intracellular receptors. 
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Nod2 and Nod1 are members of the expanding CATERPILLER family of proteins, which share 
an LRR domain similar to that found in TLRs 33. Nod2 has been linked genetically to increased 
risk for Crohn's disease 34,35, and is a sensor of bacterial peptidoglycans 36. When HEKs 
transfected with either Nod1 or Nod2 were stimulated with M. tuberculosis cell wall 
preparations, both of them—but most markedly those transfected with Nod2—showed a 
dose-dependent response. These data are consistent with the conclusion that Nod2 is a 
general sensor of bacteria through the detection of MDP, a peptidoglycan substructure 
present in bacterial cell walls 37. However, the fact that Nod1 was found to be a poor sensor 
of M. tuberculosis not only in Nod1-transfected HEK cells, but also through the lack of a 
defective response in Nod1−/− macrophages, is somewhat puzzling. Indeed, Nod1 detects 
diaminopimelic acid (DAP)-type peptidoglycans, and earlier reports had suggested that M. 
tuberculosis peptidoglycan is of this category. Further investigation is therefore required to 
discover why Nod1 detects M. tuberculosis poorly. 
 
To test whether the data in transfected cell lines could be reproduced in primary cells, we 
stimulated MNCs isolated from Crohn's disease patients homozygous for the 3020insC null-
mutant allele with M. tuberculosis. This mutation leads to the deletion of the last 32 amino 
acids of the LRR region responsible for the detection of peptidoglycan, and we have recently 
shown that cells isolated from these patients are completely unable to recognize MDP or 
gram-positive peptidoglycan 38. In line with the hypothesis that Nod2 is involved in the 
recognition of mycobacteria, both peritoneal macrophages from Nod2-deficient mice and 
MNCs isolated from patients homozygous for the 3020insC mutation of Nod2 were found to 
synthesize significantly less cytokines after stimulation with M. tuberculosis. Interestingly, 
the very strong defect in the response to M. tuberculosis of the cells of patients with the 
Nod2 3020insC mutation suggests that Nod1 is not able to compensate for the defective 
Nod2 recognition. This is in line with the weak stimulation of Nod1-transfected HEKs by M. 
tuberculosis and our recent finding that Nod2 is needed for normal signaling by Nod1 ligands 
such as Mur-Tri-DAP 39. The reverse is not true in the case of Nod1: Macrophages harvested 
from Nod1−/− mice responded normally to M. tuberculosis, demonstrating that the absence 
of Nod1 can be compensated by other recognition systems, most likely Nod2. 
 
The finding of strongly reduced cytokine production after stimulation with M. tuberculosis in 
cells of patients with a defective Nod2 and of Nod2 knock-out mice demonstrates that Nod2 
is a key sensor of M. tuberculosis in mammalian cells. Interestingly, inhibition of both Nod2 
and TLR2 systems blocked stimulation of cytokines by M. tuberculosis by substantially more 
than 50%. This suggests that the signaling pathways induced by these receptors interact and 
potentiate each other, and, conversely, that defects in one pathway lead to a loss of synergy. 
We have recently shown that Nod2 signals strongly synergize with specific TLR pathways 
such as TLR2, TLR4, and TLR3 40. We therefore investigated whether Nod2 activation leads to 
similar synergistic cytokine stimulation by TLR2 ligands specifically derived from M. 
tuberculosis. Indeed, MDP had strong synergistic effect on the cytokine production induced 
by the 19-kDa lipoprotein of M. tuberculosis, and this synergy was lost both in individuals 
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homozygous for the Nod2 3020insC mutation and in macrophages harvested from TLR2−/− 
mice. 
 
An issue yet to be resolved is represented by the mechanism through which mycobacterial 
peptidoglycans come in contact with Nod2. Nod2 is an intracytoplasmic molecule, while M. 
tuberculosis remains located mainly in phagosomes. Although shedding of cell wall 
components from the microorganism is likely responsible for the release of peptidoglycans 
that are ultimately recognized by Nod2, the precise mechanism through which 
peptidoglycans translocate from the phagosome into the cytoplasm remains to be identified. 
 
The data presented in this study demonstrate that Nod2 and TLRs are two nonredundant 
recognition mechanisms of M. tuberculosis. Both are essential for effective activation of the 
proinflammatory cytokine production by M. tuberculosis, and they strengthen each other's 
activity through synergistic effects. This demonstrates that host cells sense the presence of 
M. tuberculosis using multiple recognition systems in which different classes of receptors, in 
this case Nod2 and TLRs, interact with each other. 
 
The involvement of Nod2 in the recognition of M. tuberculosis has several implications. First, 
it is possible that Nod2 is involved in recognition of other gram-positive bacteria with cell 
walls rich in peptidoglycans. The recent report of Nod2 serving as a receptor for 
Streptococcus pneumoniae supports this idea 41. Second, our data suggest that Nod2 is 
involved in the recognition of other Mycobacteria species. From this point of view, M. 
paratuberculosis is of particular interest, due to its possible involvement in the pathogenesis 
of Crohn's disease 42. A defective host defense against M. paratuberculosis in individuals 
bearing loss-of-function Nod2 mutations may be responsible for the invasion of the intestine 
and may promote chronic inflammation ultimately leading to Crohn's disease. This 
hypothesis is supported by the recently described presence of M. paratuberculosis in the 
circulation of patients with Crohn's disease 43. Regarding the role of Nod2 in tuberculosis, 
one must, however, acknowledge that the present study provides information only on the in 
vitro recognition of M. tuberculosis, and studies investigating the role of Nod2 in infection 
models are warranted. 
 
In conclusion, Nod2 and TLRs appear to serve as independent, nonredundant PRRs of M. 
tuberculosis. The intracellular pathways induced by Nod2 and TLR2 during recognition of 
mycobacterial components synergize, and the stimulation of cytokine production by M. 
tuberculosis is greatly impaired in individuals with Nod2 mutations. 
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Materials and methods  
 
 
Reagents and microorganisms 
Synthetic Pam3Cys and 19-kDa lipoprotein were purchased from EMC Microcollections 
(Tübingen, Germany). MDP and LPS (E. coli serotype 055:B5) were purchased from 
Calbiochem (San Diego, California, United States) and Sigma (St. Louis, Missouri, United 
States), respectively. The synthetic MDP was tested for contamination with lipoproteins or 
LPS in mice deficient in TLR2 or TLR4, respectively. No defect in cytokine production was 
apparent in these mice after stimulation with MDP, demonstrating the absence of 
contamination. 
 
Cultures of M. tuberculosis H37Rv were grown to mid-log phase in Middlebrook 7H9 liquid 
medium supplemented with oleic acid/albumin/dextrose/catalase (Difco, Becton-Dickinson, 
Palo Alto, California, United States), washed three times in sterile saline, and resuspended in 
RPMI 1640 medium at the various concentrations. Separate culture suspensions were 
sonicated for 10 min on ice, in order to obtain cell lysates. 
 
Genotyping of Nod2 variants 
Blood was collected from 74 patients with Crohn's disease and ten healthy volunteers. PCR 
amplification of Nod2 gene fragments containing the polymorphic site 3020insC was 
performed in 50-μl reaction volumes containing 100–200 ng of genomic DNA as previously 
described 44. The 3020insC polymorphism was analyzed by Genescan analysis on an ABI-
Prism 3100 Genetic Analyzer according to the protocol of the manufacturer (Applied 
Biosystems, Nieuwerkerk a/d IJssel, The Netherlands). 
 
Four patients with Crohn's disease were found to be homozygous for the 3020insC mutation, 
and they were further investigated in the cytokine studies. As control groups, five patients 
with Crohn's disease who were heterozygous for the 3020insC Nod2 mutation, five patients 
with Crohn's disease bearing the wild-type allele, and five healthy volunteers homozygous 
for the wild-type Nod2 allele were included. None of the patients with Crohn's disease used 
immunosuppressive medication at the time of the study. 
 
Isolation of MNCs and stimulation of cytokine production 
After informed consent, venous blood was drawn from the cubital vein of patients and 
healthy volunteers into three 10-ml EDTA tubes (Monoject, s-Hertogenbosch, The 
Netherlands). Isolation of MNCs was performed as described elsewhere 45, with minor 
modifications. The MNC fraction was obtained by density centrifugation of blood diluted 1:1 
in pyrogen-free saline over Ficoll-Paque (Pharmacia Biotech AB, Uppsala, Sweden). Cells 
were washed twice in saline and suspended in culture medium (RPMI 1640 DM) 
supplemented with 10 μg/ml gentamicin, 10 mM L-glutamine, and 10 mM pyruvate. The 
cells were counted in a Coulter counter (Coulter Electronics, Mijdrecht, The Netherlands), 
and the number was adjusted to 5 × 106 cells/ml. 
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MNCs (5 × 105) were added in a 100-μl volume to round-bottom 96-well plates (Greiner, 
Alphen a/d Rijn, The Netherlands) and incubated with either 100 μl of culture medium 
(negative control), or the various stimuli: M. tuberculosis bacteria (1 × 105 to 1 × 107 
microorganisms/ml), M. tuberculosis sonicate (10 μg/ml), MDP (1 μg/ml), LPS (10 ng/ml), 19-
kDa lipoprotein (concentrations as described below), or combinations of MDP and 19-kDa 
lipoprotein. The influence of internalization of M. tuberculosis on cytokine production was 
investigated by adding 20 μg/ml cytochalasin B during stimulation with the microorganism. 
Positive control stimulation for the effects of cytochalasin B was provided by stimulation of 
cells with zymosan (1 μg/ml; Sigma). All stimuli were checked for the contamination with LPS 
in the Limulus amoebocyte lysate assay and found to be negative. Cytochalasin B did not 
influence cell viability (unpublished data). To evaluate the role of TLR4 in the induction of 
cytokines, cells were preincubated with 10 μg/ml of a blocking monoclonal anti-TLR4 
antibody (eBioscience, San Diego, California, United States). 
 
Cytokine production by murine peritoneal macrophages 
Resident peritoneal macrophages from either ScCr (TLR4-defective) or C57Bl/10J (TLR4 
control) mice, TLR2−/− or control TLR2+/+ mice (kindly provided by S. Akira, Osaka, Japan) 46, 
Nod1−/− and Nod1+/+ littermates (kindly provided by E. Abraham, Denver, Colorado, United 
States), or Nod2+/+ and Nod2−/− (from M. Giovannini, CEPH, Paris), backcrossed to the 
seventh generation into the C57BL6/J background, were harvested by injection of 4 ml of 
sterile PBS containing 0.38% sodium citrate 47. After centrifugation and washing, the cells 
were resuspended in RPMI 1640 containing 1 mM pyruvate, 2 mM L-glutamine, 100 μg/ml 
gentamicin, and 2% fresh mouse plasma. Cells were cultured in 96-well microtiter plates 
(Greiner) at 1 × 105 cells/well, in a volume of 100 μl. The cells were stimulated with purified 
LPS (1 μg/ml), Pam3Cys (1 μg/ml), FK-156 ligand of murine Nod1 (1 μg/ml) as a control 
stimulation, or a sonicate of M. tuberculosis (1 μg/ml). After 24 h incubation at 37 °C, the 
supernatants were collected and stored at −70 °C until cytokine assays were performed. 
 
Cytokine measurements 
Human and murine TNFα concentrations were determined by specific RIAs as described 48,49. 
IL-10 and IL-6 were measured by a commercial ELISA kits (Pelikine Compact, CLB, 
Amsterdam, The Netherlands), according to the instructions of the manufacturer. 
 
Signaling through human TLR2 and TLR4 in transfected cell lines 
CHOs stably transfected with human CD14 (3E10-CD14), a combination of CD14 and TLR2 
(3E10-TLR2), or TLR4 (3E10-TLR4), were a kind gift from R. Ingalls 50. All cell lines express 
inducible membrane CD25 under control of a region from the human E-selectin (ELAM-1) 
promoter containing NF-κB binding sites. Cells were maintained at 37 °C and 5% CO2 in 
HAM's F12 medium (Gibco, Invitrogen, Breda, The Netherlands) supplemented with 10% 
FCS, 0.01% L-glutamine, 50 μg/ml gentamicin, and either 400 U/ml hygromycin and 0.5 
mg/ml of G418 (for 3E10-TLR2) or 0.05 mg/ml of puromycin (for 3E10-TLR4) as additional 
selection antibiotics. TLR2 and TLR4 expression was confirmed by flow cytometry (Coulter 
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Epics XL-MCL, Beckman Coulter, Mijdrecht, the Netherlands) using PE-labeled anti-TLR2 
(clone TL2.1) or anti-TLR4 (clone HTA125) (Immunosource, Halle-Zoersel, Belgium). 
 
For stimulation experiments, 500 μl of cells in culture medium at a density of 1 × 105/ml 
were plated in 24-well culture plates. After an overnight incubation, cells were incubated 
with control medium, M. tuberculosis sonicate (10 μg/ml), Pam3Cys (10 μg/ml), or LPS (1 
μg/ml) for 20 h, and thereafter cells were harvested using trypsin/EDTA (Cambrex, East 
Rutherford, New York, United States) and prepared for flow cytometry (Coulter FACS-scan). 
CD25 expression of the CHOs was measured using FITC-labeled anti-CD25 (DAKO, Glostrup, 
Denmark), and expressed as folds-over-mean increase. 
 
Stimulation of Nod-transfected cell lines and NF-κB translocation 
Studies examining the activation of NF-κB by M. tuberculosis in cells overexpressing Nod1 or 
Nod2 were carried out as previously described 51. Briefly, 1 × 106/ml HEK293T cells were 
transfected overnight with 1 ng of either Nod1 or Nod2 plus 75 ng luciferase reporter 
plasmid. At the same time, heat-killed whole M. tuberculosis preparations (ratio of 
microorganisms and effector cells 1:10, 1:1, and 10:1) were added to cell culture medium, 
and the NF-κB–dependent luciferase activation was then measured following 24 h of 
incubation. NF-κB–dependent luciferase assays were performed in duplicate, and data 
represent three independent experiments52. 
 
Statistical analysis 
The human experiments were performed in triplicate with blood obtained from patients and 
volunteers. The mouse experiments were performed twice in 10 mice per group, and the 
data are presented as cumulative results of all experiments performed. The differences 
between groups were analyzed by unpaired Student t-test, and where appropriate by paired 
t-test. The level of significance between groups was set at p < 0.05. The data are given as 
means ± standard deviation (SD). 
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Abstract  
 
  
Mycobacterium paratuberculosis has been suggested to be involved in the pathogenesis of 
Crohn's disease (CD). The importance of microorganisms in CD is supported by the 
association of CD with mutations in the intracellular pathogen recognition receptor (PRR) 
nucleotide-binding oligomerization domain 2 (Nod2). The aim of this study is to investigate 
the PRR involved in the recognition of M. paratuberculosis. Methods used include in vitro 
stimulation of transfected cell lines, murine macrophages, and human PBMC. M. 
paratuberculosis stimulated human TLR2 (hTLR2)-Chinese hamster ovary (CHO) cells 
predominantly and hTLR4-CHO cells modestly. Macrophages from TLR2 and TLR4 knockout 
mice produced less cytokines compared with controls after stimulation with M. 
paratuberculosis. TLR4 inhibition in human PBMC reduced cytokine production only after 
stimulation with live M. paratuberculosis. TLR-induced TNFα, IL-1ß and IL-10 production is 
mediated through MyD88, whereas Toll-IL-1R domain-containing adaptor inducing IFN-ß 
(TRIF) promoted the release of IL-1ß. hNod2-human embryo kidney (HEK) cells, but not 
hNod1-HEK cells, responded to stimulation with M. paratuberculosis. PBMC of individuals 
homozygous for the 3020insC Nod2 mutation showed a 70% defective cytokine response 
after stimulation with M. paratuberculosis. These results demonstrate that TLR2, TLR4, and 
Nod2 are involved in the recognition of M. paratuberculosis by the innate immune system.  
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Introduction  
  
  
Mycobacteria are an important group of pathological microorganisms causing disease in 
humans. Almost 2 billion people are infected with Mycobacterium tuberculosis worldwide, 
and more than 2 million people die each year as a result of tuberculosis 1. Other 
mycobacterial species, such as Mycobacterium leprae, are endemic in developing countries 
and are responsible for high morbidity and invalidate many people 2. In developed countries, 
the prevalence of infections with mycobacteria is increasing, especially in patients with a 
compromised immune system. Under these circumstances, nonpathogenic mycobacteria 
may cause disease, such as Mycobacterium avium complex (MAC) in HIV-infected patients.  
Mycobacterium paratuberculosis is a member of the MAC, which has been suggested to be 
associated with Crohn's disease (CD), a chronic granulomatous inflammation of the gut. This 
association is controversial, but some findings support a causative role of M. 
paratuberculosis in the pathogenesis of CD 3. In cows, M. paratuberculosis causes Johne's 
disease, which is very similar to CD in humans 4. Although M. paratuberculosis is not a known 
pathogenic for humans, it can be cultured from intestinal biopsies of CD patients and even 
from the blood 5,6. Furthermore, there is some evidence that treatment of CD with 
antibiotics has a beneficial effect on the disease activity 7,8.  
 
It is thought that the innate immune response contributes to the difference in susceptibility 
to mycobacteria. The innate immune system constitutes the first line of defense against 
pathogens such as mycobacteria. The recognition of pathogen-associated molecular patterns 
by pathogen recognition receptors (PRR) is crucial for the initiation and coordination of this 
response. The importance of these receptors is emphasized further by the current concepts 
that the adaptive immune response is partly under control of the innate immune system 9,10. 
The extracellular TLR 11,12 and C-type lectins 13,14 are membrane-bound PRR, which are 
complemented by the intracellular nucleotide-binding oligomerization domain-like receptor 
(NLR) family 15,16. In animal models, it is well established that deficiencies of most of these 
receptors lead to an impaired immune response against pathogens and a higher 
susceptibility to infection 17.  
 
Mutations in the LRR region of the nucleotide-binding oligomerization domain 2 (Nod2) 
gene, a member of the NLR family, are strongly associated with CD 18,19. Nod2 is expressed in 
leukocytes and epithelial cells of the gastrointestinal tract 20, and this intracellular receptor 
can recognize peptidoglycans (PGNs) of Gram-positive and Gram-negative bacteria 21. 
Stimulation of Nod2 can induce production of cytokines 22, chemokines 23, and defensins 
24,25. All these features suggest a key role for Nod2 in the innate immune response of the 
gastrointestinal tract. Not only does the intracellular PRR Nod2 seem to be important, but 
also, recognition of the commensal microflora and pathogens by extracellular TLRs in the gut 
is essential for the maintenance of the intestinal homeostasis and involved in the 
development of colitis 26. Mutations in other genes of innate immunity have also been 
reported to be associated with susceptibility to CD 27,28, which is considered to have a 
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multifactorial pathogenesis, and there is consensus that the interaction of the innate 
immune system with the luminal bacterial flora is essential for developing the chronic 
inflammation of the intestinal mucosa 29. However, it is still not clear whether pathogens, 
such as M. paratuberculosis, may cause or perpetuate inflammation in CD.  
 
Despite the possible role of M. paratuberculosis in CD, there is not much known about the 
interaction of M. paratuberculosis and the innate immune system. A recent study has 
reported association of live M. paratuberculosis in blood cultures and biopsies with CD 6, and 
it has also been reported that CD patients with mutations in the Nod2 gene are infected 
more frequently with M. paratuberculosis than CD patients without these mutations 30. 
Recently, we have shown that TLRs and Nod2 are nonredundant PRR of M. tuberculosis 31. In 
the present study, we further explore the receptors involved in the recognition of the 
intracellular pathogen M. paratuberculosis. By using animal and human in vitro models, we 
were able to show that TLR2, TLR4, and Nod2 are involved in the recognition of M. 
paratuberculosis.  
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Results 
  
  
M. paratuberculosis recognition by TLR2 and TLR4 
 
To investigate the recognition of M. paratuberculosis by TLR2 and TLR4, both known to 
recognize M. tuberculosis, CHO cells transfected with human TLRs were stimulated with 
sonicated M. paratuberculosis. Whereas stimulation of CHO-TLR2 with M. paratuberculosis 
resulted in a robust expression of the reporter molecule CD25 (47±6%) as a measure of NF-
κB activation (Fig. 1A), almost no expression of CD25 was seen after stimulation of CHO-TLR4 
(8±3%; Fig. 1B). To verify these results in a more complex system, TLR knockout mice were 
used. Indeed, peritoneal macrophages of TLR2–/– mice produced significantly less cytokines 
compared with control mice after stimulation with M. paratuberculosis (Fig. 2). 
 
 
 
Figure 1. M. paratuberculosis stimulates TLR2-transfected CHO cells predominantly and TLR4-
transfected CHO cells modestly, and CHO cells co-transfected with TLR2 and CD14 induced potent 
expression of CD25 on the cell membrane as a measure for NF-κB activation, after stimulation 
with a sonicated M. tuberculosis (MTB) or M. paratuberculosis (10 µg/ml) measured by FACS 
analysis (A). In contrast, cells transfected with CD14 and TLR4 were hardly activated by M. 
tuberculosis or M. paratuberculosis (B). LPS (1 µg/ml) and Pam3Cys (5 µg/ml) served as control 
stimuli for TLR4 and TLR2, respectively. Experiments were performed twice. 
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Figure 2. TLR2 mediates recognition of M. paratuberculosis. Peritoneal macrophages of TLR2–/– 
mice were stimulated with Pam3Cys (10 µg/ml), sonicated M. tuberculosis (10 µg/ml), or 
sonicated M. paratuberculosis (10 µg/ml). Cytokines TNFα, IL-1ß, and IL-10 were measured in the 
supernatant by ELISA or radioimmunoassay (RIA) after 24 h incubation at 37°C. Groups of five 
mice/group were stimulated. Data presented as mean ± SEM and were compared by Mann-
Whitney U test (*, P<0.05). 
 
After M. paratuberculosis stimulation, TLR4–/– murine macrophages also produced 
significantly less cytokines than controls (TNFα, Fig. 3A; IL-6, IL-10, and IL-1ß also reduced, 
not shown), although the difference was less pronounced, as seen in the macrophages of 
TLR2–/– mice. To further investigate the role of TLR4 in the recognition of M. 
paratuberculosis, human PBMC were stimulated with sonicated M. paratuberculosis in the 
presence and absence of anti-TLR4. Under these conditions, the TNFα production after 
stimulation with LPS was inhibited by over 50%, whereas no inhibitory effect on TNFα was 
seen when cells were stimulated with M. paratuberculosis (Fig. 3B). In addition, IL-1ß 
production induced by M. paratuberculosis was not influenced by TLR4 blockade (1255 
pg/ml stimulation by M. paratuberculosis alone vs. 1860 pg/ml by M. paratuberculosis in the 
presence of the TLR4 antagonist). As heat-killing and sonication might influence the ability of 
M. paratuberculosis to stimulate TLR4, we next stimulated human PBMC with live M. 
paratuberculosis. Under these conditions, the cytokine production was decreased 
significantly in the presence of anti-TLR4 (Fig. 4). Thus, M. paratuberculosis is recognized by 
TLR2 and TLR4.  
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Figure 3. TLR4 involvement in M. paratuberculosis induced cytokine production. Peritoneal 
macrophages of TLR4–/– mice were stimulated with LPS (1 µg/ml), sonicated M. tuberculosis (10 
µg/ml), or sonicated M. paratuberculosis (10 µg/ml). TNFα was measured in the supernatant by 
RIA after 24 h incubation at 37°C. Groups of five mice/group were stimulated (A). Human MNC of 
five healthy volunteers were stimulated with LPS (10 ng/ml), MTB (10 µg/ml), or sonicated M. 
paratuberculosis (10 µg/ml) in the presence or absence of TLR4 antagonist. TNFα was measured in 
the supernatant by ELISA after 24 h incubation at 37°C (B). Data presented as mean ± SEM and 
were compared by Mann-Whitney U test (mice) and Wilcoxon paired test (human; *, P<0.05). 
 
As TLR2 and TLR4 are involved in the recognition of M. paratuberculosis, MyD88 and TRIF 
knockout mice were used to decipher which adaptor molecule is important for the cytokine 
signal pathway. Stimulation of peritoneal macrophages of MyD88–/– mice with M. 
paratuberculosis resulted in significant, reduced cytokine production compared with control 
(Fig. 5A). Peritoneal macrophages of TRIF–/– mice stimulated with M. paratuberculosis 
produced significantly less IL-1ß compared with control cells, whereas there was no 
difference in production of other cytokines (Fig. 5B). Thus, TLR signaling after stimulation 
with M. paratuberculosis is mediated through MyD88 and TRIF, although the MyD88-
dependent pathway seems to be more important.  
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Figure 4. Live M. paratuberculosis stimulates TLR4 in human. Human MNC of five healthy 
volunteers were stimulated with sonicated M. paratuberculosis (10 µg/ml) or live M. 
paratuberculosis (107/ml) in the presence or absence of TLR4 antagonist. TNFα and IL-10 were 
measured in the supernatant by ELISA after 24 h incubation at 37°C. Data presented as mean ± 
SEM and compared by Wilcoxon paired test (*, P<0.05). 
 
 
 
 
Figure 5. M. paratuberculosis induced cytokine production is TLR-adaptor molecules MyD88- and 
TRIF-dependent. Peritoneal macrophages of MyD88–/– mice (A) or TRIF–/– (B) were stimulated 
with sonicated M. paratuberculosis (10 µg/ml). Cytokines TNFα, IL-1ß, and IL-10 were measured in 
the supernatant by ELISA or RIA after 24 h incubation at 37°C. Groups of six mice/group were 
stimulated. Data presented as mean ± SEM and compared by Mann-Whitney U test (*, P<0.05). 
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M. paratuberculosis recognition of Nod1 and Nod2 
To investigate the role of Nod1 and Nod2 in the recognition of M. paratuberculosis, HEK293 
cells transfected with human Nod1 or Nod2 and a NF-κB-driven, luciferase-reporter system 
were stimulated with sonicated M. paratuberculosis. Nod2-transfected cells responded in a 
dose-dependent NF-κB activation, expressed as fold-increase luciferase activity, whereas 
Nod1-transfected cells responded marginally to high concentrations of M. paratuberculosis 
(Fig. 6). To explore the role of Nod2 recognition of M. paratuberculosis in human cells, MNC 
of CD patients homozygous for the 3020insC frameshift mutation (Nod2fs), known to be 
nonfunctional, were stimulated with sonicated M. paratuberculosis or a control TLR2 ligand 
(the lipopeptide Pam3Cys). When stimulated with Pam3Cys, TNFα production was similar in 
cells isolated from healthy volunteers (202±55 pg/ml), CD patients with wild-type Nod2 
(213±35 pg/ml), and CD patients homozygous for the 3020insC mutation (175±53 pg/ml). 
After stimulation with M. paratuberculosis, cytokine production of Nod2fs cells was less than 
30% of that by wild-type Nod2 allele (Nod2wt) and controls (Fig. 7). Thus, Nod2 is involved in 
the M. paratuberculosis-induced cytokine production by human primary PBMC.  
 
 
 
Figure 6. Nod1 and Nod2 recognize M. paratuberculosis in transfected HEK cells. HEK293 cells 
with a luciferase reporter construct (HEK-ctr) were transfected with Nod1 (A) or Nod2 (B) and 
stimulated with M. paratuberculosis. MDP (1 µg/ml) and TriDAP (1 µg/ml) served as control 
stimuli for Nod2 and Nod1, respectively. The NF-κB-dependent luciferase activation was 
measured following 24 h of incubation. NF-κB-dependent luciferase assays were performed in 
duplicate, and data represent three independent experiments. 
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Figure 7. Human Nod2 is a receptor for M. paratuberculosis. MNC isolated from four patients with 
CD homozygous for the 3020insC Nod2 mutation (Nod2fs), five patients with the Nod2wt, and five 
healthy volunteers with wild-type Nod2 (HC) were stimulated with 10 µg/ml M. paratuberculosis. 
TNFα, IL-1ß, and IL-10 were measured after 24 h stimulation at 37°C by ELISA. MDP (100 nM), LPS 
(data not shown), and Pam3Cys (data not shown) served as control stimuli. Data are presented as 
means ± SEM and compared by Mann-Whitney U test (*, P<0.05). 
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Discussion 
  
  
In this study, we demonstrate that TLR2, TLR4, and Nod2 are PRR for M. paratuberculosis, 
which are responsible for mediating cytokine production and stimulation of host defense.  
In the first part of the study, we show that murine and human TLR2 recognize sonicated M. 
paratuberculosis. The role of TLR2 for M. tuberculosis recognition was already established in 
different experimental models 31,32, and it is known that 19-kD lipoprotein of M. tuberculosis 
is recognized by TLR2 33,34. Which structure of M. paratuberculosis engages TLR2 is yet 
unknown, but various immune-active lipoproteins, such as19-kD lipoprotein 35, 22-kD 
lipoprotein 36, and 34-kD lipoprotein 37,38, have been identified in M. paratuberculosis. It is 
therefore tempting to speculate that M. paratuberculosis lipoproteins may be recognized by 
TLR2.  
 
The role of TLR4 in the recognition of mycobacteria is more controversial. Sonicated M. 
tuberculosis has failed to stimulate human TLR4 in various experimental models. Conversely, 
it seems that TLR4 plays a beneficial role in tuberculosis infection models in mice 39,40, 
although not all groups could confirm these findings 41. One remarkable aspect is that TLR4 
responds differently to intact compared with sonicated mycobacteria 31, indicating that the 
sonication procedure changes the structure of certain cell wall components, which are 
important for TLR4 ligation. Our data show that TLR4 does not play a role in the recognition 
of sonicated M. paratuberculosis in human PBMC and transfected CHO cells. However, the 
role of TLR4 becomes apparent if human MNC are infected with live M. paratuberculosis, as 
under these conditions, cytokine responses were reduced by inhibition of TLR4. By contrast, 
macrophages from TLR4–/– mice did produce less TNFα after stimulation with sonicated M. 
paratuberculosis. This finding indicates that there are differences between the interaction of 
murine and human TLR4 with M. paratuberculosis. In addition, the interaction of leukocytes 
with components of live M. paratuberculosis at the level of the cell membrane is responsible 
for the TLR4-induced signaling. In contrast, Nod2 is an intracellular receptor, and recognition 
of M. paratuberculosis by Nod2 most likely requires prior internalization and digestion of the 
microorganism, leading to presentation of Nod2-stimulating motifs, as is probably the case 
in sonicated M. paratuberculosis. The structures of M. paratuberculosis responsible for 
interaction with human TLR4 are not known, but data obtained with M. tuberculosis indicate 
that structures sensitive for heat inactivation are responsible 32. This might explain the 
different response after recognition of sonicated and living M. paratuberculosis by human 
TLR4.  
 
The intracellular signals induced by TLRs leading to cytokine production are mediated by a 
limited number of adaptor molecules 42. For TLR4, there are two intracellular pathways 
mediating its effects, represented by the adaptor molecules MyD88 and TRIF, whereas TLR2 
depends entirely on the MyD88 pathway. We investigated which of the adaptor molecules 
are involved in the TLR signaling induced by M. paratuberculosis. The data from MyD88–/– 
and TRIF–/– mice showed that MyD88 is important for the induction of TNFα, IL-10, and IL-
Nod2 recognizes M. paratuberculosis 
181 
 
1ß, whereas TRIF only seems to be important for the induction of IL-1ß. This is in line with 
early studies showing that TRIF is involved in the IL-1ß production 43. In addition, TRIF-
mediated signaling is associated mainly with IFN-ß production.  
 
NLRs are a class of intracellular receptors, which complement the extracellular TLRs. Among 
the NLRs, Nod1 and Nod2 are the main receptors for PGN, and Nod1 recognizes the PGN of 
Gram-negative bacteria, whereas Nod2 recognizes the PGN of Gram-negative and Gram-
positive bacteria. We have shown recently that Nod2 is involved in the recognition of M. 
tuberculosis and acts synergistically with TLR2 and TLR4 for the induction of cytokines 31. 
When HEK cells transfected with Nod2 were stimulated with sonicated M. paratuberculosis, 
a dose-dependent effect was observed, suggesting that Nod2 recognizes M. 
paratuberculosis. In contrast, Nod1 only showed a marginal stimulation. We were able to 
confirm this finding in human primary cells. The MNC of CD patients homozygous for the 
3020insC mutation, which are nonresponsive for MDP 44, had a significant, reduced cytokine 
response after stimulation with sonicated M. paratuberculosis. By sonicating M. 
paratuberculosis or during killing by macrophages, fragments of the complete bacteria will 
be exposed and be able to stimulate the different PRR. How small these components are and 
how far they are degraded still remain unclear. For stimulation of the intracellular receptors, 
these fragments have to be taken up by leukocytes and digested further by enzymes in the 
leukocytes before they can stimulate receptors such as Nod2. The PGN of mycobacteria 
contains muramyl peptides with the N-acetylglucosamine-N-glycolylmuramic acid backbone 
and the L-Ala-D-Glu-meso-DAP-D-Ala peptide side-chain 45. This muramyl peptide contains 
motifs, such as L-Ala-D-Glu-meso-DAP (TriDAP), which can stimulate Nod1 46. Although it is 
known that the N-acetylmuramyl-L-Ala-D-Glu (MDP) structure is the minimal motif to 
stimulate Nod2 46, our data also suggest that an N-glycocylmuramic acid-containing 
dipeptide can stimulate Nod2. As shown previously, the Nod2 3020insC mutation also leads 
to an impaired cytokine production after stimulation of Nod1 in human primary cells, 
suggesting that Nod1 and Nod2 are needed for an efficient response of the cells to Nod1 
ligands 47. Therefore, the lack of functional Nod2 in Crohn's patients with 3020insC mutation 
may lead to defective responses to mycobacterial PGNs, which contain strong Nod2-binding 
motifs but also weaker Nod1 ligands. In conclusion, as M. paratuberculosis is an intracellular 
pathogen, Nod2 might play an important role in the defense against this mycobacterium.  
 
In the present study, we describe for the first time the receptors and mechanisms involved 
in the recognition of M. paratuberculosis. TLRs, such as TLR2 and TLR4, as well as Nod2 are 
independent recognition systems of M. paratuberculosis. It is tempting to speculate about 
the consequences of the finding that M. paratuberculosis is recognized by Nod2, as Nod2 
polymorphism and M. paratuberculosis are associated with CD. One might hypothesize that 
a defective recognition of M. paratuberculosis by cells of Crohn's patients with Nod2 
mutations is involved in the pathogenesis of CD.  
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Materials and methods 
  
  
Reagents and microorganisms 
Synthetic tripalmitoyl-S-glycero-Cys-(Lys)4 (Pam3Cys) was purchased from EMC 
Microcollections (Tübingen, Germany). Muramyl dipeptide (MDP) and LPS (Escherichia coli 
serotype 055:B5) were purchased from Calbiochem (San Diego, CA, USA) and Sigma 
Chemical Co. (St. Louis, MO, USA), respectively. The synthetic MDP was tested for 
contamination with lipoproteins or LPS in mice deficient in TLR2 or TLR4 (TLR2–/– or TLR4–/– 
respectively), demonstrating the absence of contamination. Diaminopimelic acid-containing 
muramyl tripeptide (M-TriDAP) was obtained as described previously 46. As a specific TLR4 
antagonist, we used LPS derived from the cell membrane of the Gram-negative bacterium 
Bartonella quintana, which has been demonstrated to be a highly specific TLR4 antagonist 48.  
Cultures of M. tuberculosis H37Rv and M. paratuberculosis were grown to mid-log phase in 
Middlebrook 7H9 liquid medium supplemented with oleic acid/albumin/dextrose/catalase 
(Difco Laboratories, Detroit, MI, USA), washed three times in sterile saline, and resuspended 
in RPMI-1640 medium at the various concentrations. Separate culture suspensions were 
washed three times in sterile saline; subsequently, the bacteria were heat-killed and 
disrupted in a bead-beater (Biospec Products, Bartlesville, OK, USA) using 0.1 mm glass 
beads.  
 
Genotyping of Nod2 variants 
Blood was collected from 154 patients with CD and 10 healthy volunteers. PCR amplification 
of Nod2 gene fragments containing the polymorphic site 3020insC was performed in 50 µl 
reaction volumes containing 100–200 ng genomic DNA as described previously 49. The 
3020insC polymorphism was analyzed by Genescan analysis on an ABI-Prism 3100 genetic 
analyzer according to the protocol of the manufacturer (Applied Biosystems, Nieuwerkerk, 
The Netherlands).  
 
Seven patients with CD were found homozygous for the 3020insC frameshift mutation, and 
four of them were investigated further in the cytokine studies. As control groups, five 
patients with CD bearing the wild-type alleles and five healthy volunteers homozygous for 
the wild-type Nod2 allele were included.  
 
Isolation of PBMC and stimulation of cytokine production 
After informed consent, venous blood was drawn from the cubital vein of patients and 
healthy volunteers into three 10 ml EDTA tubes (Monoject, s-Hertogenbosch, The 
Netherlands). Isolation of mononuclear cells (MNC) was performed as described elsewhere 
50 with minor modifications. The MNC fraction was obtained by density centrifugation of 
blood diluted 1:1 in pyrogen-free saline over Ficoll-Paque (Pharmacia Biotech AB, Uppsala, 
Sweden). Cells were washed twice in saline and suspended in culture medium RPMI 1640, 
supplemented with gentamicin 10 µg/ml, L-glutamine 10 mM, and pyruvate 10 mM. The 
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cells were counted in a Coulter counter (Coulter Electronics, Mijdrecht, The Netherlands), 
and the number was adjusted to 5 x 106 cells/ml.  
 
MNC (5x105) in a 100-µl vol were added to round-bottom, 96-well plates (Greiner, Alphen 
a/d Rijn, The Netherlands) and incubated with 100 µl culture medium (negative control) or 
the various stimuli: M. tuberculosis sonicate (10 µg/ml), M. paratuberculosis sonicate (10 
µg/ml), MDP (100 nM), LPS (10 ng/ml), or TLR4 antagonist (10 µg/ml).  
 
Cytokine production by murine peritoneal macrophages 
Resident peritoneal macrophages from TLR4–/–, TLR2–/–, MyD88–/–, or control C57Bl/6N 
mice (kindly provided by Dr. Shizuo Akira, Research Institute for Microbiological Diseases, 
Osaka University, Osaka, Japan) 51 and LPS2 [Toll-IL-1R domain-containing adaptor-inducing 
IFN-ß (TRIF)-defective] mice (kindly provided by Dr. Bruce Beutler, The Scripps Institute, La 
Jolla, CA, USA) 52 were harvested by injection of 4 ml sterile PBS containing 0.38% sodium 
citrate 53. After centrifugation and washing, the cells were resuspended in RPMI 1640 
containing 1 mM pyruvate, 2 mM L-glutamine, 100 µg/ml gentamicin, and 2% fresh mouse 
plasma. Cells were cultured in 96-well microtiter plates (Greiner, Alphen a/d Rijn) at 1 x 105 
cells/well in a volume of 100 µl. The cells were stimulated with purified LPS (1 µg/ml), 
Pam3Cys (1 µg/ml), sonicate of M. tuberculosis (10 µg/ml), or sonicate of M. 
paratuberculosis (10 µg/ml). After 24 h incubation at 37°C, the supernatants were collected 
and stored at –70°C until cytokine assays were performed.  
 
Cytokine measurements 
Murine TNFα and IL-1ß concentrations were determined by specific radioimmunoassays as 
described 54,55. Murine IL-10 and human IL-10 and IL-1ß were measured by commercial ELISA 
kits (Pelikine Compact, Sanquin, Amsterdam, The Netherlands), according to the instructions 
of the manufacturer. Human TNFα concentrations were determined by specific ELISA 56.  
 
Signaling through human TLR2 and TLR4 in transfected cell lines 
Chinese hamster ovary (CHO) fibroblasts stably transfected with human CD14 (3E10-CD14), a 
combination of CD14 and TLR2 (3E10-TLR2) or TLR4 (3E10-TLR4), were a kind gift from Dr. 
Robin Ingalls (Boston Medical Center, Boston University School of Medicine, Boston, MA, 
USA). Cell lines express inducible membrane CD25 under control of a region from the human 
E-selectin (endothelial leukocyte-adhesion molecule 1) promoter containing NF-κB-binding 
sites. Cells were maintained at 37°C and 5% CO2 in HAM's F12 medium (Gibco, Invitrogen, 
Breda, the Netherlands), supplemented with 10% FCS, 0.01% L-glutamine, 50 µg/mL 
gentamicin and 400 U/mL hygromycin, and 0.5 mg/mL G418 (for 3E10-TLR2) or 0.05 mg/mL 
puromycine (for 3E10-TLR4) as additional selection antibiotics. TLR2 and TLR4 expression 
was confirmed by flow cytometry (Coulter Epics XL-MCL, Beckman Coulter, Mijdrecht, the 
Netherlands) using PE-labeled anti-TLR2 (Clone TL2.1) or anti-TLR4 (Clone HTA125; 
Immunosource, Halle-Zoersel, Belgium).  
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For stimulation experiments, 500 µl cells in culture medium at a density of 1 x 105/mL were 
plated in 24-well culture plates. After an overnight incubation, cells were incubated with 
control medium, M. tuberculosis sonicate (10 µg/ml), M. paratuberculosis sonicate (10 
µg/ml), Pam3Cys (10 µg/ml), or LPS (1 µg/ml) for 20 h, and thereafter, cells were harvested 
using trypsin/EDTA (Cambrex, East Rutherford, NY, USA) and prepared for flow cytometry 
(Coulter FACSscan). CD25 expression of the CHO cells was measured using FITC-labeled anti-
CD25 (Dako, Glostrup, Denmark) and expressed as a percentage of CD25-positive cells.  
 
Stimulation of NOD cell lines and NF-κB translocation 
Studies examining the activation of NF-κB by M. paratuberculosis sonicates in cells 
overexpressing Nod1 or Nod2 were carried out as described previously 57. Briefly, human 
embryo kidney (HEK)293T cells were transfected overnight with 1 ng Nod1 or Nod2 plus 75 
ng luciferase reporter plasmid. At the same time, sonicated, heat-killed M. paratuberculosis 
preparations were added to cell culture medium, and the NF-κB-dependent luciferase 
activation was then measured following 24 h of incubation. NF-κB-dependent luciferase 
assays were performed in duplicate, and data represent three independent experiments and 
expressed as a folds-over-mean increase.  
 
Statistical analysis 
The human experiments were performed in triplicate with blood obtained from patients and 
volunteers. The mouse experiments were performed twice in 10 mice per group, and the 
data are presented as cumulative results of all experiments performed. The differences 
between groups were analyzed by Mann-Whitney U test or Wilcoxon and where 
appropriate, by Kruskal-Wallis ANOVA test. The level of significance between groups was set 
at P < 0.05. The data are given as means ± SEM.  
  
Nod2 recognizes M. paratuberculosis 
185 
 
Reference List 
 
 
1 Frieden,T.R. et al. (2003) Tuberculosis. Lancet 362, 887-899 
2 Engers,H. and Morel,C.M. (2003) Leprosy. Nat. Rev. Microbiol. 1, 94-95 
3 Shanahan,F. and O'Mahony,J. (2005) The mycobacteria story in Crohn's disease. Am. J. 
Gastroenterol. 100, 1537-1538 
4 Chacon,O. et al. (2004) Johne's disease, inflammatory bowel disease, and Mycobacterium 
paratuberculosis. Annu. Rev. Microbiol. 58, 329-363 
5 Naser,S.A. et al. (2002) In situ identification of mycobacteria in Crohn's disease patient tissue using 
confocal scanning laser microscopy. Mol. Cell Probes 16, 41-48 
6 Naser,S.A. et al. (2004) Culture of Mycobacterium avium subspecies paratuberculosis from the 
blood of patients with Crohn's disease. Lancet 364, 1039-1044 
7 Hulten,K. et al. (2000) Antibacterial therapy for Crohn's disease: a review emphasizing therapy 
directed against mycobacteria. Dig. Dis. Sci. 45, 445-456 
8 Shafran,I. et al. (2002) Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. 
Dig. Liver Dis. 34, 22-28 
9 Janeway,C.A., Jr. and Medzhitov,R. (1998) Introduction: the role of innate immunity in the adaptive 
immune response. Semin. Immunol. 10, 349-350 
10 Medzhitov,R. and Janeway,C.A., Jr. (1998) Innate immune recognition and control of adaptive 
immune responses. Semin. Immunol. 10, 351-353 
11 Takeda,K. et al. (2003) Toll-like receptors. Annu. Rev. Immunol. 21, 335-376 
12 Medzhitov,R. et al. (1997) A human homologue of the Drosophila Toll protein signals activation of 
adaptive immunity. Nature 388, 394-397 
13 Figdor,C.G. et al. (2002) C-type lectin receptors on dendritic cells and Langerhans cells. Nat. Rev. 
Immunol. 2, 77-84 
14 McGreal,E.P. et al. (2005) Ligand recognition by antigen-presenting cell C-type lectin receptors. 
Curr. Opin. Immunol. 17, 18-24 
15 Ting,J.P. and Davis,B.K. (2005) CATERPILLER: a novel gene family important in immunity, cell 
death, and diseases. Annu. Rev. Immunol. 23, 387-414 
16 Inohara,N. and Nunez,G. (2003) NODs: intracellular proteins involved in inflammation and 
apoptosis. Nat. Rev. Immunol. 3, 371-382 
17 Netea,M.G. et al. (2004) Toll-like receptors and the host defense against microbial pathogens: 
bringing specificity to the innate-immune system. J. Leukoc. Biol. 75, 749-755 
18 Ogura,Y. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's 
disease. Nature 411, 603-606 
19 Hugot,J.P. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to 
Crohn's disease. Nature 411, 599-603 
20 Ogura,Y. et al. (2003) Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52, 
1591-1597 
Chapter 10 
186 
 
21 Girardin,S.E. et al. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide 
(MDP) detection. J. Biol. Chem. 278, 8869-8872 
22 Netea,M.G. et al. (2005) Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR 
Pathways for the Induction of Cytokine Release. J. Immunol. 174, 6518-6523 
23 van Heel,D.A. et al. (2005) Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated 
Crohn's disease. Lancet 365, 1794-1796 
24 Voss,E. et al. (2006) NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-
defensin-2. J. Biol. Chem. 281, 2005-2011 
25 Wehkamp,J. et al. (2004) NOD2 (CARD15) mutations in Crohn's disease are associated with 
diminished mucosal alpha-defensin expression. Gut 53, 1658-1664 
26 Rakoff-Nahoum,S. et al. (2004) Recognition of commensal microflora by toll-like receptors is 
required for intestinal homeostasis. Cell 118, 229-241 
27 Duerr,R.H. et al. (2006) A genome-wide association study identifies IL23R as an inflammatory 
bowel disease gene. Science 314, 1461-1463 
28 Cantor,M.J. et al. (2005) The role of cytokine gene polymorphisms in determining disease 
susceptibility and phenotype in inflammatory bowel disease. Am. J. Gastroenterol. 100, 1134-1142 
29 Podolsky,D.K. (2002) Inflammatory bowel disease. N. Engl. J. Med. 347, 417-429 
30 Sechi,L.A. et al. (2005) Mycobacterium avium subsp. paratuberculosis, genetic susceptibility to 
Crohn's disease, and Sardinians: the way ahead. J. Clin. Microbiol. 43, 5275-5277 
31 Ferwerda,G. et al. (2005) NOD2 and toll-like receptors are nonredundant recognition systems of 
Mycobacterium tuberculosis. PLoS. Pathog. 1, 279-285 
32 Means,T.K. et al. (1999) Human toll-like receptors mediate cellular activation by Mycobacterium 
tuberculosis. J. Immunol. 163, 3920-3927 
33 Gehring,A.J. et al. (2003) The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits 
gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like 
receptor 2. Infect. Immun. 71, 4487-4497 
34 Hertz,C.J. et al. (2001) Microbial lipopeptides stimulate dendritic cell maturation via Toll-like 
receptor 2. J. Immunol. 166, 2444-2450 
35 Huntley,J.F. et al. (2005) Immunoreactivity of the Mycobacterium avium subsp. paratuberculosis 
19-kDa lipoprotein. BMC. Microbiol. 5, 3 
36 Dupont,C. et al. (2005) Identification and characterization of an immunogenic 22 kDa exported 
protein of Mycobacterium avium subspecies paratuberculosis. J. Med. Microbiol. 54, 1083-1092 
37 Silbaq,F.S. et al. (1998) Characterization of a 34-kilodalton protein of Mycobacterium leprae that 
is isologous to the immunodominant 34-kilodalton antigen of Mycobacterium paratuberculosis. 
Infect. Immun. 66, 5576-5579 
38 Gioffre,A. et al. (2006) Lpp34, a novel putative lipoprotein from Mycobacterium avium subsp. 
paratuberculosis. J. Vet. Med. B Infect. Dis. Vet. Public Health 53, 34-41 
39 Abel,B. et al. (2002) Toll-like receptor 4 expression is required to control chronic Mycobacterium 
tuberculosis infection in mice. J. Immunol. 169, 3155-3162 
40 Heldwein,K.A. et al. (2003) TLR2 and TLR4 serve distinct roles in the host immune response 
against Mycobacterium bovis BCG. J. Leukoc. Biol. 74, 277-286 
Nod2 recognizes M. paratuberculosis 
187 
 
41 Shim,T.S. et al. (2003) Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium 
tuberculosis infection. Tuberculosis. (Edinb. ) 83, 367-371 
42 Beutler,B. (2004) Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430, 
257-263 
43 Toshchakov,V.U. et al. (2005) Differential involvement of BB loops of toll-IL-1 resistance (TIR) 
domain-containing adapter proteins in. J. Immunol. 175, 494-500 
44 Netea,M.G. et al. (2005) NOD2 3020insC mutation and the pathogenesis of Crohn's disease: 
impaired IL-1beta production points to a loss-of-function phenotype. Neth. J. Med. 63, 305-308 
45 Adam,A. et al. (1974) Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem. 
Biophys. Res. Commun. 56, 561-567 
46 Girardin,S.E. et al. (2003) Peptidoglycan molecular requirements allowing detection by Nod1 and 
Nod2. J. Biol. Chem. 278, 41702-41708 
47 Netea,M.G. et al. (2005) The frameshift mutation in Nod2 results in unresponsiveness not only to 
Nod2- but also Nod1-activating peptidoglycan agonists. J. Biol. Chem. 280, 35859-35867 
48 Abdollahi-Roodsaz,S. et al. (2007) Inhibition of TLR4 Breaks the Inflammatory Loop in 
Autoimmune Destructive Arthritis. Arthritis Rheum. 
49 Netea,M.G. et al. (2004) NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: 
implications for Crohn's disease. Eur. J. Immunol. 34, 2052-2059 
50 Endres,S. et al. (1988) Measurement of immunoreactive interleukin-1 beta from human 
mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with 
interleukin-1 alpha and tumor necrosis factor. Clin. Immunol. Immunopathol. 49, 424-438 
51 Takeuchi,O. et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and 
gram-positive bacterial cell wall components. Immunity. 11, 443-451 
52 Hoebe,K. et al. (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR 
signalling. Nature 424, 743-748 
53 Kullberg,B.J. et al. (1993) Recombinant interferon-gamma enhances resistance to acute 
disseminated Candida albicans infection in mice. J. Infect. Dis. 168, 436-443 
54 Drenth,J.P. et al. (1995) Endurance run increases circulating IL-6 and IL-1ra but downregulates ex 
vivo TNFalpha and IL-1 beta production. J. Appl. Physiol 79, 1497-1503 
55 Netea,M.G. et al. (1996) Low-density lipoprotein receptor-deficient mice are protected against 
lethal endotoxemia and severe gram-negative infections. J. Clin. Invest 97, 1366-1372 
56 Grebenchtchikov,N. et al. (2005) Development of a sensitive ELISA for the quantification of human 
tumour necrosis factor-alpha using 4 polyclonal antibodies. Eur. Cytokine Netw. 16, 215-222 
57 Girardin,S.E. et al. (2003) Nod1 detects a unique muropeptide from gram-negative bacterial 
peptidoglycan. Science 300, 1584-1587 
  
Chapter 10 
188 
 
 
  
 189 
 
Chapter 11 
 
 
Crohn's disease patients homozygous for the 3020insC Nod2 
mutation have a defective Nod2/TLR4 cross-tolerance to 
intestinal stimuli 
 
 
Bart Jan Kullberg, Gerben Ferwerda, Dirk J. de Jong, Joost P.H. Drenth, Leo A. 
Joosten, Jos W.M. Van der Meer and Mihai G. Netea 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
Immunology. 2008 Apr;123(4):600-5 
 
Chapter 11 
190 
 
  
Nod2 and TLR4 cross-tolerance 
191 
 
Abstract 
 
 
Mutations in nucleotide-binding oligomerization domain-2 (Nod2), leading to defective 
recognition of bacterial peptidoglycans, are associated with Crohn's disease. The underlying 
mechanism that results in increased inflammation in the guts of the patients bearing Nod2 
mutations is still unclear. We hypothesized that Nod2 engagement leads to cross-tolerance 
to stimulation of Toll-like receptors (TLR), and we investigated whether patients with Crohn's 
disease who bear Nod2 mutations display a disturbed Nod2/TLR cross-tolerance. Peripheral 
blood mononuclear cells preincubated with Nod2 ligands were specifically down-regulated 
for the production of tumor necrosis factor-α (TNFα) induced by the TLR4 ligand 
lipopolysaccharide, as well as by intestinal microorganisms, whereas the production of anti-
inflammatory cytokines was not modulated. While in cells isolated from patients with 
Crohn's disease with the wild-type Nod2 allele, the Nod2 engagement led to a similar cross-
tolerance to TLR4-dependent stimulation of TNFα, the cross-tolerance between Nod2 and 
TLR4 was absent in the cells of five patients homozygous for the 3020insC Nod2 mutation, 
leading to uninhibited release of TNFα by TLR4 ligands and intestinal bacteria. In conclusion, 
we propose the absence of Nod2/TLR4 cross-tolerance as a central mechanism for the 
increased susceptibility to Crohn's disease in individuals with Nod2 mutations. 
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Introduction 
 
 
The IBD1 locus on chromosome 16 has been identified as a susceptibility locus for Crohn's 
disease 1, and subsequently, nucleotide-binding oligomerization domain-2 (Nod2) has been 
identified as the candidate gene within the IBD1 locus 2-4. Nod2 is a member of the NACHT-
LRR receptor (NLR) protein family, which is known to be involved in recognition of microbial 
structures, and is expressed intracellularly in antigen-presenting cells 5. Subsequent studies 
have identified Nod2 as the intracellular receptor for the muramyl dipeptide (MDP) 
component of peptidoglycan 6,7. However, the pathophysiological mechanisms responsible 
for the increased susceptibility to Crohn's disease in patients with Nod2 mutations are 
unclear. Crohn's disease patients who are homozygous for the 3020insC mutation of the 
Nod2 gene were found to have a defective release of cytokines after stimulation with 
peptidoglycan and its MDP components 8,9. How this defect paradoxically translates into 
increased local inflammation in the intestine has not been clarified. Several potential 
mechanisms have been proposed, including defective release of anti-inflammatory cytokines 
8, or defective production of defensins, leading to bacterial overgrowth 10,11. Whereas a gain-
of-function effect of the mutation on interleukin-1β (IL-1β) release was demonstrated in a 
mouse model 12, the latter mechanism was refuted in human studies 13. None of these 
mechanisms satisfactorily explains the increased inflammatory reaction found in the 
intestines of patients with Crohn's disease. 
 
In addition to its role as receptor for peptidoglycan, Nod2 also modulates signaling induced 
by Toll-like receptors (TLRs). Several studies have suggested that concomitant stimulation of 
Nod2 and TLR synergistically induces cytokines, although controversy exists around this issue 
9,14. Such synergism between different receptors is a known amplification mechanism aimed 
at enforcing innate immunity. In addition, tolerance may be induced by repeated or chronic 
exposure to a stimulus. Such tolerance has been extensively described for bacterial 
lipopolysaccharide (LPS, endotoxin), and cross-tolerance to LPS and other stimuli at the level 
of TLR2 and TLR4 has been established 15,16. It is not known whether stimulation of Nod2 is 
able to induce cross-tolerance to TLR signaling. If this were the case, the chronic stimulation 
of Nod2 by intestinal peptidoglycans could tolerize for subsequent bacterial stimulation of 
TLRs, resulting in down-modulation of the proinflammatory cytokine response. Such a 
mechanism may contribute to maintaining intestinal homeostasis in the presence of a large 
quantity of bacterial stimuli. 
 
Here we describe five patients who are homozygous for the 3020insC Nod2 mutation, and 
we demonstrate that Nod2 engagement leads to cross-tolerance to TLR4-dependent 
production of tumor necrosis factor-α (TNFα), the central cytokine mediating inflammation 
in Crohn's disease. The cross-tolerance between Nod2 and TLR4 was absent in the patients 
with the Nod2 mutation, and this leads to uninhibited release of TNFα by intestinal bacteria 
and other TLR4 ligands. The tolerizing effect of Nod2 is specific for TLR4 stimulation; 
stimulation by TLR2 ligands was not affected. 
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Results 
 
 
Nod2-induced cross-tolerance for TLR4-induced TNFα 
 
Prestimulation of peripheral blood mononuclear cells (PBMC) isolated from healthy 
volunteers with various concentrations of MDP significantly reduced their capacity to 
synthesize TNFα after stimulation of TLR4 by LPS, but not after stimulation with the TLR2 
ligands Pam3Cys or MALP (Fig. 1a). To investigate whether MDP can also induce tolerance to 
intestinal pathogens, cells exposed to MDP were subsequently stimulated with heat-killed S. 
typhimurium or B. fragilis. Although both are intestinal microorganisms, S. typhimurium 
induces intracellular signals through both TLR4 and TLR2 17, whereas TLR2 is the main 
receptor mediating the cytokine production induced by B. fragilis 18. In line with the results 
obtained with purified TLR ligands, stimulation of Nod2 by MDP led to tolerance to the 
induction of TNFα by S. typhimurium (Fig. 1b). The effect of Nod2 engagement was less 
pronounced on the stimulation of cytokines by B. fragilis (Fig. 1b). 
 
 
 
Figure 1. Nod2 induces cross-tolerance for TLR4-induced TNFα. (a) Mononuclear cells isolated 
from five healthy volunteers were preincubated for 24 hr with various concentrations of MDP 
(0.1, 1 and 10 μg/ml), and subsequently stimulated for 24 hr with LPS (1 ng/ml), Pam3Cys (10 
μg/ml) or MALP (10 μg/ml). (b) To investigate whether MDP can also induce tolerance to 
stimulation with intestinal pathogens, mononuclear cells tolerized with MDP in various 
concentrations (see above) were subsequently stimulated with heat-killed S. typhimurium or B. 
fragilis (both at a concentration of 1 × 106 microorganisms/ml). Concentrations of TNFα were 
measured by enzyme-linked immunosorbent assay. Data are presented as mean ± SD, and 
compared by Wilcoxon paired test (n = 5, *P < 0.05). 
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Figure 2. Nod2 does not influence the induction of IL-6 and IL-10 stimulated by TLRs. MNC 
isolated from five healthy volunteers were preincubated for 24 hr with MDP (10 μg/ml), and 
subsequently stimulated for another 24 hr with LPS (1 ng/ml) or Pam3Cys (10 μg/ml). 
Concentrations of IL-6 (a) and IL-10 (b) were measured by enzyme-linked immunosorbent assay. 
Data are presented as mean ± SD, and compared by Wilcoxon paired test (n = 5, all differences 
not significant). 
 
In contrast to TNF production, the synthesis of IL-6 in response to the various stimuli was not 
changed by the preincubation of PBMC with MDP (Fig. 2). Similarly, IL-10 production induced 
by TLR2 or TLR4 ligands was not changed by preincubation of PBMC with MDP (Fig. 2). 
Production of IL-12 was undetectable in all the samples, irrespective of the stimulus used. 
 
Presence of bacterial peptidoglycans in the intestinal wall 
 
The hypothesis that Nod2 signals induce tolerance for subsequent stimulation of TLR would 
require the presence of sufficient amounts of peptidoglycan in enterocytes. Indeed, 
immunostaining for peptidoglycans clearly demonstrated the intracellular presence of 
peptidoglycan in colonic enterocytes, both in healthy individuals (Fig. 3a) and in patients 
with Crohn's disease (Fig. 3b). 
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Figure 3. Peptidoglycan is present in the intestinal mucosa. Immunostaining using a monoclonal 
mouse anti-MDP antibody (0.3 μg/ml) was performed in the colonic mucosa of healthy individuals 
(a) and patients with Crohn's disease (b). The secondary antibody, biotinylated rabbit anti-mouse 
immunoglobulin G, was added to the incubation for 30 min. Slides were stained with streptavidin 
peroxidase, developed with DAB, and counterstained with haematoxylin for 30 seconds 
(magnification 400×). 
 
 
Nod2/TLR4 cross-tolerance in Crohn's disease patients with a 3020insC Nod2 mutation 
 
Nod2-induced cross-tolerance on TLR4-mediated TNFα production was investigated in 
volunteers, Crohn's disease patients with the wild-type Nod2 allele (Nod2wt), and patients 
who were homozygous for the 3020insC mutation (Nod2fs). Cross-tolerance between Nod2 
and TLR4 was only absent in patients with the Nod2fs mutation (Fig. 4). 
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Figure 4. Cross-tolerance induced by Nod2 stimulation is absent in patients with the 3020insC 
mutation. Cross-tolerance between Nod2 and TLR4, as measured by the effect of MDP (10 μg/ml) 
preincubation on LPS-induced (1 ng/ml) TNFα production, was assessed in five healthy controls, 
five Crohn's patients bearing the wild-type allele (Nod2wt), and five patients with the 3020insC 
Nod2 mutation (Nod2fs). Data are presented as mean ± SD, and compared by Mann–Whitney test 
(n = 5, *P < 0.05). 
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Discussion 
 
 
In this study we have demonstrated that stimulation of Nod2 by MDP induces tolerance to 
subsequent induction of TLR4 by intestinal microorganisms and other ligands. This tolerance 
affects the production of TNFα, a proinflammatory cytokine with a central role in the 
pathogenesis of Crohn's disease 19. Neutralization of TNF by monoclonal antibodies has been 
proved to be the most effective immunotherapy for Crohn's disease 20. The observed 
tolerance may represent an important mechanism allowing the presence of colonizing 
intestinal flora without activating the immune system. The absence of such tolerization in 
individuals with Nod2 mutations predisposes to excessive inflammation, and is likely to 
represent a key factor in the increased susceptibility of these individuals to develop Crohn's 
disease. 
 
Several mechanisms have been proposed to explain the correlation between loss-of-function 
mutations in Nod2 and Crohn's disease. We previously proposed that defective synthesis of 
the anti-inflammatory cytokine IL-10, known to protect against experimental colitis 21, is 
important for the development of Crohn's disease. Others have proposed that defective 
barrier defense, through ineffective production of defensins at the level of the intestinal 
mucosa, could explain bacterial persistence and the induction of inflammation 10,11. Other 
hypotheses included Nod2-dependent inhibition of TLR2 signaling 22, or Nod2 3020insC gain-
of-function effects on IL-1β release in a mouse model 12, but these two mechanisms could 
not be confirmed in subsequent studies. Instead, several studies in human primary cells 
demonstrated synergism between Nod2 and TLR2 stimulation, whereas monocytes isolated 
from Nod2 3020insC homozygous patients demonstrated defective IL-1β production 9,13,14. 
Thus, none of these mechanisms adequately explains the excessive inflammation found in 
Crohn's disease. Although other pathways may also be involved, we propose that intestinal 
inflammation in the mucosa of these patients is the result of the absence of Nod2/TLR4 
cross-tolerance, leading to subsequent TNFα production induced by intestinal flora triggering 
TLR4. Although patients with Crohn's disease bearing the Nod2 mutations had a slightly (not 
significant) lower TNF release compared with the other two groups, they were completely 
refractory to the Nod2-induced cross-tolerance for LPS stimulation. However, we have to 
underline that the present study has been performed only with circulating monocytes. 
Lamina propria monocytes and enterocytes have been reported to have a more tolerant 
phenotype, and the Nod2/TLR cross-tolerance experiments from the present study should 
be repeated in lamina propria cells. 
 
Marks et al. recently proposed an intriguing hypothesis for the pathogenesis of Crohn's 
disease, demonstrating that patients with Crohn's disease have defective production of 
proinflammatory cytokines, including IL-8, and deficient neutrophil recruitment 23. This 
immunodeficient state may lead to ineffective bacterial clearance from the intestinal wall, 
with subsequent inflammation. However, these defects were reported for Crohn's disease 
patients irrespective of their Nod2 make-up. Our study presents evidence for a 'second hit' 
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mechanism in patients bearing Nod2 mutations. Healthy individuals with wild-type Nod2 can 
mount a proper IL-1β and IL-8 response after challenge with Nod2 ligands 23 enabling 
elimination of invading organisms, and have an attenuated TNFα release because of the 
Nod2/TLR4 cross-tolerance. In contrast, patients with Crohn's disease with wild-type Nod2 
have an intrinsic IL-8 defect, but this defect can be partly overcome by MDP–Nod2 ligation 
23. However, patients with Crohn's disease and the 3020insC Nod2 mutation have both a 
deficient IL-8 response, leading to persistence of microbial stimuli, and respond with an 
abundant TNFα response to intestinal flora because of absence of Nod2/TLR4 cross-
tolerance. 
 
The relevance of our data for the pathogenesis of Crohn's is supported by two additional 
lines of evidence: first, we demonstrated the presence of intracellular peptidoglycans in 
enterocytes, enabling prolonged interaction with Nod2 and induction of tolerance; and 
second, tolerance was not only demonstrated for LPS but also for whole intestinal 
microorganisms. Finally, it should be noted that Nod2 induces specific tolerance for TLR4 
stimulation, but not that by TLR2. While both TLR2 and TLR4 mediate nuclear factor-κB 
translocation and TNF transcription through the myeloid differentiation factor 88 (MyD88)-
dependent pathway, in the case of TLR4 (but not TLR2) a second pathway of nuclear factor-
κB/TNF induction involves TIR domain-containing adaptor-inducing interferon-β (TRIF)/TRIF-
related adaptor molecule (TRAM)-dependent signaling. Thus, one may speculate that it is the 
TRIF/TRAM TLR4-specific pathway that is modulated by Nod2, although additional 
experiments are needed to confirm that. In addition, several studies have now shown that 
TLR4 primarily induces strong proinflammatory signals, whereas TLR2 predominantly 
provokes an anti-inflammatory profile 24. Thus, whereas Nod2 induces cross-tolerance 
against proinflammatory TLR4 signals, it preserves the attenuating TLR2 stimulation. In line 
with this, only LPS-induced production of TNF, a strong proinflammatory cytokine, has been 
inhibited by preincubation of cells with MDP, whereas production of the anti-inflammatory 
cytokines IL-10 and IL-6 was not affected. This demonstrates a specific cross-tolerance effect 
between Nod2 and TLR4 on TNF release, resulting in a net proinflammatory bias in patients 
lacking a functional Nod2. 
 
In conclusion, we provide in this study the proof-of-concept that Nod2 can specifically 
induce cross-tolerance to TNFα stimulation by TLR4 ligands and intestinal microorganisms. 
This may represent an important mechanism through which overwhelming inflammatory 
responses to intestinal flora are prevented. However, these effects should be validated in 
future experiments on lamina propria cells. In addition, additional studies on the precise 
molecular mechanism of the cross-tolerance are also warranted. This protective cross-
tolerance mechanism is absent in patients with Crohn's disease who are homozygous for the 
3020insC Npd2 mutation, and this may contribute to their susceptibility to Crohn's disease. 
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Materials and methods 
 
 
Patients 
Blood was collected from 74 patients with Crohn's disease. Polymerase chain reaction 
amplification of Nod2 gene fragments containing the polymorphic site 3020insC was 
performed in 50-μl reaction volumes containing 100–200 ng genomic DNA, as previously 
described 8. The 3020insC polymorphism was analysed by Genescan analysis on an ABI Prism 
3100 Genetic Analyzer according to the protocol of the manufacturer (Applied Biosystems, 
Nieuwerkerk a/d IJssel, the Netherlands). Five patients identified as homozygous for the 
3020insC Nod2 allele were included in the study. From the patients with Crohn's disease 
who were homozygous for the wild-type Nod2 allele, five were recruited as a control group, 
in addition to five healthy volunteers with the wild-type allele. None of the patients had 
active disease at the time of blood donation, and none had used corticosteroids or other 
anti-inflammatory medication for at least 2 weeks prior to the experiment. 
   
Isolation of mononuclear cells and cross-tolerance 
Blood from patients and volunteers was drawn into ethylenediaminetetraacetic acid tubes, 
and isolation of mononuclear cells was performed as described elsewhere 25. Mononuclear 
cells (5 × 105 in 100 μl) were added to round-bottom 96-well plates and preincubated for 24 
hr with either 100 μl culture medium (negative control), or MDP at concentrations 0.1, 1 or 
10 μg/ml. After incubation for a further 24 hr, the supernatant was discarded, the adherent 
cells were washed, and restimulation with various stimuli was performed: control medium, 
highly purified Salmonella typhimurium LPS (1 ng/ml), synthetic Pam3Cys or macrophage-
activating lipopeptide 2 (MALP) (both at 10 μg/ml), or heat-killed S. typhimurium or 
Bacteroides fragilis (both at a concentration of 1 × 106 microorganisms/ml). Enzyme-linked 
immunosorbent assay was used to measure TNFα, IL-6, IL-10 and IL-12 in the supernatants 
(Pelikine Compact, Sanquin, the Netherlands). 
   
Immunohistochemistry of intestinal wall peptidoglycans 
After obtaining informed consent, colonic biopsies were taken from three patients 
undergoing routine follow-up colonoscopy for colonic polyps, and three patients with 
Crohn's disease bearing the wild-type Nod2 allele who were undergoing a routine check-up. 
Tissue samples were fixed with 4% formaldehyde. After 2 hr the specimens were transferred 
to a solution of 70% alcohol, and then embedded in paraffin. After dewaxing and 
dehydration, sections were blocked with normal swine serum followed by 60 min of 
incubation with a monoclonal mouse anti-MDP antibody (kindly provided by Dr George M. 
Bahr, Pasteur Institute, Lille, France) at 0.3 μg/ml. The secondary antibody, biotinylated 
rabbit anti-mouse immunoglobulin, was added to the incubation for 30 min. Slides were 
stained with streptavidin peroxidase, developed with diaminobenzidine (DAB), and 
counterstained with haematoxylin for 30 seconds. 
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Statistical analysis 
Experiments were performed in duplicate. Data are given as mean ± SD. The differences 
between groups were analysed by Mann–Whitney U-test, and where appropriate by paired 
Wilcoxon test. The level of significance was set at P < 0.05. 
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Abstract 
 
 
NOD2/CARD15 is the first characterized susceptibility gene in Crohn disease. The Nod2 
1007fs (Nod2fs) frameshift mutation is the most prevalent in Crohn disease patients. 
Muramyl dipeptide from bacterial peptidoglycan is the minimal motif detected by Nod2 but 
not by Nod2fs. Here we investigated the response of human peripheral blood mononuclear 
cells (PBMCs) from Crohn disease patients not only to muramyl dipeptide but also to several 
other muramyl peptides. Most unexpectedly, we observed that patients homozygous for the 
Nod2fs mutation were totally unresponsive to MurNAc-l-Ala-d-Glu-meso-diaminopimelic 
acid (DAP) (M-TriDAP), the specific agonist of Nod1, and to Gram-negative bacterial 
peptidoglycan. In contrast, PBMCs from a patient homozygous for the Nod2 R702W 
mutation, also associated with Crohn disease, displayed normal response to Gram-negative 
bacterial peptidoglycan. In addition, the blockage of the Nod1/M-TriDAP pathway could be 
partially overcome by co-stimulation with the Toll-like receptors agonists lipoteichoic acid or 
lipopolysaccharide. Investigation into the mechanism of this finding revealed that Nod2fs did 
not act as a dominant-negative molecule for the Nod1/M-TriDAP pathway, implying that the 
blockage is dependent upon the expression or activity of other factors. We demonstrated 
that PBMCs from Nod2fs patients express high levels of the peptidoglycan recognition 
protein S, a secreted protein known to interact with muramyl peptides. We proposed that 
through a scavenger function, peptidoglycan recognition protein S may dampen M-TriDAP-
dependent responses in Nod2fs patients. Together, our results identified a cross-talk 
between the Nod1 and Nod2 pathways and suggested that down-regulation of Nod1/M-
TriDAP pathway may be associated with Crohn disease.  
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Introduction 
 
 
Nod2 (also known as CARD15) is a member of the Nod family of pattern recognition 
molecules involved in peptidoglycan sensing 1,2. Although Nod2 detects a muramyl dipeptide 
(MDP)3 motif found in peptidoglycans from all classes of bacteria 3-5, Nod1 detects a 
diaminopimelic acid (DAP)-containing muramyl tripeptide (M-TriDAP) found primarily in 
Gram-negative bacterial peptidoglycan 4,6,7. In addition to its role as an intracellular pattern 
recognition molecule, genetic evidence has identified Nod2 as the first susceptibility gene for 
Crohn disease 8,9. Crohn disease is an inflammatory disorder affecting the digestive tract, the 
etiology of which remains largely unknown. However, the recent association between the 
disease and Nod2 on the one hand and between Nod2 and bacterial sensing on the other 
hand suggests that Crohn disease is likely a consequence of a breakdown in tolerance to the 
intestinal bacterial flora. Still, it remains unclear why Nod2 dysfunction is a risk factor 
favoring the onset of Crohn disease. Indeed, although Nod2fs is fully defective for 
peptidoglycan sensing, other Nod2 mutant proteins found in Crohn disease patients display 
only minor differences in peptidoglycan detection 10,11.  
 
Through the identification of new important functions of Nod2, substantial progress has 
been made over the past few years toward understanding the link between Nod2 mutations 
and Crohn disease 1,2,12. Indeed, Nod2 function has been shown to be related to intracellular 
bacterial killing 13, defensin activity due to its expression in Paneth cells 14-16, as well as the 
induction of the anti-inflammatory cytokine IL-10 17. Also, Nod2 –/– mice display an 
increased TH1 profile of cytokine responses following stimulation with Toll-like receptor 
(TLRs) agonists 18, which is an observation compatible with some features of Crohn disease. 
Finally, a recent study has reported the characterization of a knock-in mouse homozygous 
for the Nod2fs mutation, thus mimicking the natural human mutation associated with Crohn 
disease 19. Most surprisingly, macrophages from these animals displayed increased response 
to MDP, which contradicts results obtained by groups studying human cells 5,17,20. It is still 
unclear why Nod2fs mutation seems to represent a loss-of-function in humans and a gain-of-
function in the mouse model.  
 
In the present study, we aimed to investigate the response of primary mononuclear cells 
isolated from Crohn disease patients not only to MDP but also to several muramyl peptides 
or peptidoglycan agonists. Most surprisingly, we observed that M-TriDAP, the specific 
agonist of Nod1, failed to induce cytokine response in PBMCs from Nod2fs patients, 
although it stimulated cells efficiently from either healthy donors or non-Nod2 Crohn disease 
patients. The importance of this result is further reinforced by the observation that cells 
from Nod2fs patients were totally unresponsive to peptidoglycan from Helicobacter pylori, 
which is an efficient activator of both Nod1 and Nod2 signaling pathways. Because Nod2fs 
was unable to act directly as a dominant-negative molecule for the Nod1 pathway, our 
results rather suggest that the blockage relies on additional factors expressed in Nod2fs 
cells. Accordingly, we provide evidence that PBMCs from Nod2fs patients express 
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significantly higher levels of peptidoglycan recognition protein S (PGRP-S) than cells from 
healthy donors. We propose that PGRP-S expression contributes to the down-regulation of 
Nod1-dependent responses in Crohn disease patients with Nod2fs mutation. Therefore, 
these observations suggest the existence of an unexpected cross-talk between the Nod1 and 
Nod2 signaling pathways. Moreover, our results imply that defects in Nod1 function could 
participate in the development of Crohn disease. Together, this study provides a basis for 
the design of original therapeutic approaches for Crohn disease, aiming at establishing a 
functional Nod1 pathway in Nod2fs patients.  
  
Chapter 12 
208 
 
Results and discussion 
 
 
In the search for MDP-derived muramyl peptides that could stimulate the Nod2 signaling 
pathway, we generated several molecules differing in the length of their peptidic moiety, 
including M-TriLys and M-TetraLys (Fig. 1A). These molecules were then tested for their 
ability to activate Nod2 by using co-transfection assays in HEK293T epithelial cells and 
measuring NF-κB activity as a read-out (Fig. 1B). By using such tests, we reported previously 
that the activation of Nod2 was maximal with the addition of 10 pmol of MDP/ml of culture 
medium (leading to a concentration of 10 nm) 4. Here a larger range of muramyl peptide 
concentration was used (10–250 nm) to allow for the identification of even weak inducers of 
the Nod2 pathway. Through this approach, we observed that MDP and M-TriLys activated 
Nod2 with similar efficiency, whereas M-TetraLys represented a poor agonist (Fig. 1B). These 
results are consistent with our previous observations showing that the length of the 
muramyl peptide stem peptide is a key requirement for induction of Nod2 4. Because our 
goal was to use MDP-derived muramyl peptides to stimulate primary human PBMCs (see 
below), we searched for other MDP-derived molecules that could represent the optimal 
negative controls for M-TriLys and M-TetraLys agonists. We took advantage of our previous 
observation that the sugar moiety of muramyl peptides also plays a key role for optimal 
activation of Nod2 4. We generated modified forms of M-TriLys and M-TetraLys in which the 
MurNAc moiety is dehydrated to form anhydro-muramyl peptides (see Fig. 1A), and we 
observed that this subtle modification was sufficient to abolish stimulation of Nod2 (Fig. 1B). 
Therefore, anhydro-M-TriLys and anhydro-M-TetraLys were subsequently used as control 
inactive muramyl peptides for M-TriLys and M-TetraLys, respectively. Finally, M-TriDAP, the 
specific muramyl peptide agonist of Nod1, failed to activate Nod2, even at the highest dose 
(250 nm) used.  
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Figure 1. Detection of MDP-derived muramyl peptides by Nod2. A, schematic representation of 
the muramyl peptides used in this study. B, human HEK293 epithelial cells were transfected with 
several muramyl peptides (MDP, M-TriLYS, Anh-M-TriLYS, M-TetraLYS, and Anh-M-TetraLYS) at 
the following concentrations: 10 nm (white bars), 50 nm (gray bars), or 250 nm (black bars) in the 
presence of an expression vector for Nod2. The activity of an NF-κB-driven luciferase reporter 
gene was measured, and Nod2-dependent activation of the reporter gene in the presence of 
muramyl peptides was reported to the one obtained without stimulation with muramyl peptides. 
Data show the mean ± S.E. of duplicate experiments. Experiments were performed three times 
with similar results 
 
The six muramyl peptides characterized above (MDP, M-TriLys, M-TetraLys, anhydro-M-
TriLys, anhydro-M-TetraLys, and M-TriDAP) were used to stimulate PBMCs obtained from 
human blood. PBMCs from three groups of individuals were collected: healthy donors 
(control, CTR), Crohn disease patients without Nod2 mutations (Crohn), and Crohn disease 
patients carrying homozygous Nod2fs frameshift mutation (Nod2fs). Muramyl peptides were 
directly added to the culture medium at a final concentration of 50 nm, and supernatants 
were collected following overnight stimulation. IL-1β, IL-10, and TNFα were measured in the 
supernatant, whereas intracellular IL-1α was measured from cell lysates (Fig. 2A). First, our 
results identified MDP and M-TriLys as potent activators of human PBMC responses, and we 
confirmed that the detection of these muramyl peptides depends upon Nod2 because 
Nod2fs cells were not stimulated by MDP and M-TriLys (Fig. 2A). In addition, our observation 
that M-TetraLys was a poor inducer of Nod2 in vitro was reinforced by our findings that this 
agonist only marginally induced cytokine secretion from human PBMCs, and that this effect 
was further blunted in cells from Nod2fs patients (Fig. 2A). More importantly, our results 
showed that Nod2-independent Crohn disease patients still reacted to MDP and M-TriLys, 
thus demonstrating that the inability of cells from Nod2fs patients to detect these agonists 
resulted from their Nod2 mutation and was not an indirect consequence of the disease. 
Consequently, this observation also suggested that defects in muramyl peptide sensing are 
not the sole cause of Crohn disease development. Second, the conclusion that sensing of M-
TriLys in PBMCs from healthy donors and non-Nod2 Crohn disease patients depends on 
Nod2 is reinforced by the observation that anhydro-M-TriLys failed to stimulate these cells, 
which is in agreement with the results obtained in HEK293T cells (see Fig. 1B). Finally, we 
aimed to use M-TriDAP in order to stimulate PBMCs in a Nod1-dependent but Nod2-
independent manner. M-TriDAP stimulation induced cytokine secretion in human PBMCs 
from healthy donors or non-Nod2 Crohn disease patients (Fig. 2A). However, M-TriDAP was 
strikingly unable to stimulate PBMCs from Nod2fs patients. This result was unexpected 
because M-TriDAP is a specific activator of Nod1 but not of Nod2. Therefore, these results 
identified an unexpected link between Nod2 mutations and the Nod1 signaling pathway.  
 
Muramyl peptides are naturally occurring degradation products of peptidoglycan, which are 
useful tools to study precisely the involvement of signaling pathways dependent upon the 
specific activation of Nod1 or Nod2. However, in physiological situations, macrophages 
would likely encounter the presence of both intact peptidoglycan polymers together with 
muramyl peptides. Therefore, we aimed to investigate the response of PBMCs from the  
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Figure 2. Response to muramyl peptides and peptidoglycans of PBMCs from healthy donors (CTR; 
n = 5), Crohn disease patients without defects in Nod2 (Crohn; n = 5), or Crohn disease patients 
homozygous for the frameshift mutation (Nod2fs; n = 4). A and B, IL-1β, TNF, and IL-10 were 
measured from the cell culture medium. Intracellular IL-1α was measured from cell lysates. 
Muramyl peptides (A, all 50 nm) or peptidoglycans (B, all peptidoglycans at 10 μg/μl; LPS (100 
ng/ml)) were added directly to the cell culture medium for 18 h. 
 
same individuals to peptidoglycans from H. pylori, S. pneumoniae, and S. aureus. We decided 
to use peptidoglycan from H. pylori because it is the prototype of Gram-negative bacterial 
peptidoglycan (DAP-type peptidoglycan) and is relatively easy to purify. Similarly, 
peptidoglycan from S. pneumoniae was chosen because it represents a classical  
peptidoglycan (Lys-type peptidoglycan) from Gram-positive bacteria. Finally, peptidoglycan 
from S. aureus was also included in this study because it is widely studied; however, because 
of the extremely high degree of peptidic cross-linking found in this peptidoglycan, its 
structure is less representative of Gram-positive bacterial peptidoglycan than that of S. 
pneumoniae. For such studies, the level of purification of the peptidoglycan polymer is a 
crucial feature. Several quality control tests were performed along the purification steps to 
ensure that other cell wall contaminants are excluded, such as LPS, lipoproteins, or LTA. To 
this end, the absence of LPS contamination was assessed by the Limulus amebocyte lysate 
test, showing that purified peptidoglycans contained less than 4 pg of LPS/ml of sample 
(data not shown). To address the difficult question of contamination by lipoproteins or LTA, 
we took advantage of our recent observation that contaminant-free peptidoglycans failed to 
stimulate thioglycollate-induced peritoneal macrophages from mice 21. Our purified 
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peptidoglycans failed to induce the secretion of TNFα or IL-6 from peritoneal mouse 
macrophages (data not shown), showing that only traces amounts, if any, of lipoproteins or 
LTA contaminants were present in our peptidoglycan preparations. These peptidoglycan 
preparations were then added (each at 10 μg/ml) to the human PBMCs from the same 
individuals as described above, and the cytokines were measured after overnight stimulation 
(Fig. 2B). As a control, cells were also stimulated with LPS (100 ng/ml). First, by analyzing the 
cytokine response of cells from the healthy donors, we noticed that purified peptidoglycans 
activate human PBMCs, which contrasts with the lack of response in mouse peritoneal 
macrophages (see above). The reason for this discrepancy remains unknown, but it strongly 
correlates with the blunted response of mouse macrophages to muramyl peptides.4 Second, 
we observed that cells from non-Nod2 Crohn disease patients also responded to 
peptidoglycans as well (or even slightly more, depending on the cytokines) as the healthy 
donors (Fig. 2B). Finally, we found that PBMCs from the Nod2fs group of patients were 
totally unresponsive to the three peptidoglycans used in this study, regardless of the 
cytokine analyzed. More importantly, these cells were still fully responsive to LPS 
stimulation, thus demonstrating that Nod2fs PBMCs did not display a global 
unresponsiveness to any stimulation. Again, these results are in agreement with the data 
from cells stimulated with muramyl peptides (see Fig. 2A).  
 
 
 
Figure 3. Expression of Nod1 in PBMCs from 13 individuals by real time PCR. Expression of Nod1 
was analyzed by real time PCR in cells from healthy donors (CTR), Crohn disease patients without 
defects in Nod2 (Crohn), or Crohn disease patients homozygous for the frameshift mutation 
(Nod2fs). Expression of Nod1 is reported to the internal control β-actin. 
 
Our observation that PBMCs from Nod2fs patients are unresponsive to Gram-positive 
bacterial peptidoglycans allows us to draw some important conclusions. First, this result 
shows that Nod2 is a key sensor of the Gram-positive bacterial peptidoglycan. Second, this 
observation suggests that, within the peptidoglycan polymer, the MDP and M-TriLys motifs 
are the key structures that drive the response of the host through their detection by Nod2. 
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Third, our assumption that these peptidoglycans are free of bacterial contaminants is 
reinforced by this result, because unpurified peptidoglycans would have induced a TLR-
driven response. In the case of the Gram-negative bacterial peptidoglycan, it was anticipated 
that, in the cells from Nod2fs patients, the defective Nod2 sensing could be compensated by 
the activation of the Nod1 signaling pathway. Indeed, unlike Gram-positive bacterial 
peptidoglycan, Gram-negative bacterial peptidoglycan is able to stimulate both Nod1 and 
Nod2. The lack of Nod1-dependent signaling in Nod2fs cells (Fig. 2B) again suggests that a 
functional Nod2 signaling pathway is required for Nod1-driven signaling to take place. This 
result confirms and extends the conclusions from the study of muramyl peptide stimulation 
of PBMCs (see Fig. 2A). Taken together, it can be concluded that any peptidoglycan sensing 
(dependent upon Nod2, Nod1, or any uncharacterized peptidoglycan sensor) is abrogated in 
PBMCs from Nod2fs patients. This defect is not found in non-Nod2 Crohn disease patients, 
therefore suggesting that if lack of peptidoglycan sensing contributes to the onset of Crohn 
disease, the pathology can also arise from other causes.  
 
In an attempt to better understand the origin of the defective Nod1-dependent signaling in 
cells from Nod2fs patients, we aimed to define whether such a defect was specific to the 
Nod2fs mutation. We took advantage that one individual in our cohort of Crohn disease 
patients had been genotyped as homozygous for the Nod2 R702W mutation, which is the 
second most frequent Nod2 mutation associated with increased risk for Crohn disease. Most 
strikingly, PBMCs from this patient were responsive to H. pylori peptidoglycan to a similar 
extent as the control group (TABLE ONE), which contrasts with the results obtained from 
Nod2fs patients. Obviously, these results will need further confirmation by analyzing larger 
populations of patients carrying diverse Nod2 mutation; still, this initial characterization 
suggests that the defect in the Nod1/M-TriDAP pathway that we have identified is likely to 
be associated with the Nod2fs genotype and not other Nod2 mutations.  
 
 
 
Table 1Response of PBMCs from a Crohn disease patient homozygous for the R702W mutation to 
H. pylori PG. IL-1β, TNF, and IL-10 were measured from the cell culture medium. Intracellular IL-1α 
was measured from cell lysates. H. pylori peptidoglycan (10 μg/ml) and LPS (100 ng/ml) were 
added directly to the cell culture medium for 18 h. Values given represent pg/ml of cytokine 
measured ± S.E. 
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Figure 4.Nod2fs does not act as a dominant-negative molecule on the Nod1/M-TriDAP pathway. 
A, human HEK293 epithelial cells were transfected with several constructs that trigger the NF-κB 
pathway: Nod1 (1 ng of DNA added; simultaneously, addition of 50 nm M-TriDAP); Nod2 (0.5 ng of 
DNA added; simultaneously, addition of 50 nm MDP); Rip2 (50 ng); MyD88 (1 ng). Co-transfection 
of the above constructs was then performed together with increasing amounts (1, 5, and 20 ng) of 
expression vector for Nod2fs, and the activity of a NF-κB-driven luciferase reporter gene was 
measured. NF-κB activations are presented as a percentage of the value obtained in the absence 
of Nod2fs expression. Data show the mean ± S.E. of duplicate experiments. Experiments were 
performed three times with similar results. B, the response of PBMCs from healthy donors (CTR; n 
= 4) and Crohn disease patients heterozygous for the Nod2fs mutation (heterozygote; n = 4) to H. 
pylori peptidoglycan (PG) was analyzed. Intracellular IL-1α was measured from cell lysates. H. 
pylori peptidoglycan (10 μg/μl) and LPS (100 ng/ml) were added directly to the cell culture 
medium for 18 h. 
 
Next, we investigated whether Nod1 expression was decreased in Nod2fs PBMCs. Nod1 
expression was analyzed by real time PCR on 13 individuals (6 “CTR”, 3 “Crohn,” and 4 
“Nod2fs”). Even though expression of Nod1 was found quite variable among individuals, no 
correlation could be observed between expression levels of Nod1 and the three groups 
analyzed (Fig. 3). Therefore, the lack of the Nod1-dependent response in Nod2fs PBMCs 
cannot be accounted for by a defect in Nod1 expression in these cells. One likely explanation 
for the defective Nod1/M-TriDAP pathway in cells from Nod2fs patients is that the Nod2fs 
protein would simply behave as a dominant-negative for Nod1 signaling. To test this 
hypothesis, HEK293 cells were transfected with Nod1 plus M-TriDAP (1 ng of Nod1; 50 nm 
M-TriDAP; according to standard procedures 4) in the presence of increasing amounts of 
Nod2fs. Clearly, Nod2fs was unable to block the Nod1/M-TriDAP pathway (Fig. 4A), even at 
the highest dose tested (50 ng of Nod2fs DNA transfected). Also, we found no effect of 
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Nod2fs overexpression on NF-κB activation triggered by either Rip2 or MyD88 (Fig. 4A), 
whereas the molecule blocked only partially the NF-κB activation induced by Nod2/MDP (–
45%). Therefore, in light of these results, one can rule out a direct effect of Nod2fs on Nod1 
signaling. Accordingly, if Nod2fs protein had behaved as a dominant-negative molecule on 
the Nod1 pathway, it is likely that patients heterozygous for the Nod2fs mutation would 
have displayed altered sensing of H. pylori peptidoglycan. This was indeed not the case (Fig. 
4B; similar results were obtained with the other cytokines measured (data not shown)).  
 
Next, we analyzed whether the lack of response of Nod2fs cells to M-TriDAP was still 
observed in the case of co-stimulation with other agonists. Indeed, it is well characterized 
that muramyl peptides act in synergy with TLR agonists to induce cytokine secretion from 
PBMCs 22-26. Therefore, we stimulated PBMCs from individuals in our three groups (CTR, 
Crohn, and Nod2fs) with M-TriDAP, LPS (TLR4 agonist), or LTA (TLR2 agonist) either alone or 
in combination (M-TriDAP + LPS or M-TriDAP + LTA). For the three groups of individuals, we 
observed that M-TriDAP could function in synergy with LPS or LTA to potentiate cytokine 
secretion (Fig. 5; similar results were obtained with the other cytokines measured (data not 
shown)). These results are in agreement with the recent evidence presented in two 
independent studies, in which PBMCs from healthy donors were used 27,28. As a control, 
PBMCs were also stimulated with MDP in combination with LPS or LTA. As reported 
previously 17, synergistic induction of cytokine secretion was observed in the case of healthy 
individuals or non-Nod2 Crohn disease patients but not in the Nod2fs group (Fig. 5). 
Together, these results suggest that even though M-TriDAP does not directly induce cytokine 
secretion in Nod2fs PBMCs, the blockage can be partially overcome in the case of co-
stimulation with TLR ligands.  
 
 
 
Figure 5. Synergistic activation of PBMCs by MDP or M-TriDAP plus either LPS or LTA. PBMCs from 
healthy donors (CTR; n = 6), Crohn disease patients without defects in Nod2 (Crohn; n = 3) or 
Crohn disease patients homozygous for the frameshift mutation (Nod2fs; n = 4) were analyzed. 
Cells were stimulated either with MDP or M-TriDAP, LPS, or LTA alone or in combination: LPS + 
MDP, LTA + MDP, LPS + M-TriDAP, or LTA + M-TriDAP with the agonists added simultaneously. 
Intracellular IL-1α was measured from cell lysates. LPS (1 ng/ml), LTA (5 μg/ml), MDP (50 nm), and 
M-TriDAP (50 nm) were added directly to the cell culture medium for 18 h.  
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Figure 6. Expression of Nod1, PGRP-L, PGRP-S, Rip2, and hPepT1 in PBMCs from 13 individuals by 
real time PCR. A–E, expressions of Nod1 (A), PGRP-L (B), PGRP-S (C), Rip2 (D), and hPepT1 (E) were 
analyzed by real time PCR in cells from healthy donors (CTR), Crohn disease patients without 
defects in Nod2 (Crohn), or Crohn disease patients homozygous for the frameshift mutation 
(Nod2fs). In each case, expression of the gene of interest is reported to the internal control β-
actin. Asterisk indicates that the difference of expression of PGRP-S between the control and 
Nod2fs groups has been found as statistically significant using the Mann-Whitney test (p < 0.05). 
F, schematic model illustrating the possible role of PGRP-S as a scavenger molecule for muramyl 
peptides in the extracellular compartment of PBMCs. An up-regulation of PGRP-S (as observed in 
Nod2fs patients) would favor the titration of muramyl peptides (including M-TriDAP) out of the 
activation pathway. 
 
In order to gain more insights into the mechanism responsible for the blockage of the Nod1 
pathway in Nod2fs cells, real time PCR analysis of selected candidate genes was performed 
in PBMCs isolated from our three groups of individuals (6 healthy donors (CTR), 3 Crohn 
disease patients without mutations in the Nod2 gene (Crohn), and 4 Nod2fs patients). The 
selected genes were the following and were chosen based on their potential roles in 
muramyl peptide signaling: PGRP-L, PGRP-S, RIP2, and hPEPT1 (Nod1 expression was also 
presented as a comparison). Indeed, PGRP-L and PGRP-S both interact with muramyl 
peptides and peptidoglycan 29-31. Rip2 is a crucial adaptor protein downstream of both Nod1 
and Nod2 pathways 32-37. Finally, hPepT1 has been demonstrated to allow for the 
internalization of muramyl dipeptide, at least in epithelial cells 38. Even though differences in 
expression were noted for these genes among the groups tested (Fig. 6, A–E), all except one 
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case, these variations were not judged statistically significant (95% confidence) using the 
Mann-Whitney test for nonparametric samples. The only strong correlation was found in the 
Nod2fs group, in which a significant increase of PGRP-S expression was observed as 
compared with the control group of healthy donors (Fig. 6C; p < 0.05). Because PGRP-S is a 
secreted protein known to bind muramyl peptides, one can speculate that excessive 
expression of PGRP-S by Nod2fs PBMCs might contribute to dampening the response of 
these cells to muramyl peptides, thereby acting as a scavenger molecule (Fig. 6F). In this 
context, it is interesting to note that PGRP-SC1B, a Drosophila homolog of mammalian PGRP-
S, has been proposed to modulate the innate immunity in the fruit fly also via a scavenger 
function 39. Further investigation will be required to define precisely the role of PGRP-S in 
muramyl peptide-dependent signaling in both normal and inflammatory conditions.  
 
The defective Nod1 function in PBMCs from Nod2fs patients was, at least in part, overcome 
when cells were co-stimulated with TLR ligands, such as LPS or LTA (see Fig. 5). This 
observation strongly suggests that in cells expressing functional TLRs, the defective Nod1 
pathway may not have a crucial impact on the etiology of Crohn disease. However, this 
defect could prove of critical importance in epithelial cells lining the mucosal surfaces. 
Indeed, these cells are permanently in contact with microbes and microbial products, and 
therefore down-regulation of TLR function represents a common mechanism to avoid 
constitutive inflammation due to the microbial flora 40. Accordingly, by using ex vivo 
experiments, we have been able to show that intestinal epithelial cells detect nonflagellated 
bacteria exclusively through Nod1 (6). As a consequence, it can be envisioned that defective 
function of Nod1 in intestinal epithelial cells from Nod2fs patients may participate in the 
establishment of Crohn disease. This hypothesis has recently found strong support through 
the identification of genetic variation in Nod1 associated with predisposition to 
inflammatory bowel disease 41.  
 
The results presented here may have an impact on the design of new therapeutic treatments 
for Crohn disease. Nod2 1007fs mutation represents one-third to one-half of the Nod2 
mutations found in Crohn disease patients. In this group of patients, a therapeutic approach 
aimed at restoring functional Nod1 signaling can be envisioned. Indeed, up until now, the 
idea of targeting Nod1 pathway in Crohn disease patients was not envisioned in this way, 
because it was assumed that Nod1 remained fully functional. Restoring a functional Nod1 
pathway in Nod2fs cells would have the important advantage of restoring partial 
homeostasis of the intestinal mucosa vis à vis the microbial environment. Therefore, if Crohn 
disease is a consequence of a breakdown in the tolerance to the intestinal bacterial flora, 
such tolerance could be restored through Nod1-dependent sensing of Gram-negative 
bacterial components of the microbial environment. Because such therapy would rely on a 
fine balance defined by the host itself, it would be likely less aggressive than other 
treatments, such as those acting to reduce the inflammation induced by the disease. 
However, one can question whether restoring the sensing of Gram-negative bacterial 
species only is sufficient to promote intestinal homeostasis to the microbial environment. 
This issue is of crucial importance for both our fundamental understanding of the etiology of 
Crohn disease and the rational design of new therapeutics aimed at treating the pathology.  
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Materials and methods 
 
 
Preparation of highly purified peptidoglycans from Gram-negative and Gram-positive 
bacteria 
Bacterial strains used to prepare peptidoglycans are the following: H. pylori 26695; 
Staphylococcus aureus COL (from Olivier Chesneau, Institut Pasteur); and Streptococcus 
pneumoniae R800. The peptidoglycans purification procedures were exactly as described 
previously 6,21. Purity of samples was assessed by HPLC amino acid and saccharide analysis 
after HCl hydrolysis. Also, each peptidoglycan preparation was tested for the absence of LPS 
contamination using the Limulus amebocyte lysate assay as described previously 21. The 
absence of TLR2-detected contaminants (lipoproteins or lipoteichoic acids) was tested on 
thioglycollate-elicited mouse peritoneal macrophages from either C57Bl6 or TLR2–/– mice as 
described previously 21.  
 
Preparation of muropeptides 
DAP- and Lys-containing UDP-Mur-NAc-peptides were prepared as described previously 4,42. 
M-TetraLYS, M-TriLYS, and M-TriDAP were generated by mild acid hydrolysis (0.1 m HCl, 10 
min at 100 °C) of the corresponding UDP-MurNAc peptides. Replacement of meso-DAP by l-
Lys in the peptidoglycan of Escherichia coli was obtained by overexpression in the latter 
species of the murE gene from S. aureus encoding UDP-MurNAc-l-Ala-d-Glu:l-Lys adding 
enzyme 27. Cells were harvested before cell lysis occurred, and their peptidoglycan was 
extracted and purified as described previously 28. In these conditions, about 50% of the DAP 
residues at the third position of the peptides was shown to be replaced by l-Lys. This 
peptidoglycan preparation was digested by SltY lytic transglycosylase in a reaction mixture (1 
ml) consisting of 300 mm sodium acetate buffer, pH 4.5, 1 mg of PG (briefly sonicated for 
homogenization), and 100 μgof purified SltY enzyme 43. After overnight incubation at 37 °C, 
the reaction was stopped by adding 500 μl of 50 mm sodium phosphate buffer, pH 4.45 
(HPLC eluent A), and 2 μl of phosphoric acid. The two main monomer products, Anh-GM-
TetraDAP and Anh-GM-TetraLYS, were purified by HPLC on a column of nucleosyl 5C18 (4,6 × 
250 mm, Alltech). Elution was performed at 0.6 ml/min with buffer A, using a gradient of 
methanol from 0 to 25% for 180 min. Detection was at 215 nm. The retention times of these 
two compounds were 67 and 80 min, respectively. They were further purified and desalted 
using a second HPLC step on the same column but this time using 0.1% trifluoroacetic acid 
and a gradient of methanol for elution. Their purity and composition were confirmed by 
amino acid and hexosamine analysis after acid hydrolysis of samples (6 m HCl, 16 h at 95 °C), 
using an Hitachi L8800 analyzer, as well as by matrix-assisted laser desorption ionization 
time-of-flight mass spectrometry. Anh-M-TetraLYS was obtained by treatment of Anh-GM-
TetraLYS with E. coli NagZ β N-acetylglucosaminidase. The reaction mixture (200 μl) 
contained 20 mm HEPES buffer, pH 7.4, 50 mm NaCl, 0.5 mm substrate, and 20 μg of purified 
NagZ enzyme 43. Anh-GM-TriLYS and Anh-M-TriLYS were generated by treatment of the 
corresponding tetrapeptide compounds with E. coli LdcA ld-carboxypeptidase. The reaction 
mixture (200 μl) contained 50 mm Tris-HCl buffer, pH 8.0, 0.5 mm substrate, and 20 μg of 
Chapter 12 
218 
 
purified LdcA enzyme 43. In all cases, incubation was for overnight at 37 °C, and the products 
were purified by HPLC, and their identity was confirmed by the above described procedures.  
 
Cell lines and reagents 
HEK293T cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal calf 
serum. Prior to transfection, HEK293T cells were seeded into 24-well plates at a density of 1 
× 105 cells/ml as described previously 32. MDP LD (l-alanine d-glutamine) was from 
Calbiochem and reported to be 98% pure by TLC. Highly purified E. coli LPS (strain O55:B5) 
was from Invitrogen. Artificially synthesized LTA was kindly provided by Dr. Corinna 
Hermann (Konstanz University, Germany). Anti-Nod2 rabbit polyclonal antibody was from 
Cayman Chemical (Ann Harbor, MI), and anti-β-tubulin monoclonal antibody was from 
Sigma.  
 
Expression plasmids and transient transfections 
The expression plasmids for Nod1 and Nod2 were the kind gift from Gabriel Nuñez 
(University of Michigan Medical School, Ann Arbor, MI) and have been described previously 
44. The expression vector for Nod2fs was from M. Giovannini (INSERM U674, CEPH, Paris, 
France). Constructs for Rip2 and MyD88 were kind gifts from M. Thome (ISREC, Lausanne, 
Switzerland) and M. Muzio (Mario Negri Institute, Milan, Italy), respectively. The NF-κB 
luciferase reporter plasmid was from Stratagene. Transfections and Western blotting 
experiments were carried out in HEK293T cells as described previously 32.  
 
NF-κB activation assays 
Studies examining the synergistic activation of NF-κB by muramyl peptides in cells 
overexpressing Nod2 were carried out as originally described by Inohara et al. 44. Briefly, 
HEK293T cells were transfected overnight with the expression vectors of interest plus 75 ng 
of NF-κB luciferase reporter plasmid. At the same time, muramyl peptides were added to the 
cell culture medium, and the synergistic NF-κB-dependent luciferase activation was then 
measured following 24 h of co-incubation. NF-κB-dependent luciferase assays were 
performed in duplicate, and the data represent at least three independent experiments. 
Data show means ± S.E.  
 
Genotyping of Nod2 variants 
Blood was collected from 74 patients with Crohn disease and 10 healthy volunteers. PCR 
amplification of Nod2 gene fragments containing the polymorphic sites 3020insC (for 
Nod2fs) and C2104T (for R702W) was performed in 50-μl reaction volumes containing 100–
200 ng of genomic DNA, as described previously 17. The 3020insC polymorphism was 
analyzed by Genescan analysis on an ABI Prism 3100 genetic analyzer according to the 
protocol of the manufacturer (Applied Biosystems, Nieuwerkerk aan den IJssel, The 
Netherlands).  
 
Four patients with Crohn disease were found homozygous for the 3020insC mutation; one 
patient with Crohn disease was found homozygous for the C2104T mutation, and they were 
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further investigated in the cytokine studies. As control groups, five patients with Crohn 
disease heterozygous for the 3020 insC Nod2 mutation, five patients with Crohn disease 
bearing the wild type allele, and five healthy volunteers homozygous for the wild type Nod2 
allele were included. The cells isolated from the four groups of patients were isolated and 
tested at two separate occasions. The study was approved by the Ethical Committee of the 
Radboud University, Nijmegen, The Netherlands.  
 
Isolation of mononuclear cells and stimulation of cytokine production 
After informed consent, venous blood was drawn from the cubital vein of patients and 
healthy volunteers into three 10-ml EDTA tubes (Monoject, s-Hertogenbosch, The 
Netherlands). The PBMC fraction was obtained by density centrifugation of blood diluted 1:1 
in pyrogen-free saline over Ficoll-Paque (Amersham Biosciences). Cells were washed twice in 
saline and suspended in culture medium (RPMI 1640 DM) supplemented with 10 μg/ml 
gentamicin, 10 mml-glutamine, and 10 mm pyruvate. The cells were counted in a Coulter 
counter (Coulter Electronics, Mijdrecht, The Netherlands), and the number was adjusted to 5 
× 106 cells/ml. 5 × 105 PBMCs in a 100-μl volume were added to round-bottom 96-well plates 
(Greiner, Alphen aan den Rijn, The Netherlands) and were incubated with either 100 μl of 
culture medium (negative control) or the following various stimuli: 50 nm of the various 
muropeptide preparations, 10 μg/ml of the purified peptidoglycans, 100 ng/ml highly 
purified E. coli LPS (strain O55:B5), 5 μg/ml of artificially synthesized LTA (kindly provided by 
Dr. Corinna Hermann, Konstanz University, Germany), or a combination of stimuli as 
described under “Results and Discussion.”  
 
Cytokine measurements 
For detection of cytokine concentrations in the supernatants, BioPlex 100 system (Bio-Rad) 
was used. The kits were used as indicated by the manufacturer, and the sensitivity for all 
cytokines was <20 pg/ml.  
 
Real time PCR studies 
Total RNA was isolated from cells using RNeasy kits (Macherey Nagel, Hoerdt, France) 
according to the manufacturer's instructions. RNA quantification was performed using 
spectrophotometry. After treatment at 37 °C for 30 min with 20–50 units of RNase-free 
DNase I (Roche Diagnostics), oligo(dT) primers (Roche Diagnostics) were used to synthesize 
single-stranded cDNA. mRNAs were quantified using SYBR green master mix (Applera, 
Courtaboeuf, France) with specific human oligonucleotides in a GeneAmp Abiprism 7000 
(Applera, Courtaboeuf, France). The following primers were used: Nod1, sense 
GTAAAGGTGCTAAGCGAAGA and antisense TCTGATTCTGGATAAGCCAT; hPepT1, sense 
CCGCCTCCCAGGTTCAA and antisense GGTGCATGCCGCTAATCC; PGRP-S, sense 
GCAGCACTACCACATGAAGACACT and antisense GAGCCCGTCTTCTCCAATCA; PGRP-L, sense 
ACTGAGGGCTGCTGGGACCA and antisense GGCCTCAGTGAATTCCTTGG; Rip2, sense 
AAATGGATCATTAAATGAACTCCTACATAG and antisense TTCATGCAGGATGCGAAATC. In each 
assay, calibrated and no-template controls were included. Each sample was run in duplicate. 
SYBR green dye intensity was analyzed using the Abiprism 7000 SDS software (Applera, 
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Courtaboeuf, France). All results were normalized to the β-actin, an unaffected 
housekeeping gene.  
 
Statistical analysis 
The human experiments were performed in triplicate with blood obtained from patients and 
volunteers. The differences between groups were analyzed by the Mann-Whitney U test and 
where appropriate by the Kruskal-Wallis analysis of variance test. The level of significance 
between groups was set at p < 0.05. The data are given as means ± S.E.  
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Summary  
 
 
Innate immunity is considered our first line of defence against invading pathogens. With the 
discovery of pattern recognition receptors (PRRs) capable of sensing preserved molecular 
motifs of microbes, a giant step was made in understanding our inherited host defence 
mechanisms. Moreover, an important advance was achieved by developing a conceptual 
model to study and understand innate immune responses. The molecular mechanisms of 
interaction between specific ligands and PRRs were deciphered in a relative short period of 
time, meanwhile the picture emerged that the resulting immunological effects are very 
complex. This complexity is brought by the interaction between different PRRs when 
stimulated at the same time, as it happens during an infection, since microbes contain more 
than one type of ligand. 
 
In the first part of this thesis, we have studied the interaction of two major classes of PRRs: 
the Toll-like receptors (TLRs) and the C-type lectin like receptors (CLRs). By simultaneous 
stimulation with specific ligands of TLR2, TLR4 and dectin-1, we show in chapter 2 that in 
both human monocytes and macrophages this leads to synergistic TNF and IL-10 production. 
These data indicate that TLR and CLR signaling pathways converge to increase gene 
transcription, leading to enhanced production of cytokines. Almost all Toll-like receptors 
(with the exception of TLR3) have a common pathway starting with the adaptor molecule 
Myd88, leading to a cascade of interacting signal molecules and eventually achieving the 
activation and translocation of the transcription factor NF-κB. There are two signal pathways 
activated by dectin-1: a Syk-dependent and a Syk-independent route, which has recently 
been shown to signal through Raf-1 1.  Phosphorylation of Syk leads to the translocation of 
NF-κB, leading to the production of proinflammatory cytokines. In contrast, binding and 
phagocytosis of β-glucan-containing particles is Syk-independent.  In chapter 3, we used 
both human and murine models to show that the synergistic production of TNF after 
stimulation of both TLRs and dectin-1 is both MyD88 and Syk-dependent. This signal 
integration is achieved at the transcriptional level, as shown by a synergistic and sustained 
translocation of NF-κB after stimulation with both TLR ligands and β-glucan. Stimulation of 
cells with β-glucan alone leads to translocation of NF-κB, but no excretion of TNF by murine 
macrophages. Co-stimulation of the TLR MyD88-dependent pathway is needed to translate 
and excrete TNF efficiently. These results have implications for the conceptual role of PRRs 
in infections, because it indicates the importance of collaboration between different classes 
of PRR for the induction of an optimal cytokine production. While the cytokine production in 
dectin-1-deficient mice is not impaired after TLR stimulation alone, it is seriously impaired 
after stimulation with complex fungal particles activating both dectin-1 and TLR signal 
pathways 2. 
 
Engagement of dectin-1 by β-glucan induces different responses in macrophages. In chapter 
2 and 3 we have shown the interaction between TLRs and dectin-1 for the induction of 
cytokines. In chapter 4 we further explored the dectin-1-dependent modulation of 
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membrane-bound molecules by β-glucan. Coordination of the immune response depends on 
the secretion of cytokines and direct cell-cell interaction. The up-and-down regulation of 
molecules expressed on the cell membrane will induce a specific response of the interacting 
cells through activating or inhibiting signal pathways at the level of the cell membranes. 
When murine macrophages are exposed to zymosan, they will phagocytose these particles 
and secrete cytokines. Using FACS analysis, we showed a marked pattern of regulation of 
membrane bound molecules after exposure to zymosan, a β-glucan-rich particle obtained 
from the cell wall of Saccharomyces cerevisiae. When we compared the expression patterns 
of membrane-bound molecules after exposure of cells isolated from dectin-1-deficient and 
wild-type mice to zymosan, several dectin-1dependently regulated molecules were 
identified, among which CD47. The downregulation of CD47 is directly regulated by dectin-1 
signal pathways, and partly dependent on the dectin-1-mediated phagocytosis of the 
particles. CD47 is known to play a role in the induction of phagocytosis of apoptotic and 
infected cells when its expression is downregulated. We therefore propose a role for CD47 in 
regulating phagocytosis of infected cells via cell-cell interaction, and this might have a role in 
the exchange of antigens for the induction of adaptive immune responses. These findings 
further underline the concept of complex interaction of various activated signal pathways 
induced by single PRR engagement, aimed to induce effective immune responses against 
pathogens. 
 
The interaction between dectin-1 and TLRs leads to enhanced cytokine production in vitro. 
Dectin-1 deficient mice have a greater susceptibility to fungal infections. What is the 
consequence when dectin-1 is not functioning in humans? If the synergistic production of 
cytokines is important in fungal infection and this is dectin-1-dependent, one would expect a 
greater susceptibility to fungal infection in humans. However, an ‘Achilles heel’ in 
immunology is rare, and usually, many redundant mechanisms are present.  In chapter 5 we 
describe a patient with recurrent vulvovaginal candidiasis, onychomycosis and an impaired 
cytokine production to fungal stimuli. Sequencing of the dectin-1 gene led to the 
identification of an early stop codon (Tyr238Stop mutation) in the gene encoding the 
carbohydrate recognition domain (CRD), which is responsible for β-glucan recognition. 
Further analysis of the family revealed that both parents were heterozygous and two siblings 
were homozygous for this mutation. Both siblings and their mother also suffered from 
chronic onychomycosis. The mutated form of dectin-1 was poorly expressed and functional 
analysis on the cellular level showed that the synergism between TLRs and dectin-1was 
impaired. Consequently, cytokine production induced by C. albicans was lower compared to 
healthy controls, and the binding of C. albicans was impaired.  However, the phagocytosis 
and killing of C. albicans was unaffected. These results help us to define the role of dectin-1 
within the framework of anti-fungal defense mechanisms, pointing at an important role of 
dectin-1 in mucosal defense.  In the case of invasive candidiasis, the fungicidal capacity of 
phagocytes like neutrophils are crucial, which seems to be unaffected by dectin-1 defects.  
Knowing the functional consequences of this mutation and the phenotype, we subsequently 
studied the global occurrence of the polymorphism in different ethnic populations, and we 
attempted to identify when it first emerged. We used a phylogenetic-based approach to 
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show that this mutation lies in an evolutionary conserved area of the mammalian lineage. In 
further analysis of the prevalence of this mutation in populations with different ethnic 
backgrounds representing the populations of the major continental masses: Dutch 
Caucasians (Europe), Tanzanians (Africa), Han Chinese (Asia) and Surinam (Native Indians), 
we show that this mutation is only present in the European population (allele frequency 
0.069) and in the African population (0.035). This points at an ancient origin of this mutation, 
which was confirmed by haplotype analysis of two large cohorts of European and African 
populations. This analysis also revealed that there is a relative high prevalence of the 
mutation in European and African populations. It is known that the prevalence of mucosal 
candidiasis is high (5% of all women have RVVC) and this disease most probably has a 
multifactorial cause, of which this dectin-1 polymorphism may represent an important 
genetic factor. 
 
As we have shown that there is an interaction between dectin-1 and TLRs, which in turn 
seems to play an important role in the antifungal mucosal immunity, this could have 
implications for the development of new therapeutic strategies. In chapter 6 we reviewed 
the literature on the pattern recognition of C. albicans and we have placed these findings 
into the perspective of vaccine development. The clearest conclusion one can draw regards 
the importance of the innate immune system in the host defense against C. albicans. First of 
all, the cytokines induced after recognition of a fungal pathogen by the innate immune 
system are crucial for the activation and coordination of the cellular and humoral response. 
The TLRs are strong inducers of inflammatory responses, while the CLRs are potent 
modulators of these responses by enhancing or inhibiting cytokine production. Secondly, the 
proper cocktail of cytokines should be induced for an optimal protection against mucosal 
candidiasis. This is illustrated by patients with Hyper IgE syndrome, who have mutations in 
STAT3, leading to an impaired IL-17 production and consequently to an impaired Th17 
response 3. These patients suffer from severe mucosal candidiasis. Thirdly, it seems that the 
induction of the cellular immune response, especially the induction of Th1 and Th17, leads to 
an optimal protection against C. albicans infection at mucosal sites. In general, it is 
concluded that for the development of potent vaccines against C. albicans, a combination of 
both CLR and TLR ligands should be used as adjuvants for the induction of specific cellular 
immune responses against C. albicans.  
 
In the second part of this thesis we have assessed the interaction between Toll-like receptors 
and the Nod-like receptor Nod2. Nod2 is an intracellular receptor of bacterial peptidoglycans 
that is a member of the NLR family of pattern recognition receptors. A defective recognition 
of peptidoglycans by mutated forms of Nod2 has been linked to a strongly increased 
susceptibility to Crohn’s disease. In order to investigate the interaction of Nod2 with other 
classes of PRRs, we have used cells of patients with Crohn’s disease homozygous for the 
3020insC mutation, resulting in a defective recognition domain for muramyl dipeptide 
(MDP). By using pure ligands for TLRs and Nod2, we show in chapter 7 that simultaneous 
stimulation of both classes of receptors leads to a synergistic production of cytokines by 
PBMC, which was abolished in the cells bearing the 3020insC mutation. Both TLR2 and Nod2 
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are important for the induction of cytokines by peptidoglycan (PGN), and this interaction is 
impaired in cells from patients with the 3020insC mutation, leading to a defective TNF and 
IL-10 production. This impaired production of the anti-inflammatory cytokine IL-10 could 
lead to a bias to a Th1 response, potentially playing a role in the inflammation in Crohn’s 
disease (Fig 1).  
 
 
 
Figure 1. Impaired IL-10 production leads to pro-inflammatory Thelper cells. Activation of the 
inflammatory signaling pathways by peptidoglycan (PGN) is mediated by TLR2 and Nod2. 
Engagement of both receptors will lead to a synergistic production of cytokines such as IL-10 and 
differentiation of T-cells into the anti-inflammatory Tregulatory (Treg) cells. The recognition of 
MDP by Nod2 is impaired in Crohn’s disease patients with the 3020insC mutation, and the 
activated signaling pathway of TLR2 is not amplified, leading to a relative low production of IL-10. 
This will lead to an impaired differentiation of T-cells into Treg cells, and subsequent to a bias 
towards the proinflammatory Th1 and Th17 cells. 
 
The synergy between TLRs and Nod2 was also demonstrated for the induction of IL-1β, a 
potent pro-inflammatory cytokine. This cytokine is produced as a pro-peptide (proIL-1β) 
which has to be cleaved by caspase-1 into the bioactive form (IL-1β), which is subsequently 
secreted to exert its role in inflammatory responses. In chapter 8 we further investigate the 
role of Nod2 for the induction of IL-1β, and show that Nod2 is crucial for induction of 
transcription of proIL-1β and the secretion of IL-1β. The synergy between TLRs and Nod2 for 
Summary and general discussion 
231 
 
the induction of IL-1β is mediated at the post-translational level in a caspase-1-dependent 
manner. The exact mechanism for the activation of caspase-1 by Nod2 has yet to be 
clarified, although it has been shown that other members of the NLR family such as NALP3 
form protein complexes named inflammasomes, which activate caspase-1. An interaction 
has been demonstrated between Nod2 and NALP1, another member of NLRs recently shown 
to form an active inflammasome 4. Interestingly, the synergy in TNF production after 
stimulation with MDP and LPS (a TLR4 ligand) is induced at transcriptional level. This shows 
that the cross-talk between TLRs and Nod2 for the induction of cytokines is exerted at 
different levels, depending on the cytokine induced.  
 
MDP-containing peptidoglycans are an important component of the cell wall of Gram-
positive bacteria, including mycobacteria. In the next two chapters, we investigated the role 
of Nod2 and its crosstalk with TLR in the inflammatory response against mycobacteria. In 
chapter 9 we show that Mycobacterium tuberculosis is recognized by Nod2 and induces 
production of cytokines in human PBMC in a Nod2- dependent manner. By using purified cell 
wall components of M. tuberculosis, we show that there is a synergistic cytokine production 
after stimulation with the TLR2 ligand 19kDa lipoprotein and MDP, and this synergism was 
lost in cells bearing the 3020insC mutation. Because the non-redundancy of this pathway, 
and the crosstalk between both TLR and Nod2 recognition systems, the cytokine induction 
by M. tuberculosis was impaired in cells of Crohn’s disease patients bearing the 3020insC 
mutation. Crohn’s disease has thought to be associated with M. paratuberculosis for many 
years, although its role in the pathogenesis is controversial. In chapter 10 we show that M. 
paratuberculosis is also recognized by TLR2, TLR4 and Nod2 (Fig 2). The cytokine production 
by cells of Crohn’s disease patients bearing the 3020insC mutation after stimulation with M. 
paratuberculosis was impaired. Although speculative, these results are compatible with the 
idea that an impaired immune response against intracellular pathogens like M. 
paratuberculosis may play a role in the pathogenesis of Crohn’s disease. 
 
As shown in the previous chapters, a synergistic crosstalk exists between TLRs and Nod2, 
leading to an enhanced cytokine production by primary human mononuclear cells when 
stimulated simultaneously. This resembles the simultaneous activation of these pathways 
during infections. However, this differs from the situation in the gut where there is a 
continuous exposure to commensal microorganisms and their fragments. Indeed, MDP can 
be found passing the mucosal barrier in gut tissue. In chapter 11 we preincubated PBMC 
with MDP to mimic the chronic exposure to bacterial fragments, and subsequently 
stimulated these cells with TLR ligands and intestinal pathogens. With these experiments we 
show that continuous exposure to the Nod2 ligand MDP leads to a decreased TLR4-induced 
TNF production, whereas the TLR2 pathway was unaffected. This cross tolerance to TLR4 
ligands might be an important mechanism to explain how Nod2 mutations can lead to 
chronic inflammation of the gut, as seen in Crohn’s disease. In 3020insC cells, this cross 
tolerance was abolished, leading to a sustained TNF production, a cytokine central in the 
pathogenesis of Crohn’s disease (Fig 3).  
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Figure 2. Mycobacterium paratuberculosis activates both TLR and Nod2 signaling pathways. 
Stimulation of human mononuclear cells with M. paratuberculosis leads to secretion of 
proinflammatory cytokines. M. paratuberculosis is a strong inducer of cytokine production 
through the TLR2 pathway, and a weaker activator of the TLR4 signal pathway. M. 
paratuberculosis also activates the Nod2 signal pathway leading to a synergistic interaction with 
the TLR signal pathway resulting in an enhanced proinflammatory cytokine production. 
 
This model for the pathogenesis of Crohn’s disease is strengthened by the association of 
mutations in the TLR4 pathways leading to a higher incidence in different populations. The 
mechanism through which Nod2 plays a role in the pathogenesis of Crohn’s disease is still 
controversial: how can a loss of the potential for recognition of MDP, the ligand for Nod2, 
lead to a pro-inflammatory disease? The loss of cross tolerance between Nod2 and TLRs, 
leading to an enhanced production of pro-inflammatory cytokines, might be one 
explanation. In addition, the decreased production of the anti-inflammatory cytokine IL-10 
and the subsequent bias towards Th1 responses is also proposed to play a role in the gut 
inflammation. In both models, the interaction between different classes of PRRs is crucial, 
and this underlines the immunomodulatory capacity of MDP through Nod2 signaling.  
 
In chapter 12 we investigated the immunomodulatory effects of other muramyl peptides 
that are known to be ligands of Nod1, another important NLR receptor. The minimal motif to 
stimulate Nod1 is muramyl tripeptide (MTP), a component of the peptidoglycan layer of 
Gram-negative bacteria. In parallel with MDP, stimulation of PBMC with MTP and TLR ligands 
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simultaneously leads to a synergistic production of cytokines. Interestingly, cells of patients 
bearing the 3020insC mutation were unresponsive to stimulation with MTP, suggesting a 
common signal pathway for both Nod1 and Nod2, which is affected by this mutation. 
However, in these cells the synergism between Nod1 and TLRs was unaffected, indicating a 
different signal pathway involved in the cross-talk between TLRs and Nod1, then the direct 
induction of cytokines by Nod1 and Nod2. Different studies have shown that indeed the 
members of the NLR family exert their function at different levels: 1. direct NF-κB activation 
resulting in transcription of cytokines; 2. forming complexes with other molecules to activate 
enzymes and modulate post-translational processes; 3. mediating ATP signaling for the 
secretion of cytokines; and 4. the regulation of transcriptional factors independent of MDP 
activation 5. Al these findings underline the potential role of the NLR family in modulating 
immune responses through complex interaction with many signal pathways induced by TLR 
stimulation. 
 
 
 
Figure 3. Continuous exposure to MDP leads to inhibition of TLR4-induced TNF production. A: The 
luminal side of the gut is continuously exposed to microbial compounds, like peptidoglycan (PGN), 
of the commensal microbial flora. PGN can pass the epithelial barrier and can be phagocytosed by 
residential macrophages, leading to chronic stimulation of Nod2. B: in healthy individuals 
continuous stimulation of Nod2 with MDP leads to inhibition of TLR4-induced TNF production by 
lipopolysacharide (LPS), whereas in cells homozygous for the 3020insC mutation this inhibition is 
impaired, resulting in a higher TNF production after stimulation with LPS. This mechanism might 
explain how the 3020insC mutation leads to a sustained TNF production and chronic 
inflammation. 
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General conclusion 
 
In this thesis, I have demonstrated the presence of complex cross-talk networks between 
different classes of PRRs, leading to enhancement or inhibition of cytokine responses 
induced by microorganisms or their ligands. These immunomodulatory effects play a role for 
host defense to infections (resistance), but also for the homeostasis between host and 
commensal flora (tolerance). When the interaction between PRRs is disrupted (by 
mutations, inhibition by pathogens, or medication) this could lead to disease in two ways. 
First of all, an impaired immune response against pathogens caused by insufficient 
production of cytokines can lead to a greater susceptibility to pathogens. Secondly, an 
impaired tolerance caused by insufficient downregulation of pro-inflammatory cytokines can 
lead to chronic inflammation caused by commensal flora. Insight into these mechanisms will 
be very important for the development of new therapeutic strategies. For induction of 
greater resistance against pathogens through vaccination, enhancement of cytokines leading 
to the proper cellular responses, likeTh1 and Th17, will be crucial. The development of new 
adjuvants based on synergy between several PRR signal pathways can be used to achieve 
this. Illustrative is the use of CpG, a TLR 9 agonist, as an adjuvant to boost Th1 responses. For 
the induction of increased tolerance, downregulation of inflammatory signaling pathways 
induced by commensal flora may be desirable, leading to relative enhancement of anti-
inflammatory cellular responses, like induction of Th2 and Treg. Part of the beneficial effect 
of probiotics, and certain nutritional supplements might be ascribed to this mechanism. 
Insight into the induction of tolerance through PRR stimulation has received much attention 
in medical research and might lead to the development of new therapies in chronic 
inflammatory diseases like Crohn’s disease.  
In conclusion, the innate immune responses are complex processes in which the interaction 
between various classes of PRRs plays a central role. In this thesis, we attempted to shed 
light on several aspects of this complex network, in order to provide the basic knowledge for 
new potential therapies in infections and autoinflammatory diseases.  
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Samenvatting en algemene discussie 
 
De interactie tussen gastheer en micro-organismen fascineert wetenschappers al vele 
eeuwen en hun onderzoek heeft geleid tot de ontdekking van vaccinatie en antibiotica, die 
beiden een grote rol hebben gespeeld in de geschiedenis van de mensheid. Onze afweer 
wordt ingedeeld in de aangeboren afweer en de verworven afweer. De aangeboren afweer 
wordt gezien als eerstelijns verdediging tegen ziekteverwekkers, hierin spelen fagocyterende 
cellen een centrale rol. Hoe deze fagocyten micro-organismen kunnen herkennen is heel 
lang een raadsel geweest. 
 
 Sinds de ontdekking van patroon-herkennende immuunreceptoren (in het Engels worden 
deze pattern recognition receptors genoemd en afgekort met PRRs) die moleculaire 
patronen kunnen waarnemen die specifiek zijn voor micro-organismen (pathogen associated 
molecular pattern, afgekort als PAMP), is er een enorme vooruitgang geboekt in het 
begrijpen van dit aangeboren afweersysteem. Daarnaast is het belangrijk geweest dat er een 
conceptueel model van deze aangeboren immuunrespons ontwikkeld is, waardoor het 
bestuderen van deze respons snel tot meer inzicht heeft geleid. De moleculaire interactie 
tussen specifieke microbiële structuren (liganden) en PRRs is in een relatief korte tijd 
ontrafeld, waar bij er meerdere klasse PRRs zijn ontdekt (Fig 1). Binding van liganden aan 
PRRs leidt tot een intracellulaire cascade van interacterende eiwitten die we ‘signal pathway’ 
noemen. Een pathway is een reeks van eiwitten waarbij het ene eiwit telkens het volgende 
eiwit aan- of uitschakelt (stimuleert of inhibeert). Inzicht in deze signal pathways en de 
secretie van eiwitten die immuun cellen kunnen aansturen (cytokines) door fagocyten 
maakte duidelijk dat de aangeboren afweer ook een belangrijke rol speelt in de modulatie 
van de verworven immuunrespons (Fig 2). Een belangrijke vraag bleef echter, hoe relatief 
weinig receptoren in staat zijn om een specifieke immuunrespons te induceren tegen 
onvoorstelbaar veel verschillende pathogenen. Een deel van deze specificiteit zou kunnen 
worden verklaard door de interactie tussen de verschillende PRRs wanneer deze gelijktijdig 
worden gestimuleerd, zoals dit gebeurt tijdens infecties omdat micro-organismen meerdere 
liganden bevatten. 
 
 
 
 
 
 
Figuur 1. Patroon-herkennende immuunreceptoren en hun liganden. Er zijn vier verschillende 
klassen patroon herkennende receptoren bekend: Toll-like receptoren die tot expressie komen 
op de celmembraan (A) en in het fagosoom (B) hebben een herkenningsdomein met leucine rich 
repeats (LRR) en een TLR/IL-1 receptor (TIR) domein; C-type lectin receptoren die op de 
celmembraan en in het fagosoom tot expressie komen (C) hebben een carbohydraat 
herkenningsdomein; In het cytoplasma komen Nod-like receptoren voor die een nucleotide 
oligomerisatie domein en meestal een LLR domein bevatten (D); en RigI helicases met een 
helicase domein een C-terminaal repressie domein (E).  
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Figuur 2. Patroon-herkennende immuunreceptoren (PPRs) reguleren de adaptieve 
immuunrespons. Dendritische cellen en macrofagen (antigeen presenterende cellen (APC)), 
neutrofielen en natural killer cellen zijn de belangrijkste cellen van de aangeboren immuuncellen, 
terwijl de adaptieve immuun cellen bestaan uit B-cellen en T-cellen. De PRRs komen tot expressie 
op de APCs. Als een microbieel ligand aan een PRR bindt, wordt er een signal pathway 
geactiveerd en cytokines geproduceerd. Na dat het micro-organisme is gefagocyteerd en 
afgebroken in het fagolysosoom, worden antigenen gepresenteerd op het MHCII molecuul. 
Tijdens dit proces worden ook intracellulaire PRRs geactiveerd. Expressie van co-stimulerende 
moleculen op de antigeen-presenterende cel worden door activatie van PRR verhoogd. Het 
antigeen/MHCII complex en de co-stimulerende moleculen op de APC activeren de T-celreceptor 
en induceert proliferatie van de naïeve T-cel. De cytokines die door de APC worden geproduceerd 
zijn cruciaal voor de differentiatie van de T-cel in verschillende Thelper-cellen. 
 
In het eerste deel van dit proefschrift hebben we de interactie tussen twee belangrijke 
groepen van PRRs bestudeerd: de Toll-like receptoren (TLRs) en de C-type lectin like 
receptoren (CLRs). Door gelijktijdig stimulaties van TLR2, TLR4 en dectin-1 met specifieke 
liganden laten we in hoofdstuk 2 zien dat dit leidt tot een synergisme in TNF en IL-10 
productie in humane monocyten en macrofagen. Dit duidt er op dat TLR en CLR signal 
pathways convergeren en leiden tot verhoogde transcriptie van genen en een toegenomen 
cytokineproductie. Vrijwel alle Toll-like receptoren (met uitzondering van TLR3) hebben een 
gemeenschappelijke pathway die start bij adapter molecuul MyD88 en na een cascade van 
interacterende signaal moleculen leidt tot de activatie en translocatie van de transcriptie- 
factor NF-κB. Er worden twee signal pathways geactiveerd door dectin-1: een Syk-
afhankelijke en een Syk-onafhankelijke route, waarvan recent is aangetoond dat deze via 
Raf-1 loopt. Fosforilatie van Syk leidt tot translocatie van NF-κB en de productie van pro-
inflammatoire cytokines. Dit in tegenstelling tot activatie van de Syk-onafhankelijke route 
die leidt tot binding en fagocytose van β-glucan-bevattende deeltjes. In hoofdstuk 3 hebben 
we in zowel muizen als humane cellen laten zien dat de synergistische productie van TNF na 
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stimulatie van TLRs en dectin-1 zowel MyD88 als Syk afhankelijk is. Beide signalen worden 
geïntegreerd op transcriptie-niveau, zoals we laten zien door een toegenomen en 
aanhoudende translocatie van NF-κB na stimulatie met TLR liganden en β-glucan. Stimulatie 
met alleen β-glucan leidt wel tot translocatie van NF-κB, maar niet tot excretie van TNF door 
macrofagen. Co-stimulatie van de TLR MyD88 afhankelijke pathway is nodig voor translatie 
en secretie van TNF. Deze resultaten hebben invloed op de conceptuele rol die PRRs hebben 
tijdens infecties, omdat het belang van samenwerking tussen de verschillende PRRs wordt 
aangetoond voor een optimale cytokine productie. In dectin-1-deficiënte muizen is de 
cytokine productie na stimulatie van alleen TLRs niet verminderd, echter na stimulatie met 
complexe fungale deeltjes die zowel TLRs als dectin-1 stimuleren is de cytokineproductie 
ernstig gestoord. 
 
Stimulatie van dectin-1 induceert verschillende responsen in macrofagen. In hoofdstuk 2 en 
3 hebben we de interactie tussen TLRs en dectin-1 voor de inductie van cytokines laten zien, 
in hoofdstuk 4 hebben we onderzocht of dectin-1 betrokken is bij de modulatie van 
membraangebonden moleculen door β-glucan. De coördinatie van de immuunrespons 
wordt geregeld door de secretie van cytokines en directe cel-cel interactie. De up-and-down-
regulatie van moleculen die tot expressie komen op het celmembraan van fagocyten 
induceren een specifieke respons van de interacterende cel door activatie of inhibitie van 
signal pathways op het niveau van het celmembraan. Muizen macrofagen fagocyteren 
zymosan, dit bestaat uit de wand van Saccharomyces cerevisiae en bevat veel β-glucan, en 
secreteren dan cytokines. Uit FACS analyse blijkt dat er een specifiek patroon van membraan 
gebonden eiwitten ontstaat na stimulatie met zymosan. Door het vergelijken van de 
expressie patronen van dectin-1-deficiënte macrofagen met controle macrofagen, konden 
verschillende dectin-1 afhankelijk gereguleerde moleculen worden geïdentificeerd, 
waaronder CD47. Deze verminderde expressie van CD47 is direct gereguleerd door dectin-1 
signal pathways en deels door fagocytose van partikels. CD47 induceert fagocytose van 
apoptotische en geïnfecteerde cellen wanneer de expressie op het celmembraan is 
afgenomen. Mogelijk speelt de verminderde expressie van CD47 door dectin-1-binding een 
rol in de regulatie van fagocytose van geïnfecteerde cellen via cel-cel interactie. Hierdoor is 
uitwisseling van antigenen mogelijk voor een optimale adaptieve immuunrespons. Deze 
bevindingen benadrukken de complexe interactie van verschillen geactiveerde pathways 
door binding van een enkele PRR in de inductie van een effectieve immuunrespons tegen 
pathogenen. 
 
De interactie tussen dectin-1 en TLRs induceert een toegenomen cytokine productie van 
fagocyten in vitro en dectin-1 deficiënte muizen zijn gevoeliger voor schimmel infecties. Wat 
is de consequentie als dectine-1 niet functioneert in mensen? Als het synergisme in 
cytokineproductie belangrijk is in de afweer tegen schimmels en deze dectin-1 afhankelijk is, 
dan zou er ook voor mensen een verhoogde gevoeligheid voor schimmel infecties in zijn. 
Hier tegenover staat dat een ‘Achilles hiel’ in de immunologie zeldzaam is en dat er vaak 
meerdere compensatie mechanismen aanwezig zijn. In hoofdstuk 5 presenteren we een 
patiënt met een recidiverende vaginale Candid- infecties en onychomycosis (schimmel 
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nagels) met een sterk verminderde cytokine door fagocyten na stimulatie met schimmels. 
Bepaling van de nucleïnezuursequentie van het dectin-1-gen toonde aan dat er sprake was 
van een mutatie die resulteerde in een stop-codon (Tyr238Stop) in het gedeelte dat codeert 
voor het herkenningsdomein van dectin-1 voor β-glucan. Verder analyse van de familie liet 
zien dat beide ouders heterozygoot waren en twee zussen homozygoot voor dezelfde 
mutatie. Beide zussen en de moeder hadden ook onychomycosis en vaginale 
schimmelinfecties. Dectin-1 met deze mutatie kwam nauwelijks tot expressie en functionele 
analyse op cellulair niveau liet een sterk afgenomen synergisme in cytokineproductie zien 
tussen TLRs en dectin-1. Als gevolg hiervan was ook de cytokineproductie na stimulatie met 
C. albicans afgenomen in vergelijking et gezonde controle personen, daarnaast was ook de 
binding aan fagocyten afgenomen. De fagocytose en killing van C. albicans was echter niet 
veranderd. Deze resultaten helpen ons de rol van dectin-1 te definiëren binnen het 
framewerk van afweermechanismen tegen schimmels, namelijk dat dectin-1 belangrijk is in 
de mucosale immuniteit. In de afweer tegen invasieve schimmels spelen fagocytose door 
neutrofielen een cruciale rol, deze was echter niet veranderd door de dectin-1-mutatie. Na 
het vaststellen van de functionele consequenties en het fenotype van deze mutatie hebben 
we vervolgens het voorkomen in verschillend etnische populaties wereldwijd bestudeerd, 
om te achterhalen wanneer deze mutatie voor het eerst voorkwam. Uit een fylogenetische 
benadering blijkt dat deze mutatie in een evolutionair geconserveerd gebied ligt van de 
zoogdieren-lijn. In de verdere analyse naar het voorkomen van deze mutatie in populaties 
met een verschillende etnische achtergrond die de belangrijkste continenten representeren: 
Nederlands caucasische (Europa), Tanzaniaanse (Afrika), Han Chinese (Azië) en Surinaamse 
(Inheemse Amerikanen), laten we zien dat deze mutatie alleen aanwezig is in de Europese 
populatie (allel-frequentie 0.069) en in de Afrikaanse populatie (allel-frequentie 0.035). Dit 
duidt erop dat de mutatie al zeer oud is. Door middel van haplotypering in twee grote 
cohorten uit Europa en Afrika is dit bevestigd. Uit deze analyse blijkt ook dat deze mutatie 
vrij veel in de populatie voorkomt in Afrika en Europa. Het is dan ook bekend dat mucosale 
Candida vaak voorkomen (5% van de vrouwen heeft recidiverende vaginale Candida-
infecties) en dat er meest waarschijnlijk een multifactoriële oorzaak aan ten grondslag ligt, 
waarvan deze dectin-1-polymorfisme een belangrijke genetische factor kan zijn. 
 
Uit het voorgaande blijkt dat er interactie bestaat tussen dectin-1 en TLRs, en dat deze 
interactie een belangrijke rol speelt in de afweer tegen mucosale schimmels, maar kan dit 
ook gebruikt worden voor nieuwe therapieën? In hoofdstuk 6 wordt er een overzicht 
gegeven van de literatuur die over PRRs en de herkenning van C. albicans gaat en wordt 
belicht hoe deze kennis gebruikt kan worden voor vaccin-ontwikkeling. Het meest duidelijk 
komt er naar voren dat het aangeboren afweersysteem een cruciale rol speelt bij de afweer 
tegen C. albicans. Ten eerste is de cytokineproductie die wordt geïnduceerd na herkenning 
van C. albicans door het aangeboren afweersysteem essentieel voor de activatie en 
coördinatie van cellulaire en humorale afweer. De TLRs induceren een sterke inflammatoire 
respons, terwijl de CLRs een sterk modulerend effect hebben door inhibitie of synergie van 
de cytokineproductie. Ten tweede blijkt de juiste combinatie van verschillende cytokines te 
leiden tot een optimale bescherming tegen mucosale schimmelinfecties. Dit wordt 
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geïllustreerd door patiënten met het hyper-IgE-syndroom, waarbij een mutatie in STAT3 
leidt tot een verminderde IL-17 productie en als gevolg hiervan een verminderde Th17-
respons. Deze patiënten hebben zeer ernstige mucosale schimmelinfecties. Ten derde komt 
naar voren dat inductie van de cellulaire Th1 en de Th17 respons cruciaal is voor optimale 
bescherming tegen mucosale schimmel infecties. Er wordt geconcludeerd dat adjuvants die 
zowel TLRs en CLRs stimuleren kunnen worden gebruikt om een specifiek cellulaire respons 
tegen C. albicans te induceren die tot bescherming tegen schimmelinfecties leidt. 
 
In het tweede deel van dit proefschrift wordt de interactie tussen Toll-like receptoren en de 
Nod-like receptor Nod2 onderzocht. Nod2 is een intracellulaire receptor die bacteriële 
peptidoglycanen kan herkennen en behoort tot de NLR familie van patroon-herkennende 
receptoren. Een verhinderde herkenning van peptidoglycanen door mutaties in het Nod2-
gen is sterk geassocieerd met de ziekte van Crohn. Om de interactie tussen Nod2 en TLRs te 
bestuderen, hebben we cellen van patiënten met de ziekte van Crohn en een homozygote 
3020insC mutatie in het Nod2-gen gebruikt. Door middel van stimulatie met zuivere liganden 
voor TLRs en Nod2 tonen we in hoofdstuk 7 aan dat gelijktijdige stimulatie van beide 
receptoren in leukocyten er een synergie in cytokine productie ontstaat. Deze synergie is 
afwezig in cellen met de 3020insC mutatie. Zowel TLR2 als Nod2 zijn belangrijk voor de 
herkenning van peptidoglycan en de inductie van cytokines, maar bij cellen van patiënten 
met de 3020insC mutatie is dit verstoord, waardoor er een verminderde productie van TNF 
en IL-10 optreedt. Deze verminderde productie van de anti-inflammatoire cytokine IL-10 kan 
leiden tot een bias naar een pro-infalmmatoire cellulaire Th1-respons en speelt mogelijk een 
rol in het ontstaan van de ziekte van Crohn. 
 
De synergie tussen TLRs en Nod2 bestaat ook voor de inductie van de pro-inflammatoire 
cytokine IL-1β. Deze cytokine wordt geproduceerd als een pro-peptide (pro-IL1β) en moet 
eerst worden geactiveerd door caspase-1, om vervolgens te worden uitgescheiden om een 
biologisch effect te hebben in de inflammatoire respons. In hoofdstuk 8 wordt de rol van 
Nod2 in de inductie van IL-1β verder onderzocht. Er wordt aangetoond dat Nod2 voor zowel 
de inductie van pro-IL1β transcriptie als de excretie van actieve IL-1β essentieel is. De 
synergie tussen TLRs en Nod2 voor de inductie van IL-1β ontstaat op post-translationeel 
niveau en is afhankelijk van caspase-1-activatie. Hoe caspase-1 door Nod2 geactiveerd wordt 
is nog niet bekend, wel is het bekend dat andere leden van de NLR familie, door middel van 
eiwit complexen die we inflammasomen noemen, betrokken zijn bij de activatie van 
caspase-1. Recent is aangetoond dat Nod2 een interactie kan aangaan met NALP1, een 
ander lid van de NLR familie waarvan bekend is dat deze een inflammasoom kan vormen. 
Het is interessant dat de synergie voor de productie van TNF na stimulatie van Nod2 en TLR4 
op transcriptie niveau ontstaat. Dit toont aan dat de interactie van de TLR en Nod2 signal 
pathways op verschillend niveaus plaats vindt, afhankelijk van de cytokine die wordt 
geïnduceerd. 
 
MDP-bevattende peptidoglycanen zijn een belangrijke component van de celwand van 
Gram-positieve bacteriën en ook mycobacteriën. In de volgende twee hoofdstukken hebben 
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we de rol van de interactie tussen TLRs en Nod2 in de aangeboren immuunrespons tegen 
mycobacteriën onderzocht. In hoofdstuk 9 laten we zien dat Mycobacterium tuberculosis 
door Nod2 wordt herkend en essentieel is voor de productie van cytokines door leukocyten. 
Door gezuiverde componenten van de celwand van M. tuberculosis te gebruiken, wordt er 
aangetoond dat er een synergisme in cytokineproductie ontstaat na stimulatie van TLR2 met 
19kDa lipoproteïne en Nod2 met MDP. Deze synergie is er niet in de cellen van Crohn-
patiënten met de 3020insC mutatie. Omdat er geen alternatieve pathways zijn die tot deze 
synergie kunnen leiden, is de inductie van cytokines door M. tuberculosis ernstig gestoord bij 
Crohn patiënten met de 3020insC-mutatie. De ziekte van Crohn wordt van oudsher 
geassocieerd met M. paratuberculosis, hoewel hierover veel controversie bestaat. In 
hoofdstuk 10 tonen we aan dat M. paratuberculosis door TLR2, TLR4 en Nod2 wordt 
herkend. De cytokine productie door cellen van Crohn patiënten met de 30220insC mutatie 
was ernstig gestoord. Hoewel speculatief, deze resultaten passen in het concept dat een 
verstoorde afweer tegen intracellulaire pathogenen zoals M. paratuberculosis mogelijk een 
rol speelt in de pathogenese van de ziekte van Crohn. 
 
In de voorgaande hoofdstukken hebben we laten zien dat er tussen TLRs en Nod2 een 
synergistische interactie bestaat als beide receptoren simultaan worden gestimuleerd op 
primair humane cellen. Dit model komt overeen met de simultane activatie van pathways 
tijdens een infectie. In de darm is er echter sprake van een continue expositie aan 
commensale micro-organismen en fragmenten van deze micro-organismen. Zo kan MDP 
inderdaad de mucosa van de darm passeren en aan worden getroffen in het weefsel. In 
hoofdstuk 11 hebben we humane mononucleaire cellen gepreïncubeerd met MDP om de 
chronische stimulatie in de darm te simuleren, en vervolgens zijn deze cellen met TLR 
liganden en intestinale pathogenen gestimuleerd. Met deze experimenten laten we zien dat 
chronische stimulatie van Nod2 met MDP tot een verminderde TNF productie leidt na 
stimulatie van TLR4, terwijl de TLR2 pathway niet werd beïnvloed. Deze kruis-tolerantie voor 
TLR4-ligand kan een verklaring zijn waarom Nod2-mutaties leiden tot een chronische 
inflammatie van de darm in de ziekte van Crohn. In cellen met de 3020insC-mutatie is deze 
kruis-tolerantie inderdaad verdwenen en leidt dit tot een verhoogde productie van TNF zoals 
dit wordt gezien in de ziekte van Crohn. Het mechanisme hoe Nod2 een rol speelt in de 
pathogenese van de ziekte van Crohn is nog steeds controversieel: hoe kan een verhinderde 
herkenning van MDP door Nod2 leiden tot een pro-inflammatoire ziekte? Het verlies van 
kruis tolerantie zou een verklaring kunnen zijn. Anderzijds is de verminderde productie van 
anti-inflammatoire cytokine IL-10 met als gevolg een bias naar Th1-respons een ander 
mogelijk mechanisme. In beide modellen speelt de interactie van verschillend klasse PRRs 
een centrale rol en onderstreept het de immunomodulerende eigenschap van MDP door 
Nod2-herkenning. 
 
In hoofdstuk 12 hebben we de immunomodulerende effecten van andere muramylpeptiden 
onderzocht waarvan bekend is dat ze worden herkend door Nod1, een andere belangrijke 
NLR receptor. Muramyltripeptide (MTP) is de ligand voor Nod1 en geeft, net als MDP, een 
synergistische cytokine productie als MNC simultaan met TLR liganden worden gestimuleerd. 
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Daarbij viel op dat cellen met de 3020inC mutatie ook geen cytokine produceerde op MTP. 
Dit suggereert een gemeenschappelijke pathway voor Nod1 en Nod2 die door deze mutatie 
is aangedaan. De synergie tussen Nod1 en TLRs was echter niet aangedaan in deze cellen, dit 
betekent dat de signal pathway die tot deze interactie leidt, verschilt met de pathway die 
direct leidt tot cytokine inductie door Nod1 en Nod2. Er zijn verschillende studies die 
aantonen dat NLRs op verschillende niveaus functies hebben: 1. activeert pathways die 
direct tot NF-κB-activatie leiden en transcriptie van cytokines; 2. vormt complexen met 
andere moleculen om enzymen te activeren voor post-translationele modificatie van 
cytokines; 3. interfereert met ATP-signalering voor de secretie van cytokines; 4. reguleert 
transcriptiefactoren onafhankelijk van MDP. Al deze mechanismen onderstrepen de 
potentiële rol van NLRs in de modulatie van de immuun respons door interactie met vele 
signal pathways geactiveerd door TLR stimulatie. 
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Algemene conclusie 
 
In mijn proefschrift toon ik aan dat er sprake is van een complexe interactie tussen 
verschillende klassen PRRs, dit leidt tot de inhibitie of versterking van de cytokinerespons 
geïnduceerd door micro-organismen en hun liganden. Deze immunomodulerende effecten 
spelen een rol in de afweerreactie tegen infecties (resistentie), maar ook in de homeostase 
tussen gastheer en commensale micro-organismen (tolerantie). Als deze interactie tussen 
PRRs is verstoord (door mutaties, blokkade door pathogenen of medicatie) kan dit op twee 
manieren tot ziekte leiden. In de eerste plaats kan een afgenomen immuunrespons ontstaan 
door de verminderde cytokine productie leiden tot een verhoogde vatbaarheid voor 
infecties. Ten tweede kan door een afgenomen demping van pro-inflammatoire cytokines er 
een verminderde tolerantie van commensale micro-organismen ontstaan en hierdoor 
chronische inflammatie. Het begrijpen van deze mechanismen zal belangrijk zijn voor het 
ontwikkelen van nieuwe therapeutische strategieën. Verbetering van resistentie tegen 
pathogenen door vaccinatie kan worden bereikt door verhoging van cytokineproductie die 
leidt tot een optimale cellulaire respons, zoals een Th1- en Th17-respons. Ontwikkeling van 
nieuwe adjuvantia gebaseerd op de synergie tussen verschillende PRR signal pathways kan 
hieraan bijdragen. Dit wordt onder andere geïllustreerd door CpG, een TLR9-agonist, die als 
adjuvans wordt gebruikt om de Th1 respons te stimuleren. Geactiveerde inflammatoire 
signal pathways door commensaal microbiële flora zouden kunnen worden gedempt 
waardoor er een relatieve toename van de anti-inflammatoire respons ontstaat die leidt tot 
de inductie van Th2 and Treg. Een deel van de effecten van probiotica en 
voedingssupplementen kan mogelijk aan dit mechanismen worden toegeschreven. Deze 
inzichten in de inductie van tolerantie door stimulatie van PRRs heeft veel aandacht in het 
medische onderzoek en kan mogelijk leiden tot nieuwe therapieën voor chronisch 
inflammatoire ziekten, zoals de ziekte van Crohn. 
Concluderend kan men stellen dat de regulatie van de aangeboren afweer complex is, 
waarbij de interactie tussen de verschillende klassen receptoren centraal staat. In dit 
proefschrift hebben we geprobeerd een aantal aspecten van dit complexe netwerk te 
belichten, om zo een basis te leggen voor de ontwikkeling van nieuwe therapieën voor 
infectie- of auto-inflammatoire ziekten. 
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Dankwoord 
 
 
Nu eindelijk echt het laatste loodje, maar mijn dank betuigen is zeker niet zwaar. Met hulp 
van vele mensen is mijn proefschrift tot een heus boekje volbracht. Hierbij heeft het ‘ik -
gedicht’ van Jules Deelder en mijn levensmotto mij telkens weer leren relativeren: ik maak 
me geen illusies, maar ik blijf optimist. 
 
Beste Mihai, wat is het bijzonder om met jou te werken! Jij bent uitzonderlijk in alle 
opzichten. Niet alleen op wetenschappelijk gebied ben je een inspiratie, maar juist ook in 
alles er omheen. Je zult je vaak hebben afgevraagd of het ooit nog goed met mijn promotie 
zou komen. Als ik weer eens in zeven sloten tegelijk liep en het overzicht kwijt was, dan wist 
jij met enkele woorden en suggesties alles weer twee stappen vooruit te helpen. Ook jij bent 
een optimist en jouw ‘maar dat is fantastisch!’ zal voor altijd bijdragen aan mijn visie op de 
wetenschap. Mede door jouw enthousiasme heb ik de stap durven nemen om mijn weg 
verder te gaan in het wetenschappelijk onderzoek. 
 
Beste Bart Jan, zoals iedereen weet gaat het niet altijd om de kwantiteit, maar juist vaak om 
de kwaliteit. Wij hebben in de afgelopen jaren niet altijd even intensief met elkaar gewerkt, 
maar als ik jouw hulp en visie nodig had, dan was je er telkens weer. Ik nam altijd de 
gelegenheid om even in de deuropening van je kamer mijn gedachten te spuien, jij nam 
altijd de tijd om te luisteren. Ook wil ik je danken voor de mogelijkheid om een half jaar in 
Oxford te mogen werken. 
 
Beste professor Van der Meer, of eigenlijk beste Jos. Het tutoyeren is me nooit goed 
afgegaan. U hebt het mogelijk gemaakt dat ik tijdens mijn opleiding onderzoek mocht doen 
bij Mihai, waarvoor ik u zeer dankbaar bent. U hebt mij laten zien dat er geen mooier vak is 
dan Interne Geneeskunde en dat het mogelijk is om zowel in de kliniek uit te blinken als in 
het onderzoek. Zoiets is niet voor een ieder weggelegd! Ook ben ik door u heel trots om een 
Radboudiaan te zijn en zal ik dit waar ik kan uitdragen. 
 
Het lab interne, HET lab interne. De groep is in de laatste jaren gegroeid van het labje in de 
kelder, naar een lab dat niet meer op twee etages past. Onderzoekers zijn gekomen en weer 
gegaan. Allereerst wil ik Trees en Liesbeth bedanken voor het bijbrengen van mijn 
pipetteervaardigheid. Er is niemand in de wereld die zo goed PBMCs kan stimuleren als jullie 
en ik mocht dat van jullie leren (en heb het inmiddels al vele andere ook geleerd). Daarnaast 
heb ik altijd uitgekeken naar ons koffiedrinken om bij te praten over werkelijk alles 
(Monsters of Folk is inderdaad geweldig!). Natuurlijk wil ik ook Johanna, Ineke, Anneke, 
Helga, Heidi en Magda bedanken, zonder jullie hulp was het nooit gelukt. Geen lab zonder 
AIO’s, AGIKO’s en andere klojo’s. Jeroen, Chantal, Anna, Alieke, Tom, Evelien, Matthew en 
Theo bedankt voor alle zin en onzin die ik de afgelopen jaren met jullie heb mogen delen. In 
het bijzonder wil ik Quirijn en Frank bedanken, sinds COIG infectieziekten kruisen onze 
paden. Als geen ander weet ik hoe belangrijk ‘cross-talk’ is en kan leiden tot synergie. De lat 
Dankwoord 
252 
 
ligt torenhoog, met minder geen genoegen. Beste Calin, Ik bewonder je enorme daadkracht 
en doorzettingsvermogen. Ik mocht jouw paranimf zijn en vond die dag echt geweldig, ik ben 
je dankbaar voor je vertrouwen in mij en je betrokkenheid. Ook wil ik Bart(je) op deze plek 
bedanken. Ik heb nu de gelegenheid om nogmaals te zeggen dat ik enorm trots op jou ben. 
De laatste jaren heb ik vaak moeten uitleggen dat niet ik de auteur was, maar jij. Sinds je je 
op een wetenschappelijke manier met evolutie bezighoudt, ben je gegroeid tot een top-
wetenschapper en lijken alle puzzelstukjes (ook van je leven) een plek te hebben gekregen. 
Dit is nog maar het begin! Ze zullen vaker van ons horen. Dan wil ik nog Leo bedanken, het 
hoofd van dit geweldige lab. Wij hebben de laatste twee jaar intensiever samengewerkt. Je 
hebt het focus van het lab verruimd van innate naar adaptieve, van academisch naar 
toegepast (commercieel) en van infectie naar auto-immuun (en auto-inflammatoir). Ik hoop 
dat ik in de toekomst bij je binnen mag blijven lopen voor de ins and outs van het 
wetenschappelijk bedrijf. 
 
Beste Gosse, dank voor de mogelijkheid om in de keuken van de moleculaire biologie te 
kijken. Je hebt me alle vrijheid gegeven om te zoeken naar mijn eigen vraagstelling. Ook was 
je altijd oprecht blij als ik met een ‘Amsterdams’ accent bij je binnen kwam stuiteren omdat 
ik mijn enthousiasme weer eens niet in de hand had. Je hebt me ooit gezegd dat ik die 
onbevangenheid moest vasthouden en daar heb ik me altijd aan gehouden. Het stuk over 
chaos komt er ooit, dat beloof ik je bij deze. Twee mensen van het TIL wil ik in het bijzonder 
bedanken: Friederike en Matthijs. Zoals jullie zien is het proefschrift in gelijke mate aan 
dectin-1 en Nod2 opgedragen. Heel erg bedankt voor de hulp en discussies op het TIL, ik zal 
jullie op afstand blijven volgen. 
 
Dear Simon Gordon, I like to thank you for the opportunity to work in your lab at the Sir 
William Dunn School of Pathology in Oxford. It has been one of the most inspirational 
periods of my life and has helped me to appreciate science as a meaningful fulfillment of a 
medical career. I also like to thank all the people of your lab for their friendship and a 
wonderful time in Oxford. Of course I would specially like to thank you, Sigrid for your help 
and hope that you enjoy your move to Amsterdam. We’ll stay in touch. 
 
Beste Martijn, Michel, Hans en Klaas (de mannen), ik heb het gevoel dat ik ook jullie moet 
bedanken voor de bijdragen aan het tot stand komen van dit boekje. Onze vriendschap is 
bestand geweest tegen vele aardse zaken, hoewel ik me realiseer dat ook vriendschap 
onderhouden moet worden. Ons laatste weekend heeft weer tot vele inzichten geleid en ik 
kijk uit naar het volgende.  
 
Jongens waren we, maar aardige jongens. David, het is wat de tijd kan doen met twee 
mensen, maar het is nooit weg geweest. Mijn geneeskunde studie had ik geen half jaar 
volgehouden zonder jou en zie waartoe het geleid heeft! Onze paden zullen elkaar in de 
toekomst nog kruisen. Erno, wij hebben regelmatig contact met elkaar (voor de zeven 
heuvelenloop) en hebben veel gemeen. Reflecteren heb jij aan mij geleerd en ik kijk uit naar 
Dankwoord 
253 
 
onze volgende ontmoeting. Verder wil ik Floris en Bart bedanken voor alle mooie 
herinneringen aan mijn studietijd. 
 
Natuurlijk wil ik ook mijn supervisoren en opleiders bedanken voor mijn opleiding interne 
geneeskunde. Het heeft lang geduurd voordat ik wist dat ik internist wilde worden. 
Doorslaggevend is de motivatie van Kees Brinkman geweest. Beste Kees, door jou ben ik in 
Nijmegen terecht gekomen, nogmaals bedankt voor je geweldige aanbevelingsbrief. Je hebt 
mij daarin met Reinout van Crevel vergeleken, wat voldoende was voor een aanstelling. Je 
had gelijk, ik pas in Nijmegen en ben hier op mijn plek terecht gekomen. Beste Reinout, jij 
ook bedankt, ook al bleek ik niet veel op je te lijken, je bent een voorbeeld voor mij als arts 
en een baken voor mijn Amsterdamse hart. Beste Dirk, ik realiseer me dat ons contact de 
afgelopen jaren bepalend is geweest voor mijn onderzoek en carrière, ik hoop dat onze 
samenwerking zijn vruchten ook in de toekomst zal afwerpen.  
 
Lieve papa en mama, de basis van mijn leven ligt bij jullie. Dankzij jullie liefde, vertrouwen, 
warmte en gezelligheid thuis ben ik de optimist geworden die ik nu ben. Woorden voor mijn 
dankbaarheid zouden tekort schieten. Ik hou van jullie. 
Lieve Judith en Lourens, ik noem jullie in een adem, want jullie zijn voor mij een enorm 
voorbeeld hoe het zou kunnen. Misschien werken jullie wel wat te hard, maar nergens is het 
zo relaxed als bij jullie thuis. Judith, ik ben blij dat wij elkaar de laatste jaren (sinds Oxford) 
steeds meer zien. Lieve Jelle en Sarah, jullie zijn veel te ver weg en ik heb jullie gemist. Toch 
ben jij, Jelle, heel belangrijk in mijn leven. Je bent mijn grootste vriend en mijn steun en 
toeverlaat (op afstand), er is niets dat ik niet met jou zou bespreken. Ik ben blij dat je 
binnenkort je ook aan de wetenschap gaat laven en kan niet wachten op nieuwe discussies. 
Lieve Bart en Clara, jullie zijn een geweldig stel! Ik heb me om minder medisch en meer 
biologisch georiënteerd te zijn geabonneerd op Bionieuws. 
 
Lieve Jan en Mieke, dank jullie wel voor de steun in de afgelopen jaren. Soms heel praktisch 
(oppassen, vakantie in Italië), maar ook jullie vertrouwen in mijn keuzes is belangrijk voor mij 
geweest. Lieve Walter en Lies, het leven is ook rock-’n-roll, dank jullie wel voor het vleugje 
wild in mijn leven.  
 
Lieve, lieve, lieve Roos, bedankt! We hebben het maar druk gehad de laatste jaren met ons 
gezinnetje en het werk. Dan moest ik ook nog zonodig promoveren en kies ik voor ‘de 
wetenschap’. Het zal niet altijd even gemakkelijk voor je geweest zijn, toch heb ik me altijd 
door jou gesteund gevoeld. Het zit em in de kleine dingen. Zonder jou was er niets van 
terecht gekomen. Straks gaan we weer lekker opladen, veel wandelen, weg met ons 
campertje, misschien wel skiën, we hebben nog een heel leven voor ons! Ik hou van je. 
 
Lieve Pien, Lode en Saar, door jullie is alles de moeite waard! Dikke kus. 
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